{"version": "v1.0", "data": [{"id": "3708949_1_0", "context": "After therapy with parenteral amiodarone (2300 mg in 3 days) and other measures, signs of congestive heart failure disappeared; subsequently the patient developed jaundice, marked increase in serum transaminase levels and fall in prothrombin time, and histologic changes of severe centrilobular necrosis were observed in hepatic biopsy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] After [Treatment] parenteral amiodarone (2300 mg in 3 days) and other measures [Effect] jaundice, marked increase in serum transaminase levels and fall in prothrombin time, and histologic changes of severe centrilobular necrosis were observed in hepatic biopsy"}, {"id": "8467620_3_1", "context": "We report one case of non-Hodgkin lymphoma in a patient, with a 30-year history of rheumatoid arthritis, taking low dose methotrexate weekly over a 10-month period.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] taking [Subject] a patient, with a 30-year history of rheumatoid arthritis [Treatment] low dose methotrexate weekly over a 10-month period [Effect] non-Hodgkin lymphoma"}, {"id": "1422497_6_2", "context": "We recommend the cautious use of alum irrigation in patients with renal impairment and monitoring of serum aluminum levels to prevent excessive accumulation and toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Subject] patients [Treatment] alum irrigation [Effect] excessive accumulation and toxicity."}, {"id": "10082597_3_3", "context": "RESULTS: A 44-year-old man taking naproxen for chronic low back pain and a 20-year-old woman on oxaprozin for rheumatoid arthritis presented with tense bullae and cutaneous fragility on the face and the back of the hands.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] a 20-year-old woman [Treatment] oxaprozin [Effect] tense bullae and cutaneous fragility on the face and the back of the hands [Adverse event] presented [Subject] A 44-year-old man [Treatment] naproxen [Effect] tense bullae and cutaneous fragility on the face and the back of the hands"}, {"id": "16018164_1_4", "context": "CASE REPORT: We report a case of intracerebral hemorrhage occurring in a middle-aged man who suffered from chronic sinusitis and had been ingesting pseudoephedrine daily for one year.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurring [Subject] middle-aged man who suffered from chronic sinusitis [Treatment] ingesting pseudoephedrine daily for one year [Effect] intracerebral hemorrhage"}, {"id": "8467620_1_5", "context": "Lymphoma developing in a patient with rheumatoid arthritis taking methotrexate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developing [Subject] a patient with rheumatoid arthritis [Treatment] methotrexate [Effect] Lymphoma"}, {"id": "14742791_4_6", "context": "The Naranjo probability scale suggests a highly probable relationship between AIN and pantoprazole therapy in this patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] relationship [Subject] patient [Treatment] pantoprazole [Effect] AIN"}, {"id": "8442800_11_7", "context": "In one case, disulfiram was the only potential teratogen exposed to the fetus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] exposed [Subject] fetus [Treatment] disulfiram [Effect] teratogen"}, {"id": "15368548_4_8", "context": "Pancreatitis has been noted to be a complication in 2-16% of patients undergoing treatment with L-asparaginase for a variety of pediatric neoplasms.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Subject] in 2-16% of patients [Treatment] L-asparaginase for a variety of pediatric neoplasms [Effect] Pancreatitis"}, {"id": "21630612_2_9", "context": "Myopathy, including rhabdomyolysis, is a well-known, albeit rare complication of statin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] statin [Effect] Myopathy, including rhabdomyolysis"}, {"id": "18855892_1_10", "context": "Management and successful desensitization in methotrexate-induced anaphylaxis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] methotrexate [Effect] anaphylaxis"}, {"id": "12166705_1_11", "context": "Mitomycin-C induced hemolytic uremic syndrome: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Mitomycin-C [Effect] hemolytic uremic syndrome"}, {"id": "15588385_1_12", "context": "Acute hepatic failure is a rare and potentially lethal complication of propylthiouracil (PTU) use for hyperthyroidism.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] propylthiouracil (PTU) [Effect] Acute hepatic failure"}, {"id": "748238_1_13", "context": "Monoclonal gammopathy and subsequent multiple myeloma in a patient on chronic diphenylhydantoin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] on [Subject] a patient [Treatment] chronic diphenylhydantoin therapy. [Effect] Monoclonal gammopathy and subsequent multiple myeloma"}, {"id": "3359700_3_14", "context": "Unexpected severe reversible cyclosporine A-induced nephrotoxicity in a patient with systemic lupus erythematosus and tubulointerstitial renal disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient with systemic lupus erythematosus and tubulointerstitial renal disease [Treatment] cyclosporine A [Effect] nephrotoxicity"}, {"id": "9352164_2_15", "context": "As far as we know, this is the first case report of acute hemorrhagic gastritis associated with AZ intoxication.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] AZ [Effect] acute hemorrhagic gastritis; AZ intoxication"}, {"id": "3693034_1_16", "context": "Toxic epidermal necrolysis resulted after 19 days of treatment with 5-fluorocytosine and amphotericin B.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] 19 days of treatment with 5-fluorocytosine and amphotericin B [Effect] Toxic epidermal necrolysis"}, {"id": "16018164_4_17", "context": "Since 1979, over 30 published case reports have documented the relationship between phenylpropanolamine and stroke.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] relationship [Treatment] phenylpropanolamine [Effect] stroke"}, {"id": "18523232_1_18", "context": "CASE SUMMARY: A 61-year-old woman with no apparent risk factors for liver injury developed acute hepatitis one week after the final dose of a long-term course of pulse itraconazole therapy (200 mg orally twice daily, 1 wk on, 3 wk off, for 24 wk) for onychomycosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 61-year-old woman with no apparent risk factors for liver injury [Treatment] long-term course of pulse itraconazole therapy (200 mg orally twice daily, 1 wk on, 3 wk off, for 24 wk) [Effect] acute hepatitis"}, {"id": "9352164_4_19", "context": "We experienced a case of chronic renal failure in a patient suffering from acute hemorrhagic gastritis associated with AZ intoxication.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated with [Subject] a case of chronic renal failure in a patient [Treatment] AZ [Effect] acute hemorrhagic gastritis"}, {"id": "16192734_1_20", "context": "Rhabdomyolysis caused by tocolysis with oral ritodrine hydrochloride in a pregnant patient with myotonic dystrophy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Subject] a pregnant patient with myotonic dystrophy [Treatment] tocolysis with oral ritodrine hydrochloride [Effect] Rhabdomyolysis"}, {"id": "536470_2_21", "context": "While sulindac failed to affect significantly warfarin-induced hypoprothrombinemia in normal male volunteers, it markedly prolonged prothrombin time in a patient with a renal tubular defect who had been anticoagulated with warfarin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] a patient with a renal tubular defect [Treatment] sulindac; had been anticoagulated with warfarin [Effect] markedly prolonged prothrombin time [Adverse event] induced [Treatment] warfarin [Effect] hypoprothrombinemia [Adverse event] affect [Subject] normal male volunteers [Treatment] sulindac [Effect] affect significantly warfarin-induced hypoprothrombinemia"}, {"id": "8912599_7_22", "context": "Painful erosion of psoriatic plaques is a less common sign of methotrexate toxicity that may precede evidence of bone marrow suppression.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] sign [Treatment] methotrexate [Effect] Painful erosion of psoriatic plaques; methotrexate toxicity; bone marrow suppression"}, {"id": "16728538_2_23", "context": "Drug-induced hepatitis in an acromegalic patient during combined treatment with pegvisomant and octreotide long-acting repeatable attributed to the use of pegvisomant.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] an acromegalic patient [Treatment] combined treatment with pegvisomant and octreotide long-acting repeatable [Effect] hepatitis"}, {"id": "7978578_2_24", "context": "We report the first case of a patient in a promethazine-induced coma responding to treatment with flumazenil.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] responding to [Subject] a patient in a promethazine-induced coma [Treatment] treatment with flumazenil"}, {"id": "18425523_3_25", "context": "Ocular hypertension occurred 1 month after the second ranibizumab injection in patients 1 and 3, and 1 month after the first ranibizumab in patient 2.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Subject] patients 1 and 3; in patient 2 [Treatment] 1 month after the second ranibizumab injection [Effect] Ocular hypertension"}, {"id": "12022905_5_26", "context": "Priapism associated with zuclopenthixol.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] zuclopenthixol [Effect] Priapism"}, {"id": "12488741_3_27", "context": "Reversible MR imaging and MR spectroscopy abnormalities in association with metronidazole therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association [Treatment] metronidazole therapy [Effect] Reversible MR imaging and MR spectroscopy abnormalities"}, {"id": "15857283_3_28", "context": "PURPOSE: The aim of this study was to report on the possible development of corneal endothelial deposits resulting from the use of rifabutin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulting [Treatment] rifabutin [Effect] corneal endothelial deposits"}, {"id": "19318596_3_29", "context": "OBJECTIVE: To report a case of calcineurin-induced pain syndrome (CIPS) in a child undergoing his second hematopoietic stem cell transplant (HSCT).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a child undergoing his second hematopoietic stem cell transplant (HSCT) [Treatment] calcineurin [Effect] pain syndrome (CIPS)"}, {"id": "14684937_4_30", "context": "We experienced a male patient with psoriasis and hypertension whose conditions were treated with tacalcitol ointment and thiazide, respectively, resulting in hypercalciuria and hypercalcemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulting [Subject] a male patient with psoriasis and hypertension [Treatment] tacalcitol ointment and thiazide [Effect] hypercalciuria and hypercalcemia"}, {"id": "16341621_3_31", "context": "To our knowledge, this is the first granulomatous reaction described after calcium hydroxylapatite injection.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] calcium hydroxylapatite injection [Effect] granulomatous reaction"}, {"id": "15595320_3_32", "context": "Previous studies have demonstrated the interaction of MTX and a variety of non-steroidal, anti-inflammatory drugs (NSAIDs) with various clinical manifestations including acute renal failure, pancytopenia, vomiting, diarrhea, elevated liver transaminases, jaundice, mucosal ulcerations, and pyrexia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] manifestations [Treatment] MTX and a variety of non-steroidal, anti-inflammatory drugs (NSAIDs) [Effect] acute renal failure, pancytopenia, vomiting, diarrhea, elevated liver transaminases, jaundice, mucosal ulcerations, and pyrexia"}, {"id": "3868420_1_33", "context": "We present a case report of a patient with alveolar hydatid disease, whose treatment with mebendazole was brief due to side effects of alopecia and granulocytopenia; and review the features of this disease which, with increasing international migration, may be encountered more frequently in Australia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Subject] a patient with alveolar hydatid disease [Treatment] mebendazole [Effect] alopecia and granulocytopenia"}, {"id": "3174043_1_34", "context": "Niacin causes a reversible toxic cystoid maculopathy that occurs in approximately 0.67% of patients taking high doses of the drug.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] causes [Subject] approximately 0.67% of patients [Treatment] Niacin; high doses [Effect] reversible toxic cystoid maculopathy"}, {"id": "6854698_1_35", "context": "When tuberculosis patients on isoniazid eat certain varieties of fish they may develop a histamine reaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] develop [Subject] tuberculosis patients [Treatment] isoniazid [Effect] histamine reaction"}, {"id": "12022905_2_36", "context": "CONCLUSIONS: Priapism is an uncommon but potentially serious adverse effect of zuclopenthixol that practitioners, as with many other antipsychotics, should be aware of.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] serious adverse effect [Treatment] zuclopenthixol [Effect] Priapism"}, {"id": "14766993_2_37", "context": "To report a case of possible interaction of smokeless tobacco with warfarin in a patient treated after several thromboembolic events.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Treatment] warfarin [Effect] possible interaction of smokeless tobacco with warfarin"}, {"id": "17167851_1_38", "context": "Hepatotoxicity induced by cyproterone acetate: a report of three cases.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced by [Treatment] cyproterone acetate [Effect] Hepatotoxicity"}, {"id": "14561622_1_39", "context": "Neurotoxicity of intrathecal methotrexate: MR imaging findings.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] intrathecal methotrexate [Effect] Neurotoxicity"}, {"id": "11804071_2_40", "context": "Isonicotinic acid hydrazide induced anagen effluvium and associated lichenoid eruption.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Isonicotinic acid hydrazide [Effect] anagen effluvium and associated lichenoid eruption"}, {"id": "18523232_5_41", "context": "Only one case of severe symptomatic hepatitis occurring after pulse therapy with itraconazole for onychomycosis and requiring transplantation has been reported previously.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurring [Subject] one case [Treatment] pulse therapy with itraconazole [Effect] severe symptomatic hepatitis"}, {"id": "4066620_3_42", "context": "The elicitation of a movement disorder by trazodone: case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] by [Treatment] trazodone [Effect] movement disorder"}, {"id": "6572542_2_43", "context": "Pulmonary fibrosis subsequent to high doses of CCNU for chronic myeloid leukemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] subsequent [Treatment] high doses of CCNU [Effect] Pulmonary fibrosis"}, {"id": "9007910_2_44", "context": "PURPOSE/OBJECTIVES: To describe the pharmacogenetic syndrome of dihydropyrimidine dehydrogenase (DPD) deficiency, which predisposes patients with cancer to potentially lethal adverse reactions following 5-fluorouracil (5-FU)-based chemotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] predisposes [Subject] dihydropyrimidine dehydrogenase (DPD) deficiency [Treatment] 5-fluorouracil (5-FU)-based chemotherapy [Effect] lethal adverse reactions"}, {"id": "6697887_3_45", "context": "We report a case of sustained hypotension after administration of parenteral verapamil.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] administration of parenteral verapamil [Effect] sustained hypotension"}, {"id": "10212021_4_46", "context": "Methadone has two roles in human immunodeficiency viral infection: pain management and treatment of opioid abuse.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] has two roles [Treatment] Methadone [Effect] pain management and treatment of opioid abuse"}, {"id": "21515865_9_47", "context": "Each time he arrived at the anticoagulation clinic after his BCG therapy, his INR was supratherapeutic, except after his fourth treatment (INR of 2.5), which can be explained by residual effects from the phytonadione he received a week earlier.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] residual effects [Treatment] BCG; phytonadione [Effect] INR was supratherapeutic"}, {"id": "22677303_3_48", "context": "A 70-year-old man had been treated with warfarin for atrial fibrillation.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Subject] A 70-year-old man [Treatment] warfarin"}, {"id": "1703754_1_49", "context": "This is a case report of fatal cryptococcal meningitis in a child with systemic lupus erythematosus being treated with prednisolone and azathioprine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] a child with systemic lupus erythematosus [Treatment] prednisolone and azathioprine [Effect] fatal cryptococcal meningitis"}, {"id": "9352164_1_50", "context": "Acute hemorrhagic gastritis associated with acetazolamide intoxication in a patient with chronic renal failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] a patient with chronic renal failure [Treatment] acetazolamide [Effect] Acute hemorrhagic gastritis"}, {"id": "4066620_2_51", "context": "Although the movement disorder could not with certainty be attributed to trazodone alone, the drug at least acted as an eliciting agent.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] attributed [Treatment] trazodone [Effect] movement disorder"}, {"id": "18523232_2_52", "context": "CONCLUSIONS: Prolonged exposure to itraconazole, administered either continuously or intermittently, may precipitate severe and irreversible hepatotoxic events.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] precipitate [Treatment] Prolonged exposure to itraconazole, administered either continuously or intermittently [Effect] severe and irreversible hepatotoxic events"}, {"id": "507889_1_53", "context": "In two patients with mycosis fungoides, a squamous cell carcinoma developed during therapy with psoralens plus long-wave ultraviolet radiation (PUVA).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] two patients with mycosis fungoides [Treatment] psoralens plus long-wave ultraviolet radiation (PUVA) [Effect] squamous cell carcinoma"}, {"id": "15663666_1_54", "context": "Scrotal ulceration induced by all-trans retinoic acid in a patient with acute promyelocytic leukemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient with acute promyelocytic leukemia. [Treatment] all-trans retinoic acid [Effect] Scrotal ulceration"}, {"id": "6693840_1_55", "context": "A 61 year-old male patient developed gynecomastia after starting theophylline.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 61 year-old male patient [Treatment] theophylline [Effect] gynecomastia"}, {"id": "2483959_3_56", "context": "Several possible explanations of the mechanism of renal failure associated with the use of dextran-40 are discussed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] dextran-40 [Effect] renal failure"}, {"id": "20349794_2_57", "context": "We present a case of the syndrome of inappropriate antidiuretic hormone (SIADH) secondary to cisplatin therapy in a patient with advanced-stage large cell neuroendocrine carcinoma of the cervix.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Subject] a patient with advanced-stage large cell neuroendocrine carcinoma of the cervix [Treatment] cisplatin therapy [Effect] syndrome of inappropriate antidiuretic hormone (SIADH)"}, {"id": "18675768_5_58", "context": "An 80-year-old white female, followed up at the Memory Clinic for mild cognitive impairment, had been taking propafenone 900 mg/d for >10 years for paroxysmal atrial fibrillation without adverse effects.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] for [Subject] An 80-year-old white female [Treatment] propafenone 900 mg/d for >10 years"}, {"id": "20925534_12_59", "context": "A total of 109 patients had a cardiovascular event, with event rates of 4.9% with omeprazole and 5.7% with placebo (hazard ratio with omeprazole, 0.99; 95% CI, 0.68 to 1.44; P = 0.96); high-risk subgroups did not show significant heterogeneity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] had [Subject] 109 patients [Treatment] 4.9% with omeprazole and 5.7% with placebo [Effect] cardiovascular event"}, {"id": "6731466_10_60", "context": "The mechanism of anaphylactoid reaction to zomepirac in this case, therefore, remains unclear.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reaction [Treatment] zomepirac [Effect] anaphylactoid"}, {"id": "18203308_1_61", "context": "New onset of CD may be considered as an immune-mediated injury induced by etanercept.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] etanercept [Effect] CD; immune-mediated injury"}, {"id": "11109149_2_62", "context": "This supports the well-reported potential of bleomycin to trigger acral vascular toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] trigger [Treatment] bleomycin [Effect] acral vascular toxicity"}, {"id": "24918555_1_63", "context": "Results of a Phase III, double-blind, randomized, parallel-group, non-inferiority study evaluating the safety and efficacy of isotretinoin-Lidose in patients with severe recalcitrant nodular acne.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] of [Subject] patients with severe recalcitrant nodular acne [Treatment] isotretinoin-Lidose [Effect] evaluating the safety and efficacy"}, {"id": "16490518_4_64", "context": "This treatment has the potential to cause severe vision loss as a result of intractable corticosteroid-induced glaucoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] corticosteroid [Effect] severe vision loss; glaucoma"}, {"id": "3708949_4_65", "context": "Therefore, parenteral amiodarone was implicated as the cause of acute hepatitis in this patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Subject] this patient [Treatment] parenteral amiodarone [Effect] acute hepatitis"}, {"id": "11485141_5_66", "context": "Twenty-four hours after the administration of gemcitabine, a symmetric, bullous, herpetiform eruption appeared on his trunk and upper limbs.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] administration of gemcitabine [Effect] a symmetric, bullous, herpetiform eruption appeared on his trunk and upper limbs"}, {"id": "20925534_11_67", "context": "The rate of overt upper gastrointestinal bleeding was also reduced with omeprazole as compared with placebo (hazard ratio, 0.13; 95% CI, 0.03 to 0.56; P = 0.001).", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] reduced [Treatment] omeprazole"}, {"id": "8145359_2_68", "context": "The association of phenothiazine overdose and respiratory distress syndrome merits consideration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association [Treatment] phenothiazine overdose [Effect] respiratory distress syndrome"}, {"id": "6340463_4_69", "context": "Patients from endemic areas referred to transplant centers may be at high risk for disseminated histoplasmosis when treated with long-term prednisone for graft-versus-host disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Subject] Patients [Treatment] long-term prednisone [Effect] disseminated histoplasmosis"}, {"id": "12477460_1_70", "context": "Atypical endometriosis may act as a precancerous lesion in the process of tamoxifen-induced malignant transformation of endometriosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] tamoxifen [Effect] malignant transformation of endometriosis"}, {"id": "9562211_1_71", "context": "A 28 year old white schizophrenic male has been under risperidone monotherapy for about one year when he developed dyskinetic movements.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 28 year old white schizophrenic male [Treatment] risperidone monotherapy [Effect] dyskinetic movements"}, {"id": "22047557_8_72", "context": "Subjects receiving ivacaftor were 55% less likely to have a pulmonary exacerbation than were patients receiving placebo, through week 48 (P<0.001).", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] receiving [Treatment] ivacaftor [Potential therapeutic event] receiving [Treatment] placebo"}, {"id": "10759907_2_73", "context": "Spinal cord infarction during use of zolmitriptan: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] use of zolmitriptan [Effect] Spinal cord infarction"}, {"id": "12854039_3_74", "context": "Case 2, a 29-year-old woman, developed bilateral optic neuritis combined with numbness of the lower extremities as well as bowel and bladder dysfunction after a 22-month use of recombinant interferon alpha-2b for chronic myelogenous leukemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a 29-year-old woman [Treatment] 22-month use of recombinant interferon alpha-2b [Effect] bilateral optic neuritis combined with numbness of the lower extremities as well as bowel and bladder dysfunction"}, {"id": "6794018_3_75", "context": "These features have not previously been reported as side effects of glibenclamide therapy, but intrahepatic cholestasis may occur with chlorpropamide, a similar sulphonylurea agent.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occur [Treatment] chlorpropamide [Effect] intrahepatic cholestasis"}, {"id": "9562211_2_76", "context": "Risperidone-induced tardive dyskinesia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Risperidone [Effect] tardive dyskinesia"}, {"id": "9737132_2_77", "context": "Caution in longterm usage and early recognition of pentazocine toxicity as a neuromuscular complication are important in order to prevent irreversible drug-induced fibrous myopathy and localized neuropathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] pentazocine [Effect] toxicity"}, {"id": "3359700_2_78", "context": "Based upon the observed fall of the filtration fraction, the rise in the relative clearance of 99Tc-dimercaptosuccinic acid and the increase in proteinuria, we suggest that in this case the tubules and/or interstitium are the main targets for cyclosporine A nephrotoxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] observed [Treatment] cyclosporine A [Effect] fall of the filtration fraction, the rise in the relative clearance of 99Tc-dimercaptosuccinic acid and the increase in proteinuria"}, {"id": "3174043_2_79", "context": "Niacin maculopathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] maculopathy [Treatment] Niacin [Effect] maculopathy"}, {"id": "22293514_5_80", "context": "We report a case in which a potential drug interaction between clobazam and etravirine may have led to increased concentrations of clobazam and its pharmacologically active metabolite, N-desmethylclobazam, causing neurotoxic symptoms.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] led [Treatment] interaction between clobazam and etravirine [Effect] increased concentrations of clobazam and its pharmacologically active metabolite, N-desmethylclobazam; neurotoxic symptoms"}, {"id": "11202801_1_81", "context": "A review of the literature revealed two other cases of hepatic angiosarcoma in patients after long-term cyclophosphamide treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] patients [Treatment] long-term cyclophosphamide treatment [Effect] hepatic angiosarcoma"}, {"id": "18076602_3_82", "context": "We present a case of cutaneous leucocytoclastic vasculitis in which amphotericin B might presumably be the aetiological factor.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] be [Subject] a case [Treatment] amphotericin B [Effect] cutaneous leucocytoclastic vasculitis"}, {"id": "18364401_5_83", "context": "There have been numerous case reports of hyperglycemia with olanzapine in the literature, but none reported hyperglycemia within days of initiation of the medication.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] olanzapine [Effect] hyperglycemia"}, {"id": "23970584_2_84", "context": "This case report describes two severe antiretroviral drug adverse reactions that occurred in the same patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Subject] same patient [Treatment] antiretroviral drug [Effect] adverse reactions"}, {"id": "16101941_2_85", "context": "We report the first case presenting with successive anaphylactic reaction and extra-pyramidal syndrome after treatment with thiethylperazine maleate (thiethylperazine).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] treatment with thiethylperazine maleate (thiethylperazine) [Effect] successive anaphylactic reaction and extra-pyramidal syndrome"}, {"id": "2483959_2_86", "context": "Renal failure associated with the use of dextran-40.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] dextran-40 [Effect] Renal failure"}, {"id": "11510798_1_87", "context": "Acute lung injury associated with 5-fluorouracil and oxaliplatinum combined chemotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] 5-fluorouracil and oxaliplatinum combined chemotherapy [Effect] Acute lung injury"}, {"id": "11155197_3_88", "context": "Type II heparin-induced thrombocytopenia (HIT) is an immunological disorder characterized by antibodies to heparin-platelet factor 4 complexes and a high risk of thrombotic complications.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Type II heparin [Effect] thrombocytopenia"}, {"id": "7485371_3_89", "context": "RESULTS: Similar to previous findings of drug-induced vortex keratopathy, atovaquone vortex keratopathy is presumably caused by its lipophilic properties.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] atovaquone; its lipophilic properties [Effect] vortex keratopathy"}, {"id": "11109149_1_90", "context": "Gangrene of the fingertips after bleomycin and methotrexate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] bleomycin and methotrexate [Effect] Gangrene of the fingertips"}, {"id": "8404753_9_91", "context": "These cases demonstrate that CBZ can induce simple motor tics in children.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induce [Subject] children [Treatment] CBZ [Effect] simple motor tics"}, {"id": "3964363_2_92", "context": "Esophageal spasm following propranolol overdose relieved by glucagon.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] propranolol overdose [Effect] Esophageal spasm"}, {"id": "9352164_3_93", "context": "She was thus diagnosed as having AZ intoxication.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] having [Subject] She [Treatment] AZ [Effect] AZ intoxication"}, {"id": "10592946_3_94", "context": "Severe rhabdomyolysis following massive ingestion of oolong tea: caffeine intoxication with coexisting hyponatremia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] massive ingestion of oolong tea [Effect] caffeine intoxication with coexisting hyponatremia"}, {"id": "15663666_2_95", "context": "The ulcer did not respond to antibiotic treatment and healed shortly after withholding ATRA.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] respond [Treatment] antibiotic treatment [Potential therapeutic event] healed [Treatment] withholding ATRA"}, {"id": "9726762_1_96", "context": "Gemfibrozil-warfarin drug interaction resulting in profound hypoprothrombinemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulting [Treatment] Gemfibrozil-warfarin drug interaction [Effect] profound hypoprothrombinemia"}, {"id": "17665812_2_97", "context": "Drug-induced eosinophilia is a non-dose-dependent side effect of clozapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] clozapine [Effect] eosinophilia"}, {"id": "7485371_4_98", "context": "Vortex keratopathy associated with atovaquone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated with [Treatment] atovaquone [Effect] Vortex keratopathy"}, {"id": "18037876_1_99", "context": "DIAGNOSIS: Sustained ventricular tachycardia possibly owing to thalidomide treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] owing to [Treatment] thalidomide [Effect] Sustained ventricular tachycardia"}, {"id": "910864_1_100", "context": "In one instance a systemic hypoglycemic reaction resulting in head trauma and confusion ended in an emegency hospital admission following the substitution of acetohexamide for acetazolamide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] acetohexamide [Effect] systemic hypoglycemic reaction resulting in head trauma and confusion"}, {"id": "17182354_1_101", "context": "However, an association of Ritalin with glaucoma has been reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association [Treatment] Ritalin [Effect] glaucoma"}, {"id": "12854039_1_102", "context": "After a two-month interruption of interferon administration, natural interferon alpha was given but followed by another episode of the same neurological manifestations.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] followed by [Treatment] interferon alpha [Effect] neurological manifestations"}, {"id": "25842648_7_103", "context": "This article discusses the clinical manifestations of the serotonin syndrome and highlights reported cases of serotonin syndrome specifically related to an interaction between SSRIs and fentanyl, a commonly used opioid in anesthesia practice.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] cases [Treatment] SSRIs and fentanyl [Effect] serotonin syndrome"}, {"id": "2483959_4_104", "context": "While the mechanism of dextran-associated renal failure remains unsolved, plasma exchange seems to be effective therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] dextran [Effect] renal failure [Potential therapeutic event] effective [Treatment] plasma exchange"}, {"id": "9865241_4_105", "context": "The use of pamidronate for hypercalcemia secondary to acute vitamin D intoxication.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] for [Treatment] pamidronate [Adverse event] secondary [Treatment] vitamin D [Effect] hypercalcemia"}, {"id": "14614357_1_106", "context": "Early overanticoagulation with acenocoumarol due to a genetic polymorphism of cytochrome P450 CYP2C9.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] acenocoumarol [Effect] Early overanticoagulation"}, {"id": "8589490_3_107", "context": "We report an unusual pattern of supravenous hyperpigmentation occurring after CHOP chemotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] CHOP [Effect] supravenous hyperpigmentation"}, {"id": "12488741_2_108", "context": "Proton MRS examination demonstrated a persistent lactate elevation during metronidazole treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] metronidazole [Effect] persistent lactate elevation"}, {"id": "1422497_1_109", "context": "Encephalopathy and seizures induced by intravesical alum irrigations.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] intravesical alum irrigations [Effect] Encephalopathy and seizures"}, {"id": "15522120_17_110", "context": "Dermal side reactions to SSRI-drugs in these patients may be due to high activity in the serotonergic system at the dermal and epidermo-dermal junctional area rather than a hypersensitivity to the drug molecule itself.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Subject] these patients [Treatment] SSRI-drugs [Effect] Dermal side reactions"}, {"id": "12659609_3_111", "context": "CASE SUMMARY: A febrile 36-year-old seaman from Mumbai (Bombay) was prescribed >5 times the usual dose of chloroquine for malaria diagnosed empirically onboard ship.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] prescribed [Subject] A febrile 36-year-old seaman from Mumbai (Bombay) [Treatment] >5 times the usual dose of chloroquine"}, {"id": "19266307_2_112", "context": "MATERIALS AND METHODS: We present two cases of significant morbidity related to primary and secondary perforation of the bladder following two instillations of epirubicin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] two cases [Treatment] two instillations of epirubicin [Effect] significant morbidity related to primary and secondary perforation of the bladder"}, {"id": "18628507_2_113", "context": "Angio-oedema as an unusual tolerable side effect of voriconazole therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] as [Treatment] voriconazole [Effect] Angio-oedema"}, {"id": "18262450_8_114", "context": "Oxycodone-gabapentin reduced pain score by 33% from baseline to end of treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] reduced [Treatment] Oxycodone-gabapentin [Effect] reduced pain score by 33% from baseline"}, {"id": "10435399_2_115", "context": "OBJECTIVE: We report a patient who developed neutropenia on clozapine, but behind the cell count decrease showed to be a diurnal variation of the white blood cells (WBC).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient [Treatment] clozapine [Effect] neutropenia; diurnal variation of the white blood cells (WBC)"}, {"id": "11352235_5_116", "context": "RESULTS: Five of 70 patients who had begun leflunomide therapy had significant weight loss that could not be linked to other identifiable etiologies.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] had [Subject] Five of 70 patients [Treatment] leflunomide [Effect] significant weight loss"}, {"id": "16018164_2_117", "context": "Only one report links phenylpropanolamine consumption to an intracerebral hemorrhage in a patient with an AVM.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] links [Subject] a patient with an AVM [Treatment] phenylpropanolamine [Effect] intracerebral hemorrhage"}, {"id": "16101941_1_118", "context": "Anaphylactic reaction and unrelated, subsequent, known side effects during therapy with thiethylperazine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] thiethylperazine [Effect] Anaphylactic reaction"}, {"id": "8430717_4_119", "context": "PURPOSE: To investigate the concentration-side effect relationship in a patient with severe acyclovir-induced neurotoxicity and to summarize the information available in the literature about central nervous system side effects due to acyclovir.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] acyclovir [Effect] neurotoxicity; central nervous system side effects"}, {"id": "16317298_3_120", "context": "Radiation recall from gemcitabine is rare, but can potentially arise in any site that has been previously irradiated.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] from [Treatment] gemcitabine [Effect] Radiation recall"}, {"id": "15368548_3_121", "context": "Most cases of pancreatitis associated with L-asparaginase toxicity are self-limiting and respond favorably to nasogastric decompression and intravenous hyperalimentation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] Most cases [Treatment] L-asparaginase [Effect] pancreatitis"}, {"id": "23970584_6_122", "context": "Shortly after commencing the drug, the patient developed a severe adverse drug reaction manifesting as Drug Reaction (or Rash) with Eosinophilia and Systemic Symptoms (DRESS) syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] the patient [Treatment] Shortly after commencing the drug [Effect] severe adverse drug reaction manifesting as Drug Reaction (or Rash) with Eosinophilia and Systemic Symptoms (DRESS) syndrome"}, {"id": "9562211_3_123", "context": "This report presents a potential case of risperidone-induced tardive dyskinesia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a potential case [Treatment] risperidone [Effect] tardive dyskinesia"}, {"id": "16288069_4_124", "context": "The patient described feeling cold with worsening headache and chills approximately one hour after infusion of the first dose of penicillin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] The patient [Treatment] one hour after infusion of the first dose of penicillin [Effect] feeling cold with worsening headache and chills"}, {"id": "15927910_4_125", "context": "Early-onset pentamidine-associated second-degree heart block and sinus bradycardia: case report and review of the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] case [Treatment] pentamidine [Effect] Early-onset; second-degree heart block and sinus bradycardia"}, {"id": "15286697_1_126", "context": "Fatal pulmonary fibrosis associated with BCNU: the relative role of platelet-derived growth factor-B, insulin-like growth factor I, transforming growth factor-beta1 and cyclooxygenase-2.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] BCNU [Effect] pulmonary fibrosis"}, {"id": "10492493_1_127", "context": "CONCLUSIONS: This case suggests that losartan can induce late-onset angioedema in patients with normal renal function and that the reaction can recur after initial resolution of the symptoms.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induce [Subject] patients with normal renal function [Treatment] losartan [Effect] late-onset angioedema"}, {"id": "3211830_1_128", "context": "Two cases of widespread cutaneous vasculitis are described in association with diltiazem, a recently introduced calcium antagonist.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association [Treatment] diltiazem, a recently introduced calcium antagonist [Effect] widespread cutaneous vasculitis"}, {"id": "10492493_4_129", "context": "The incidence of angioedema secondary to losartan, an angiotensin II receptor antagonist, is unknown.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Treatment] losartan, an angiotensin II receptor antagonist [Effect] angioedema"}, {"id": "18347524_2_130", "context": "We report the case of a young man, affected by rheumatoid arthritis who developed a rapid-onset short-of-breath, hemoptysis, and severe weakness, about 2 weeks after the administration of leflunomide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a young man [Treatment] about 2 weeks after the administration of leflunomide [Effect] a rapid-onset short-of-breath, hemoptysis, and severe weakness"}, {"id": "12659609_1_131", "context": "Toxicity related to chloroquine treatment of resistant vivax malaria.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] chloroquine [Effect] Toxicity"}, {"id": "8250714_3_132", "context": "Patients with vitamin B12 deficiency are exceedingly sensitive to neurologic deterioration following nitrous oxide anesthesia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] Patients with vitamin B12 deficiency [Treatment] nitrous oxide anesthesia [Effect] neurologic deterioration"}, {"id": "15072497_2_133", "context": "However here we reported two patients, presenting with PD during high dose colchicine treatment for familiar mediterranean fever (FMF).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] two patients, [Treatment] high dose colchicine treatment [Effect] PD"}, {"id": "12786839_3_134", "context": "We report two patients with infectious mononucleosis-like syndrome induced by salazosulfapyridine (SASP).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] two patients [Treatment] salazosulfapyridine (SASP). [Effect] infectious mononucleosis-like syndrome"}, {"id": "1655228_2_135", "context": "Myocardial ischemia associated with high-dose carmustine infusion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] high-dose carmustine infusion [Effect] Myocardial ischemia"}, {"id": "21802143_1_136", "context": "Hepatic drug interaction between tacrolimus and lansoprazole in a bone marrow transplant patient receiving voriconazole and harboring CYP2C19 and CYP3A5 heterozygous mutations.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] between [Subject] a bone marrow transplant patient receiving voriconazole and harboring CYP2C19 and CYP3A5 heterozygous mutations [Treatment] tacrolimus and lansoprazole; voriconazole [Effect] Hepatic drug interaction"}, {"id": "12507063_2_137", "context": "Gabapentin withdrawal presenting as status epilepticus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presenting [Treatment] Gabapentin withdrawal [Effect] status epilepticus"}, {"id": "7056119_1_138", "context": "Atypical ventricular tachycardia (torsade de pointes) induced by amiodarone: arrhythmia previously induced by quinidine and disopyramide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] amiodarone [Effect] Atypical ventricular tachycardia (torsade de pointes)"}, {"id": "17619811_3_139", "context": "Colchicine-induced rhabdomyolysis is a rare complication, and the postulated mechanisms and risk factors for this severe complication are discussed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Colchicine [Effect] rhabdomyolysis"}, {"id": "4075534_2_140", "context": "Spindle coma in benzodiazepine toxicity: case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Treatment] benzodiazepine [Effect] Spindle coma"}, {"id": "2483959_1_141", "context": "A typical case of dextran-40 associated acute renal failure is presented.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] dextran-40 [Effect] acute renal failure"}, {"id": "15895899_1_142", "context": "After the second infliximab infusion, he was found to have a severe transient neutropenia (0.5 x 10(9)/L).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] found [Subject] he [Treatment] infliximab [Effect] severe transient neutropenia (0.5 x 10(9)/L)"}, {"id": "7712052_1_143", "context": "Lithium for irritability in post-traumatic stress disorder.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] for [Treatment] Lithium"}, {"id": "14684937_2_144", "context": "Iatrogenic hypercalcemia due to vitamin D3 ointment (1,24(OH)2D3) combined with thiazide diuretics in a case of psoriasis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] vitamin D3 ointment (1,24(OH)2D3) combined with thiazide diuretics [Effect] Iatrogenic hypercalcemia"}, {"id": "6362443_1_145", "context": "A case of mania associated with fluoxetine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] A case [Treatment] fluoxetine [Effect] mania"}, {"id": "7748076_3_146", "context": "RESULTS: Extensive squamous metaplasia was found in endometrial glands following progestin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] progestin therapy [Effect] Extensive squamous metaplasia was found in endometrial glands"}, {"id": "16843118_1_147", "context": "Acute generalized exanthematous pustulosis caused by morphine, confirmed by positive patch test and lymphocyte transformation test.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] morphine [Effect] Acute generalized exanthematous pustulosis"}, {"id": "9149614_1_148", "context": "Eleven days after initiation of therapy with amiodarone, the patient experienced syncope and was noted to have recurrent episodes of polymorphous ventricular tachycardia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experienced [Subject] the patient [Treatment] Eleven days after initiation of therapy with amiodarone [Effect] syncope and was noted to have recurrent episodes of polymorphous ventricular tachycardia"}, {"id": "8579054_3_149", "context": "Prolonged used of hydroxyurea in patients with ET may lead to therapy-associated acute leukemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] patients with ET [Treatment] hydroxyurea [Effect] therapy-associated acute leukemia"}, {"id": "354311_2_150", "context": "Metastatic osteomyelitis following BCG vaccination.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] BCG vaccination [Effect] Metastatic osteomyelitis"}, {"id": "1414247_1_151", "context": "Carbamyl phosphate synthetase-1 deficiency discovered after valproic acid-induced coma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] valproic acid [Effect] coma; Carbamyl phosphate synthetase-1 deficiency"}, {"id": "8912599_5_152", "context": "We describe two patients in whom painful erosions of their psoriasis developed as the presenting sign of methotrexate toxicity and review the literature, emphasizing the risk factors associated with this manifestation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Subject] two patients [Treatment] methotrexate [Effect] painful erosions of their psoriasis"}, {"id": "9413296_2_153", "context": "Methysergide-induced retroperitoneal fibrosis: successful outcome and two new laboratory features.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Methysergide [Effect] retroperitoneal fibrosis"}, {"id": "11099623_1_154", "context": "We describe 2 children with cerebral palsy who suffered significant morbidity immediately after treatment with hyperbaric oxygen.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] suffered [Subject] 2 children with cerebral palsy [Treatment] treatment with hyperbaric oxygen [Effect] significant morbidity immediately"}, {"id": "53128_2_155", "context": "A patient is described with polycythemia vera who was taking anticoagulants and developed a spontaneous retropharyngeal hemorrhage after a violent sneezing episode.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A patient [Treatment] anticoagulants [Effect] polycythemia vera; a spontaneous retropharyngeal hemorrhage after a violent sneezing episode"}, {"id": "9671138_1_156", "context": "CD4 T-lymphocyte depletion, myelosuppression, and subsequent severe infections are the major side effects of fludarabine phosphate therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] fludarabine phosphate [Effect] CD4 T-lymphocyte depletion, myelosuppression, and subsequent severe infections"}, {"id": "16288069_3_157", "context": "Penicillin-induced Jarisch-Herxheimer reaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Penicillin [Effect] Jarisch-Herxheimer reaction"}, {"id": "9550246_4_158", "context": "The authors suggest that risperidone may increase affect in patients with schizophrenia and that some patients, especially those with anxiety, may have difficulty managing the increase.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] increase [Subject] patients with schizophrenia [Treatment] risperidone [Effect] increase affect"}, {"id": "11315123_1_159", "context": "We cared for a patient with progressive renal impairment who presented with blurred vision, QRS broadening and cardiac failure due to chronic cibenzoline intoxication.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Subject] a patient with progressive renal impairment [Treatment] chronic cibenzoline intoxication [Effect] blurred vision, QRS broadening and cardiac failure"}, {"id": "1557089_1_160", "context": "In a postoperative patient with pre-existent myasthenia gravis, oral verapamil caused a marked exacerbation in myasthenic weakness.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Subject] a postoperative patient with pre-existent myasthenia gravis [Treatment] oral verapamil [Effect] marked exacerbation in myasthenic weakness"}, {"id": "16288069_1_161", "context": "An objective causality assessment suggests that the JHR in our patient was probably related to penicillin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] patient [Treatment] penicillin [Effect] JHR"}, {"id": "16490518_2_162", "context": "RESULTS: A 34-year-old man acquired visual field defects and severe vision loss in both eyes after intravitreal injection of triamcinolone for diabetic macular edema.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] A 34-year-old man [Treatment] intravitreal injection of triamcinolone [Effect] visual field defects and severe vision loss in both eyes"}, {"id": "16537817_1_163", "context": "Simvastatin-amiodarone interaction resulting in rhabdomyolysis, azotemia, and possible hepatotoxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulting [Treatment] Simvastatin-amiodarone interaction [Effect] rhabdomyolysis, azotemia, and possible hepatotoxicity"}, {"id": "21330680_13_164", "context": "A 73-year-old woman receiving high-dosage olanzapine for bipolar disorder developed parkinsonism after smoking cessation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] A 73-year-old woman [Treatment] high-dosage olanzapine; smoking cessation [Effect] parkinsonism"}, {"id": "16515630_2_165", "context": "Fatal pulmonary fibrosis induced by paclitaxel: a case report and review of the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] paclitaxel [Effect] pulmonary fibrosis"}, {"id": "23970584_1_166", "context": "Raltegravir-induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome - implications for clinical practice and patient safety.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Raltegravir [Effect] Eosinophilia and Systemic Symptoms (DRESS) syndrome"}, {"id": "19131789_1_167", "context": "A 10-year-old boy with osteosarcoma and normal renal function manifested laboratory evidence of impending renal toxicity and extreme elevation of aspartate aminotrasferase and alanine aminotransferase within 2 hours after the completion of a 4-hour infusion of high-dose methotrexate (MTX) (12 g/m2), and went on to develop acute renal failure with life-threatening hyperkalemia 29 hours later.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] develop [Subject] 10-year-old boy with osteosarcoma and normal renal function [Treatment] 4-hour infusion of high-dose methotrexate (MTX) (12 g/m2) [Effect] impending renal toxicity and extreme elevation of aspartate aminotrasferase and alanine aminotransferase; acute renal failure with life-threatening hyperkalemia 29 hours later"}, {"id": "2012922_1_168", "context": "Transient trazodone-induced hypomanic symptoms occurred in three depressed patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] three depressed patients [Treatment] trazodone [Effect] hypomanic symptoms"}, {"id": "9886213_4_169", "context": "We describe a case of disseminated muscular cysticercosis followed by myositis (fever, diffuse myalgia, weakness of the lower limbs, and inflammatory reaction around dying cysticerci) induced by praziquantel therapy, an event not described previously.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a case [Treatment] praziquantel therapy [Effect] disseminated muscular cysticercosis followed by myositis (fever, diffuse myalgia, weakness of the lower limbs, and inflammatory reaction around dying cysticerci)"}, {"id": "1888256_2_170", "context": "Drug-induced fever should be considered in patients who have unexplained high temperatures during diltiazem therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] diltiazem therapy [Effect] fever; unexplained high temperatures"}, {"id": "9443627_1_171", "context": "Hemodialysis was also shown to reverse ifosfamide-related neurotoxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] ifosfamide [Effect] neurotoxicity [Potential therapeutic event] reverse [Treatment] Hemodialysis"}, {"id": "18076602_2_172", "context": "Palpable purpuric skin lesions on the anterior surface of both legs appeared on the 55th day of amphotericin B treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] appeared [Treatment] 55th day of amphotericin B treatment [Effect] Palpable purpuric skin lesions on the anterior surface of both legs"}, {"id": "6199475_2_173", "context": "Transient left homonymous hemianopsia and encephalopathy following treatment of testicular carcinoma with cisplatinum, vinblastine, and bleomycin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] cisplatinum, vinblastine, and bleomycin [Effect] Transient left homonymous hemianopsia and encephalopathy"}, {"id": "3410226_2_174", "context": "We report a 46-yr-old woman with ovarian carcinoma who developed porphyria cutanea tarda while undergoing treatment with cisplatin and cyclophosphamide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 46-yr-old woman with ovarian carcinoma [Treatment] cisplatin and cyclophosphamide [Effect] porphyria cutanea tarda"}, {"id": "440873_2_175", "context": "In one child, a second course of carbamazepine resulted in a return of the dystonia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulted [Subject] one child [Treatment] a second course of carbamazepine [Effect] a return of the dystonia"}, {"id": "8726608_1_176", "context": "Does acyclovir increase serum lithium levels?", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] increase [Treatment] acyclovir; lithium [Effect] serum lithium levels"}, {"id": "2241449_2_177", "context": "Sulfadiazine crystalluria revisited.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] revisited [Treatment] Sulfadiazine [Effect] crystalluria"}, {"id": "16472339_1_178", "context": "Administration of sumatriptan in subarachnoid haemorrhage (SAH) patients, misdiagnosed as migraine patients, may induce symptomatic cerebral vasospasm with potentially dangerous consequences.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induce [Subject] patients [Treatment] sumatriptan [Effect] symptomatic cerebral vasospasm"}, {"id": "9550246_2_179", "context": "Six of 13 outpatients with schizophrenia who participated in a ten-week open trial of risperidone had an initial good response to the medication followed by development of intolerable affect, including feelings of agitation and depression and periods of crying and insomnia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Subject] Six of 13 outpatients with schizophrenia [Treatment] a ten-week open trial of risperidone [Effect] intolerable affect, including feelings of agitation and depression and periods of crying and insomnia"}, {"id": "10332990_1_180", "context": "Pulmonary edema during acute infusion of epoprostenol in a patient with pulmonary hypertension and limited scleroderma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] a patient with pulmonary hypertension and limited scleroderma [Treatment] acute infusion of epoprostenol"}, {"id": "3003260_3_181", "context": "Recent reports have shown that Decadron (dexamethasone; Merck Sharp & Dohme, West Point, Pa) has a significant antiemetic effect on cisplatin-induced vomiting.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] antiemetic [Treatment] Decadron"}, {"id": "16087771_1_182", "context": "Pleuropulmonary fibrosis after long-term treatment with the dopamine agonist pergolide for Parkinson Disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] long-term treatment with the dopamine agonist pergolide [Effect] Pleuropulmonary fibrosis"}, {"id": "556126_1_183", "context": "An infertile patient with amenorrhea-galactorrhea syndrome lost vision during a pregnancy occurring after Bromocryptine treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] An infertile patient with amenorrhea-galactorrhea syndrome [Treatment] Bromocryptine [Effect] lost vision"}, {"id": "8430717_2_184", "context": "CONCLUSIONS: The observation that neurotoxicity developed with a delay of 24 to 48 hours after acyclovir peak serum concentrations could explain the wide range of acyclovir levels reported in similar cases.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] acyclovir [Effect] neurotoxicity"}, {"id": "8850251_5_185", "context": "Two cases of mequitazine-induced photosensitivity reactions.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] mequitazine [Effect] photosensitivity reactions"}, {"id": "9704170_3_186", "context": "Rhabdomyolysis associated with clozapine treatment in a patient with decreased calcium-dependent potassium permeability of cell membranes.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Subject] a patient with decreased calcium-dependent potassium permeability of cell membranes [Treatment] clozapine [Effect] Rhabdomyolysis"}, {"id": "9737132_1_187", "context": "A 47 year-old woman who had a 4-year history of intramuscular pentazocine injections in the lower extremities, developed gradual stiffness and weakness of the lower extremities.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 47 year-old woman [Treatment] a 4-year history of intramuscular pentazocine injections in the lower extremities [Effect] gradual stiffness and weakness of the lower extremities"}, {"id": "10592946_5_188", "context": "The possibility of severe rhabdomyolysis should be considered in a patient with water intoxication due to massive ingestion of caffeine-containing beverages.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due to [Subject] a patient [Treatment] massive ingestion of caffeine-containing beverages [Effect] severe rhabdomyolysis; water intoxication"}, {"id": "9533061_3_189", "context": "CASE SUMMARY: A 25-year-old postpartum white woman developed multiple watery stools and abdominal cramping on day 6 of therapy with clindamycin vaginal cream for bacterial vaginosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 25-year-old postpartum white woman [Treatment] clindamycin vaginal cream for bacterial vaginosis [Effect] multiple watery stools and abdominal cramping"}, {"id": "11236070_1_190", "context": "Dose-dependent olanzapine-associated leukopenia: three case reports.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] three case [Treatment] olanzapine [Effect] leukopenia"}, {"id": "10682234_8_191", "context": "He became completely premorbid 2 weeks after administration of levodopa.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] He [Treatment] levodopa [Effect] premorbid"}, {"id": "19112808_2_192", "context": "The authors describe a case of interstitial granulomatous dermatitis associated with darifenacin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] darifenacin [Effect] interstitial granulomatous dermatitis"}, {"id": "7056119_6_193", "context": "Amiodarone was the third drug to induce AVT in this patient; she received 200 mg/day six days per week for six months.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induce [Subject] patient; she [Treatment] Amiodarone; 200 mg/day six days per week for six months [Effect] AVT"}, {"id": "3003260_1_194", "context": "A young diamond dealer developed visual impairment attributed to bilateral posterior subcapsular cataracts following only four courses of intermittent Decadron used as part of a five-drug antiemetic regimen for cisplatin-associated nausea.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] A young diamond dealer [Treatment] only four courses of intermittent Decadron used as part of a five-drug antiemetic regimen [Effect] visual impairment attributed to bilateral posterior subcapsular cataracts"}, {"id": "10492493_3_195", "context": "OBJECTIVE: To report a case of angioedema associated with losartan administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] a case [Treatment] losartan administration [Effect] angioedema"}, {"id": "16341621_2_196", "context": "The authors present a case report of a granulomatous reaction leading to urethral prolapse, 3 months after the transurethral injection of calcium hydroxylapatite.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] leading [Subject] a case report [Treatment] 3 months after the transurethral injection of calcium hydroxylapatite [Effect] granulomatous reaction; urethral prolapse"}, {"id": "15595320_1_197", "context": "Epstein-Barr virus-associated lymphoproliferative disorder in a patient with rheumatoid arthritis on methotrexate and rofecoxib: idiosyncratic reaction or pharmacogenetics?", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] a patient with rheumatoid arthritis [Treatment] methotrexate and rofecoxib [Effect] Epstein-Barr virus-associated lymphoproliferative disorder"}, {"id": "18755414_4_198", "context": "On the other hand, aspirin may have promoted the enlargement of spontaneous hemorrhage from meningioma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] promoted [Treatment] aspirin [Effect] enlargement of spontaneous hemorrhage from meningioma"}, {"id": "20925534_13_199", "context": "The two groups did not differ significantly in the rate of serious adverse events, though the risk of diarrhea was increased with omeprazole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] increased [Treatment] omeprazole [Effect] risk of diarrhea was increased"}, {"id": "1469187_1_200", "context": "Treatment of a patient with severe digitoxin intoxication by Fab fragments of anti-digitalis antibodies.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] Treatment [Subject] a patient with severe digitoxin intoxication [Treatment] Fab fragments of anti-digitalis antibodies"}, {"id": "3410226_1_201", "context": "Development of porphyria cutanea tarda after treatment with cyclophosphamide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] cyclophosphamide [Effect] porphyria cutanea tarda"}, {"id": "3242521_2_202", "context": "We report a premature infant who developed seizures associated with intraventricular administration of nafcillin and discuss the need for electroencephalographic monitoring of patients receiving intraventricular antibiotics.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated with [Subject] a premature infant [Treatment] intraventricular administration of nafcillin [Effect] seizures"}, {"id": "12022905_4_203", "context": "OBJECTIVE: To present a single case of zuclopenthixol-induced priapism and a literature review.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] zuclopenthixol [Effect] priapism"}, {"id": "16685112_1_204", "context": "CASE REPORT: We hereby report a case of radiation recall dermatitis and myositis occurring on gemcitabine monotherapy, five months after completing chemoradiation for locally advanced pancreatic cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurring [Treatment] gemcitabine monotherapy, five months after completing chemoradiation [Effect] radiation recall dermatitis and myositis"}, {"id": "6427463_1_205", "context": "Stroke-like syndrome after gold sodium thiomalate induced vasomotor reaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] gold sodium thiomalate [Effect] vasomotor reaction; Stroke-like syndrome"}, {"id": "9870779_3_206", "context": "MTX-induced hepatic injury and liver enzyme elevations have been demonstrated after treatment of leukemia, gestational disease and during treatment of psoriasis and rheumatoid arthritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] MTX [Effect] hepatic injury and liver enzyme elevations [Potential therapeutic event] demonstrated [Treatment] treatment of leukemia, gestational disease and during treatment of psoriasis and rheumatoid arthritis"}, {"id": "15522120_9_207", "context": "An adverse drug reaction (ADR) induced by fluoxetine was suspected and fluoxetine treatment was discontinued.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] fluoxetine [Effect] An adverse drug reaction (ADR)"}, {"id": "18203308_2_208", "context": "New onset of Crohn's disease during treatment of active ankylosing spondylitis with etanercept.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] etanercept [Effect] New onset of Crohn's disease"}, {"id": "18523232_3_209", "context": "Fatal hepatitis after long-term pulse itraconazole treatment for onychomycosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] long-term pulse itraconazole treatment [Effect] Fatal hepatitis"}, {"id": "3824704_1_210", "context": "Fatal outcome of intravesical formalin instillation, with changes mimicking renal tuberculosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] intravesical formalin instillation [Effect] with changes mimicking renal tuberculosis; Fatal outcome"}, {"id": "16101941_3_211", "context": "Both reactions were caused due to this anti-emetic drug, but an additive effect of clemastine fumarate, prescribed to treat the anaphylactic reaction, is suggested by the sequence of events.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] suggested [Treatment] clemastine fumarate [Effect] additive effect"}, {"id": "16357738_2_212", "context": "Reversible posterior leukoencephalopathy syndrome in systemic lupus erythematosus with thrombocytopenia treated with cyclosporine.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Treatment] cyclosporine"}, {"id": "20925534_14_213", "context": "Among patients receiving aspirin and clopidogrel, prophylactic use of a PPI reduced the rate of upper gastrointestinal bleeding.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] prophylactic use [Subject] patients receiving aspirin and clopidogrel [Treatment] PPI [Effect] reduced the rate of upper gastrointestinal bleeding"}, {"id": "11295724_3_214", "context": "Clofazimine enteropathy in a pediatric bone marrow transplant recipient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] a pediatric bone marrow transplant recipient [Treatment] Clofazimine [Effect] enteropathy"}, {"id": "11696132_2_215", "context": "Anisocoria from transdermal scopolamine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] from [Treatment] transdermal scopolamine [Effect] Anisocoria"}, {"id": "12659609_4_216", "context": "His fever resolved, but he developed symptoms consistent with those of chloroquine toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] he [Treatment] chloroquine [Effect] symptoms consistent with those of chloroquine toxicity"}, {"id": "6199475_1_217", "context": "A 36-year-old man being treated with cisplatinum, vinblastine, and bleomycin for testicular carcinoma developed a dense left homonymous hemianopsia, encephalopathy, and a partial nondominant parietal lobe syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 36-year-old man; testicular carcinoma [Treatment] cisplatinum, vinblastine, and bleomycin [Effect] dense left homonymous hemianopsia, encephalopathy, and a partial nondominant parietal lobe syndrome"}, {"id": "12410494_2_218", "context": "We report the first death associated with rhabdomyolysis in a patient treated with a statin and a protease inhibitor, which produced a significant drug-drug interaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] a patient [Treatment] a statin and a protease inhibitor [Effect] death associated with rhabdomyolysis"}, {"id": "15595320_2_219", "context": "Methotrexate (MTX) is a commonly used second line agent for RA, and there have been several recent reports of Epstein-Barr virus (EBV)-associated polyclonal B cell lymphoproliferative disorder in MTX-treated RA patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reports [Subject] RA patients [Treatment] MTX-treated [Effect] Epstein-Barr virus (EBV)-associated polyclonal B cell lymphoproliferative disorder"}, {"id": "18505911_2_220", "context": "To describe a case of azathioprine-induced warfarin resistance, present a literature review on warfarin-azathioprine interactions, and provide recommendations on appropriate management of this clinically significant interaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] azathioprine [Effect] warfarin resistance"}, {"id": "16515630_4_221", "context": "Pulmonary fibrosis is a complication of paclitaxel therapy that may occur despite treatments with corticosteroids.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] paclitaxel therapy [Effect] Pulmonary fibrosis"}, {"id": "2830062_2_222", "context": "Two patients with adrenal carcinoma treated with 2,2-bis (2-chlorophenyl-4-chlorophenyl)-1,1-dichloroethane (o,p'-DDD) as adjuvant therapy were studied.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Subject] Two patients with adrenal carcinoma [Treatment] 2,2-bis (2-chlorophenyl-4-chlorophenyl)-1,1-dichloroethane (o,p'-DDD) as adjuvant therapy"}, {"id": "8430717_3_223", "context": "METHODS: Repeated blood samples were drawn in a patient with severe acyclovir overdose who developed coma and nonoliguric renal failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient [Treatment] acyclovir overdose [Effect] coma and nonoliguric renal failure"}, {"id": "354311_1_224", "context": "An 8-year-old girl, who had been vaccinated with BCG without subsequent regional reactions, developed osteomyelitis in the left calcaneus 7 months later.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] 8-year-old girl [Treatment] BCG [Effect] osteomyelitis"}, {"id": "1469187_3_225", "context": "Since this amount of FAB was insufficient to bind all DGTX present in the serum, cardiac DGTX toxicity (total AV-block) persisted.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] persisted [Treatment] DGTX [Effect] cardiac DGTX toxicity (total AV-block)"}, {"id": "7369302_1_226", "context": "Abnormalities of the pupil and visual-evoked potential in quinine amblyopia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Treatment] quinine [Effect] amblyopia; Abnormalities of the pupil and visual-evoked potential"}, {"id": "1275625_4_227", "context": "A case is reported in which severe hypocalcemia, with a low plasma parathyroid hormone (PTH) concentration, resulted from the therapeutic use of magnesium sulfate for toxemia of pregnancy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulted [Treatment] magnesium sulfate [Effect] severe hypocalcemia, with a low plasma parathyroid hormone (PTH) concentration"}, {"id": "8124920_1_228", "context": "Concurrent acute megaloblastic anaemia and pneumonitis: a severe side-effect of low-dose methotrexate therapy during rheumatoid arthritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] low-dose methotrexate [Effect] Concurrent acute megaloblastic anaemia and pneumonitis"}, {"id": "15061230_3_229", "context": "Patients should be informed about the risk of osteonecrosis when taking dexamethasone as an antiemetic drug.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] risk [Subject] Patients [Treatment] dexamethasone [Effect] osteonecrosis"}, {"id": "16317298_5_230", "context": "We report a patient with inoperable pancreatic cancer who developed gastrointestinal bleeding secondary to radiation-recall related to gemcitabine and review literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient with inoperable pancreatic cancer [Treatment] gemcitabine [Effect] gastrointestinal bleeding; radiation-recall"}, {"id": "12836099_2_231", "context": "We report a case of SJS in a 14-year-old male with nephrotic syndrome, who was treated with oral prednisolone for 6 weeks.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Subject] a 14-year-old male [Treatment] oral prednisolone for 6 weeks [Effect] SJS"}, {"id": "6865827_1_232", "context": "A 45-year-old woman with thyrotoxicosis developed agranulocytosis after treatment with propylthiouracil.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 45-year-old woman with thyrotoxicosis [Treatment] propylthiouracil [Effect] agranulocytosis"}, {"id": "3136101_3_233", "context": "We wish to call for cautious approach at time of cessation of prolonged ACTH therapy because of possible unexpected and only partially understood hazardous side effects such as hyperkalemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] cessation of prolonged ACTH [Effect] hyperkalemia"}, {"id": "6401771_1_234", "context": "Haemolytic-uraemic syndrome complicating long-term mitomycin C and 5-fluorouracil therapy for gastric carcinoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complicating [Treatment] long-term mitomycin C and 5-fluorouracil therapy [Effect] Haemolytic-uraemic syndrome"}, {"id": "25842648_6_235", "context": "Although this article focuses on serotonin syndrome as a result of an adverse interaction of selective serotonin reuptake inhibitors (SSRI) and fentanyl, it is important for not only anesthesia professionals, but all clinicians--such as those in emergency medicine and critical care--to be aware of this syndrome and its management.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] result [Treatment] selective serotonin reuptake inhibitors; fentanyl [Effect] serotonin syndrome"}, {"id": "6794018_1_236", "context": "Intrahepatic cholestasis and cutaneous bullae associated with glibenclamide therapy are described in a 61-year-old diabetic patient who presented wit hypoglycaemic coma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] a 61-year-old diabetic patient who presented wit hypoglycaemic coma [Treatment] glibenclamide [Effect] Intrahepatic cholestasis and cutaneous bullae"}, {"id": "22677303_10_237", "context": "In the presented case, the temporal relationship between the administration of cloxacillin and increased INR suggests that the cloxacillin was responsible for the enhanced warfarin activity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] administration [Subject] case [Treatment] cloxacillin [Effect] enhanced warfarin activity.; increased INR"}, {"id": "7783891_2_238", "context": "Cardiac arrest following use of sumatriptan.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] sumatriptan [Effect] Cardiac arrest"}, {"id": "1422497_4_239", "context": "We report four cases of encephalopathy coincident with elevated aluminum levels as well as one patient who developed seizures while receiving continuous bladder irrigations with alum.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] one patient [Treatment] receiving continuous bladder irrigations with alum [Effect] seizures"}, {"id": "6671350_5_240", "context": "Nine azotemic patients who developed a coagulopathy associated with the use of either cephalosporin or moxalactam antibiotics are reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] Nine azotemic patients [Treatment] cephalosporin or moxalactam antibiotics [Effect] coagulopathy"}, {"id": "8442800_10_241", "context": "This report suggests that the poor prognosis previously given to fetuses exposed to disulfiram in the first trimester may not be warranted.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] exposed [Subject] fetuses [Treatment] disulfiram [Effect] poor prognosis"}, {"id": "10592946_6_242", "context": "We hypothesize that caffeine toxicity injured the muscle cells, which were fragile due to the potassium depletion induced by the coexisting hyponatremia, to result in unusually severe rhabdomyolysis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] injured [Treatment] caffeine toxicity [Effect] muscle cells, which were fragile due to the potassium depletion induced by the coexisting hyponatremia, to result in unusually severe rhabdomyolysis"}, {"id": "18837734_2_243", "context": "The aim of this paper is to report the case of rosaceiform eruption induced by erlotinib in an 81-year-old-man and to discuss the pathogenetic role of Demodex folliculorum mites, found in the present patient, using skin scraping.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] an 81-year-old-man [Treatment] erlotinib; skin scraping [Effect] rosaceiform eruption; Demodex folliculorum mites"}, {"id": "11295724_1_244", "context": "An 11-year-old boy developed a severe enteropathy 2 years after initiation of clofazimine treatment for graft-versus-host disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] An 11-year-old boy; graft-versus-host disease [Treatment] clofazimine treatment [Effect] severe enteropathy"}, {"id": "3174043_3_245", "context": "The authors conclude that among patients taking high doses of oral niacin only those who experience visual symptoms need to be ophthalmologically evaluated.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] taking [Subject] patients [Treatment] high doses of oral niacin [Effect] visual symptoms"}, {"id": "14697943_2_246", "context": "Reflex sympathetic dystrophy syndrome in renal transplanted patients under immunosuppression with tacrolimus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Subject] renal transplanted patients [Treatment] tacrolimus [Effect] Reflex sympathetic dystrophy syndrome"}, {"id": "17387702_2_247", "context": "We report the case of an 11-year-old female treated for mediastinal T-cell lymphoma who presented renal failure following the second cycle of high-dose methotrexate (HDMTX).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] an 11-year-old female treated for mediastinal T-cell lymphoma [Treatment] following the second cycle of high-dose methotrexate (HDMTX) [Effect] renal failure"}, {"id": "11236070_3_248", "context": "We report three cases of patients who developed leukopenia during olanzapine treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] three cases of patients [Treatment] olanzapine treatment [Effect] leukopenia"}, {"id": "17921794_2_249", "context": "Rapid onset of muscle weakness (rhabdomyolysis) associated with the combined use of simvastatin and colchicine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated with [Treatment] the combined use of simvastatin and colchicine [Effect] Rapid onset of muscle weakness (rhabdomyolysis)"}, {"id": "4063627_1_250", "context": "A 35-year-old man with seropositive rheumatoid arthritis developed selective IgA deficiency during treatment with fenclofenac.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] A 35-year-old man with seropositive rheumatoid arthritis [Treatment] fenclofenac [Effect] selective IgA deficiency"}, {"id": "15461766_1_251", "context": "In this report, two newborns with congenital heart anomalies demonstrated the harlequin color change, one whose skin findings showed a course related to the dose of systemic prostaglandin E1, suggesting a possible association.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] two newborns with congenital heart anomalies [Treatment] prostaglandin E1 [Effect] harlequin color change"}, {"id": "8442800_4_252", "context": "Nonspecific but significant abnormalities have been described in the infants of women treated with disulfiram in the first trimester of their pregnancies.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] infants [Treatment] disulfiram [Effect] abnormalities"}, {"id": "15895899_3_253", "context": "These data indicated that infliximab possibly triggered production of granulocyte and neutrophil autoantibodies with resultant autoimmune agranulocytosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] triggered [Treatment] infliximab [Effect] production of granulocyte and neutrophil autoantibodies with resultant autoimmune agranulocytosis"}, {"id": "12477460_4_254", "context": "Ovarian endometrioid adenocarcinoma arising from an endometriotic cyst in a postmenopausal woman under tamoxifen therapy for breast cancer: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] under [Subject] a postmenopausal woman [Treatment] tamoxifen therapy [Effect] Ovarian endometrioid adenocarcinoma"}, {"id": "17123120_1_255", "context": "Tacrolimus-induced HUS: an unusual cause of acute renal failure in nephrotic syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Tacrolimus [Effect] HUS"}, {"id": "17090724_2_256", "context": "OBJECTIVE: To report the clinical course of a woman with cryptococcal meningitis and no previous cardiac disease who developed a fatal cardiac arrhythmia after an acute overdose of amphotericin B and to review its toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a woman with cryptococcal meningitis and no previous cardiac disease [Treatment] an acute overdose of amphotericin B [Effect] a fatal cardiac arrhythmia"}, {"id": "3542612_2_257", "context": "We report a case of a bullous lichenoid eruption due to the intake of captopril.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Subject] a case [Treatment] captopril [Effect] bullous lichenoid eruption"}, {"id": "2830062_4_258", "context": "The hypoadrenalism was overcome by increasing steroid replacement therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] overcome [Treatment] increasing steroid replacement therapy"}, {"id": "16265343_1_259", "context": "DIAGNOSIS: Interferon alpha-2b-induced cardiomyopathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Interferon alpha-2b [Effect] cardiomyopathy"}, {"id": "8610807_1_260", "context": "Choroidal hemorrhage associated with systemic tissue plasminogen activator.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] systemic tissue plasminogen activator [Effect] Choroidal hemorrhage"}, {"id": "17665812_1_261", "context": "Clozapine-induced eosinophilia and switch to quetiapine in a patient with chronic schizophrenia with suicidal tendencies.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient with chronic schizophrenia with suicidal tendencies [Treatment] Clozapine [Effect] eosinophilia [Potential therapeutic event] switch [Subject] a patient with chronic schizophrenia with suicidal tendencies [Treatment] quetiapine"}, {"id": "18675768_1_262", "context": "Adverse effects of propafenone after long-term therapy with the addition of citalopram.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] long-term therapy with the addition of citalopram [Effect] Adverse effects"}, {"id": "7081289_2_263", "context": "The case of an adult who developed both hepatic dysfunction and an impaired macrophage migration after exposure to cimetidine is discussed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] an adult [Treatment] cimetidine is discussed [Effect] hepatic dysfunction and an impaired macrophage migration"}, {"id": "16609346_3_264", "context": "We report 4 patients who developed symptoms of myasthenia gravis within 2 weeks of starting treatment with a statin drug.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] 4 patients [Treatment] within 2 weeks of starting treatment with a statin [Effect] symptoms of myasthenia gravis"}, {"id": "15927910_1_265", "context": "After only the third dose of pentamidine, it was noted that the patient's heart rate had decreased to 48 beats/minute.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] After [Subject] patient's [Treatment] third dose of pentamidine [Effect] heart rate had decreased to 48 beats/minute"}, {"id": "7056119_2_266", "context": "A 44-year-old woman is described in whom amiodarone, disopyramide, and quinidine, administered alone separately, induced atypical ventricular tachycardia (AVT, torsade de pointes).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] A 44-year-old woman [Treatment] amiodarone, disopyramide, and quinidine [Effect] atypical ventricular tachycardia (AVT, torsade de pointes)"}, {"id": "18505911_9_267", "context": "Azathioprine was the probable causative agent of warfarin resistance according to the Naranjo probability scale, and a possible causative agent according to the Drug Interaction Probability Scale.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] causative agent [Treatment] Azathioprine [Effect] warfarin resistance"}, {"id": "8442800_2_268", "context": "Disulfiram has been used effectively to deter alcohol consumption in patients with a history of alcohol abuse.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] used [Subject] patients with a history of alcohol abuse [Treatment] Disulfiram"}, {"id": "15507779_2_269", "context": "Nevirapine is a non-nucleoside reverse transcriptase inhibitor used in the treatment of human immunodeficiency virus (HIV)-infected patients and in post-exposure prophylaxis.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Subject] human immunodeficiency virus (HIV)-infected patients [Treatment] Nevirapine"}, {"id": "8391300_2_270", "context": "Vasospasm associated with ergotamine is a well-known phenomenon.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] ergotamine [Effect] Vasospasm"}, {"id": "3359700_1_271", "context": "After a six-week course of low-dose cyclosporine A, she developed a severe but reversible loss of glomerular filtration rate and effective renal plasma flow despite of low cyclosporine A plasma levels.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] After a six-week course of low-dose cyclosporine A [Effect] loss of glomerular filtration rate and effective renal plasma flow"}, {"id": "21630612_4_272", "context": "We report a case of severe simvastatin-induced rhabdomyolysis triggered by the addition of amiodarone to previously well-tolerated chronic statin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] simvastatin; the addition of amiodarone to previously well-tolerated chronic statin therapy [Effect] rhabdomyolysis"}, {"id": "23115227_3_273", "context": "In January 2010, a 50-year-old transgender female with HIV infection and recurrent deep vein thrombosis began treatment with the TRIO study regimen.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Subject] a 50-year-old transgender female [Treatment] TRIO"}, {"id": "10870095_7_274", "context": "In vitro inhibition of CYP2C9 by zafirlukast is consistent with clinical studies showing impaired clearance of  S-warfarin and enhanced anti-thrombotic effects, although the in vitro IC(50) value is higher than the usual range of clinically relevant plasma concentrations.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] showing [Treatment] zafirlukast [Effect] impaired clearance of  S-warfarin and enhanced anti-thrombotic effects"}, {"id": "18755414_6_275", "context": "Although it is difficult to solely attribute intratumoral hemorrhage to aspirin, we have to be careful when prescribing aspirin for patients who have asymptomatic meningioma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] attribute [Subject] patients who have asymptomatic meningioma [Treatment] aspirin [Effect] intratumoral hemorrhage"}, {"id": "18751717_3_276", "context": "CONCLUSIONS: The fundus picture shown in these cases may be typical of ASPPC after IVTA injection.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] IVTA injection [Effect] ASPPC"}, {"id": "9149614_3_277", "context": "The probable proarrhythmic action of amiodarone, although rare, is reviewed along with a discussion of the novel use of intravenous magnesium sulfate therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] action [Treatment] amiodarone [Effect] proarrhythmic"}, {"id": "21658326_4_278", "context": "We present two cases of severe, atypical ASRs which occurred during NMSC treatment with imiquimod in the context of infliximab administration for psoriasis, and consider the grounds supporting a non-fortuitous association.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Treatment] imiquimod in the context of infliximab administration [Effect] atypical ASRs"}, {"id": "3964363_1_279", "context": "A case of propranolol overdose complicated by esophageal spasm preventing extrication of an orogastric lavage tube and relieved by intravenous glucagon is presented.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complicated [Treatment] propranolol overdose [Effect] esophageal spasm preventing extrication of an orogastric lavage tube [Potential therapeutic event] relieved [Treatment] intravenous glucagon"}, {"id": "4063627_2_280", "context": "Fenclofenac-induced selective IgA deficiency in rheumatoid arthritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Fenclofenac [Effect] selective IgA deficiency in rheumatoid arthritis"}, {"id": "10082597_2_281", "context": "Naproxen, the most common offender, has been associated with a dimorphic clinical pattern: a PCT-like presentation and one simulating erythropoietic protoporphyria in the pediatric population.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] pediatric population [Treatment] Naproxen [Effect] erythropoietic protoporphyria"}, {"id": "10870095_2_282", "context": "Zafirlukast is a cysteinyl leukotriene antagonist used to treat allergic and exercise-induced asthma.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treat [Treatment] Zafirlukast is a cysteinyl leukotriene antagonist"}, {"id": "18364401_3_283", "context": "Rapidly developing hyperglycemia during treatment with olanzapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] olanzapine [Effect] Rapidly developing hyperglycemia"}, {"id": "10579985_1_284", "context": "The first patient was a 61-year-old man with a 30-year history of fistulizing CD in whom B-cell non-Hodgkin's lymphoma was diagnosed 9 months after treatment with infliximab.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] diagnosed [Subject] The first patient was a 61-year-old man with a 30-year history of fistulizing CD [Treatment] 9 months after treatment with infliximab [Effect] B-cell non-Hodgkin's lymphoma"}, {"id": "7761316_2_285", "context": "Recognition of a potential drug-induced Fanconi syndrome is important when managing pediatric oncology patients previously treated with ifosfamide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] pediatric oncology patients [Treatment] ifosfamide [Effect] drug-induced Fanconi syndrome"}, {"id": "10225085_3_286", "context": "We report a patient with chronic renal failure and ischemic heart disease who developed clinically significant methemoglobinemia after an axillary block with bupivacaine and additional injection of lidocaine in the operative field.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient with chronic renal failure and ischemic heart disease [Treatment] an axillary block with bupivacaine and additional injection of lidocaine in the operative field [Effect] clinically significant methemoglobinemia"}, {"id": "19884751_1_287", "context": "Amikacin-induced type 5 Bartter-like syndrome with severe hypocalcemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Amikacin [Effect] type 5 Bartter-like syndrome with severe hypocalcemia"}, {"id": "15368548_2_288", "context": "L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Treatment] percutaneous drainage [Adverse event] induced [Treatment] L-asparaginase [Effect] severe necrotizing pancreatitis"}, {"id": "4014301_4_289", "context": "This report describes the first case of insulin-induced cardiac failure in a patient without underlying heart disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient without underlying heart disease [Treatment] insulin [Effect] cardiac failure"}, {"id": "11352235_4_290", "context": "OBJECTIVE: To determine the frequency of weight loss in patients treated with leflunomide for rheumatoid arthritis at an arthritis referral center.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] loss [Subject] patients [Treatment] leflunomide [Effect] weight loss"}, {"id": "11804071_1_291", "context": "INH, which is a leading cause of drug eruptions in the above group of drugs was withdrawn.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] a leading cause [Treatment] INH [Effect] drug eruptions"}, {"id": "19266307_1_292", "context": "Complications associated with primary and secondary perforation of the bladder following immediate instillations of epirubicin after transurethral resection of superficial urothelial tumours.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] instillations of epirubicin [Effect] Complications associated with primary and secondary perforation of the bladder"}, {"id": "11724089_5_293", "context": "Ofloxacin: a probable cause of toxic epidermal necrolysis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Ofloxacin [Effect] toxic epidermal necrolysis"}, {"id": "16515630_1_294", "context": "Fatal lung fibrosis caused by paclitaxel toxicity has not been reported In this report, we describe the case of a 62-year-old woman who received six cycles of paclitaxel and carboplatin as combination chemotherapy for advanced ovarian cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] received [Subject] 62-year-old woman; advanced ovarian cancer [Treatment] six cycles of paclitaxel and carboplatin as combination chemotherapy [Effect] Fatal lung fibrosis"}, {"id": "9704170_1_295", "context": "A 21-year-old patient developed rhabdomyolysis during his nineteenth week of treatment with clozapine for drug-resistant schizophrenia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 21-year-old patient [Treatment] during his nineteenth week of treatment with clozapine [Effect] rhabdomyolysis"}, {"id": "20349794_1_296", "context": "Cisplatin-induced syndrome of inappropriate antidiuretic hormone (SIADH) in a patient with neuroendocrine tumor of the cervix: a case report and review of the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient with neuroendocrine tumor of the cervix [Treatment] Cisplatin [Effect] syndrome of inappropriate antidiuretic hormone (SIADH)"}, {"id": "6610943_1_297", "context": "Myoglobinuria and acute renal failure associated with intravenous vasopressin infusion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] intravenous vasopressin infusion [Effect] Myoglobinuria and acute renal failure"}, {"id": "18371508_2_298", "context": "We report the first case of fulminant adult respiratory distress syndrome (ARDS) associated with pegylated interferon alpha-2a (pegIFNalpha-2a) and ribavirin use for hepatitis C, complicated by subsequent and ultimately fatal sepsis and multiorgan failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] pegylated interferon alpha-2a (pegIFNalpha-2a) and ribavirin [Effect] adult respiratory distress syndrome (ARDS)"}, {"id": "681921_1_299", "context": "Catatonia associated with disulfiram therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] disulfiram therapy [Effect] Catatonia"}, {"id": "21658326_5_300", "context": "To date, no relation has ever been suggested between TNF-alpha inhibitors and increased susceptibility to developing exaggerated ASRs with imiquimod.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developing [Treatment] TNF-alpha inhibitors; imiquimod [Effect] exaggerated ASRs"}, {"id": "10492493_2_301", "context": "Losartan-induced angioedema.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Losartan [Effect] angioedema"}, {"id": "8850251_1_302", "context": "However, dermatologists should be cautious about a photosensitivity reaction induced by mequitazine or other phenothiazine-derivative drugs.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] mequitazine [Effect] photosensitivity"}, {"id": "18262450_10_303", "context": "Oxycodone-gabapentin also significantly improved pain relief vs gabapentin alone (P = 0.003).", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] improved [Treatment] Oxycodone-gabapentin"}, {"id": "11147747_1_304", "context": "In 2 of the 3 cases the patients were also taking lithium carbonate and beta-blockers, both of which could have contributed to the incontinence.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] contributed [Subject] the patients [Treatment] lithium carbonate and beta-blockers [Effect] incontinence"}, {"id": "15286697_2_305", "context": "Pulmonary fibrosis is a severe complication associated with bis-chloronitrosourea (BCNU) therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] bis-chloronitrosourea (BCNU) therapy [Effect] Pulmonary fibrosis is a severe complication"}, {"id": "15286697_5_306", "context": "We report here a 26-year-old female with diffuse large B-cell lymphoma who died of severe pulmonary fibrosis 81 days after the administration of high-dose BCNU (600 mg/m2).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] administration [Subject] 26-year-old female with diffuse large B-cell lymphoma [Treatment] high-dose BCNU (600 mg/m2) [Effect] died of severe pulmonary fibrosis"}, {"id": "6865827_2_307", "context": "The patient was given methimazole instead of propylthiouracil but, 10 weeks later, agranulocytosis again occurred.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Subject] The patient [Treatment] methimazole [Effect] agranulocytosis"}, {"id": "18675768_6_308", "context": "Three months after starting citalopram, she experienced episodes of chest tightness and dizziness.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experienced [Subject] she [Treatment] citalopram [Effect] chest tightness and dizziness"}, {"id": "3171334_2_309", "context": "Although differential diagnostic alternatives can be considered in all described cases it is very likely that vincristine does cause severe visual loss in a small number of patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Subject] a small number of patients [Treatment] vincristine [Effect] severe visual loss"}, {"id": "18042092_3_310", "context": "This case is remarkable since 1) ECM developed after subcutaneous and not after intramuscular injection, 2) the injection was given by the patient himself, and 3) glatiramer acetate can induce skin necrosis as a side effect.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induce [Treatment] glatiramer acetate [Effect] skin necrosis"}, {"id": "15522120_4_311", "context": "SSRI-drugs increase serotonin concentrations and are known to have pruritus and other dermal side effects.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] increase [Treatment] SSRI-drugs [Effect] increase serotonin concentrations; pruritus and other dermal side effects."}, {"id": "22552763_1_312", "context": "Dabigatran etexilate and concomitant use of non-steroidal anti-inflammatory drugs or acetylsalicylic acid in patients undergoing total hip and total knee arthroplasty: no increased risk of bleeding.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] patients undergoing total hip and total knee arthroplasty [Treatment] Dabigatran etexilate and concomitant use of non-steroidal anti-inflammatory drugs or acetylsalicylic acid [Effect] no increased risk of bleeding"}, {"id": "16393774_7_313", "context": "Our literature review revealed an additional six cases of onset of inflammatory arthritis in MS patients receiving IFN-beta.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] onset [Subject] six cases; in MS patients [Treatment] receiving IFN-beta [Effect] inflammatory arthritis"}, {"id": "7056119_5_314", "context": "Two years later, 24 hours following an increase in the dose of disopyramide from 300 to 600 mg/day, AVT with syncope occurred; isoproterenol abolished the arrhythmia instantly.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Treatment] Two years later, 24 hours following an increase in the dose of disopyramide from 300 to 600 mg/day [Effect] AVT with syncope [Potential therapeutic event] abolished [Treatment] isoproterenol"}, {"id": "9865241_3_315", "context": "The patient was initially treated with hydration and furosemide but developed congestive heart failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] The patient [Treatment] furosemide [Effect] congestive heart failure"}, {"id": "21729965_4_316", "context": "We present an interesting case of an HIV-positive woman on antiretroviral therapy having tubal pregnancies on two separate occasions with Implanon in place.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] having [Subject] an HIV-positive woman [Treatment] antiretroviral [Effect] tubal pregnancies"}, {"id": "15595320_4_317", "context": "We hypothesize that decreased renal elimination of MTX induced by the COX-2 inhibitor resulted in enhanced hematopoietic toxicity and immunosuppression causing the EBV-associated lymphoproliferative disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulted [Treatment] MTX [Effect] enhanced hematopoietic toxicity and immunosuppression; causing the EBV-associated lymphoproliferative disease"}, {"id": "19212144_2_318", "context": "Temsirolimus-induced glomerulopathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Temsirolimus [Effect] glomerulopathy"}, {"id": "11485141_4_319", "context": "OBJECTIVE: To report a case of linear immunoglobulin (Ig) A bullous dermatosis (LABD) induced by gemcitabine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a case [Treatment] gemcitabine [Effect] linear immunoglobulin (Ig) A bullous dermatosis (LABD)"}, {"id": "7949255_2_320", "context": "This patient developed sequential symptoms including alternative hemiparesis, dysarthria and altered consciousness 5 days after the second course of HD-MTX (8 gm/m2 by 6 h continuous infusion) with leucovorin rescue.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] patient [Treatment] the second course of HD-MTX (8 gm/m2 by 6 h continuous infusion) with leucovorin rescue [Effect] sequential symptoms including alternative hemiparesis, dysarthria and altered consciousness"}, {"id": "16685007_5_321", "context": "Adult and adolescent patients (> or = 12 years old; n = 141) with severe, persistent, oral steroid (prednisone)-dependent asthma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] dependent [Subject] Adult and adolescent patients [Treatment] oral steroid (prednisone) [Effect] asthma"}, {"id": "17090724_1_322", "context": "DISCUSSION: Amphotericin B deoxycholate has been reported to produce significant cardiac toxicity, with ventricular arrhythmias and bradycardia reported in overdoses in children and in adults with preexisting cardiac disease, even when administered in conventional dosages and infusion rates.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] produce [Subject] in children and in adults with preexisting cardiac disease [Treatment] Amphotericin B deoxycholate; conventional dosages and infusion rates [Effect] cardiac toxicity, with ventricular arrhythmias and bradycardia"}, {"id": "11510798_2_323", "context": "Diarrhoea, T-CD4+ lymphopenia and bilateral patchy pulmonary infiltrates developed in a male 60 yrs of age, who was treated with oxaliplatinum and 5-fluorouracil for unresectable rectum carcinoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] male 60 yrs of age [Treatment] oxaliplatinum and 5-fluorouracil [Effect] Diarrhoea, T-CD4+ lymphopenia and bilateral patchy pulmonary infiltrates"}, {"id": "18580694_2_324", "context": "Thus, tardive seizures in our cases are thought to be related to piperacillin and cefotiam.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] piperacillin and cefotiam [Effect] tardive seizures"}, {"id": "6873616_1_325", "context": "A 55-yr-old man developed prolonged jaundice and sicca complex after a course of thiabendazole therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] A 55-yr-old man [Treatment] a course of thiabendazole [Effect] prolonged jaundice and sicca complex"}, {"id": "17182354_3_326", "context": "Methylphenidate (Ritalin)-associated cataract and glaucoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Methylphenidate (Ritalin) [Effect] cataract and glaucoma"}, {"id": "12410494_1_327", "context": "Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] implicated [Treatment] Simvastatin-nelfinavir interaction [Effect] rhabdomyolysis and death"}, {"id": "17955169_2_328", "context": "Uncontrolled headache induced by oxcarbazepine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] oxcarbazepine [Effect] Uncontrolled headache"}, {"id": "14697943_3_329", "context": "We now present four cases of RSDS in kidney transplant recipients treated with tacrolimus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] four cases; kidney transplant recipients [Treatment] tacrolimus [Effect] RSDS"}, {"id": "7949255_3_330", "context": "Transient neurological disturbances induced by the chemotherapy of high-dose methotrexate for osteogenic sarcoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] the chemotherapy of high-dose methotrexate [Effect] Transient neurological disturbances"}, {"id": "22372628_1_331", "context": "Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Subject] patients with uncontrolled partial-onset seizures [Treatment] adjunctive lacosamide"}, {"id": "8404753_2_332", "context": "A variety of movement disorders are known to occur in association with carbamazepine (CBZ) therapy in adults and children, but development of tics has been described infrequently and only in patients with underlying Tourette's syndrome or other movement disorders.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occur [Subject] adults and children [Treatment] carbamazepine (CBZ) therapy [Effect] movement disorders"}, {"id": "21515865_4_333", "context": "On the day before this visit, he had received the third of six serial weekly BCG bladder instillations for the treatment of bladder cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] received [Subject] he; bladder cancer [Treatment] the third of six serial weekly BCG bladder instillations"}, {"id": "7056119_3_334", "context": "Following a closed mitral valvotomy, she received quinidine, 1.2 g/day, without interruption for 17 years.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] received [Treatment] quinidine, 1.2 g/day"}, {"id": "3720318_2_335", "context": "We describe a patient in whom noncardiogenic pulmonary edema developed during intrabiliary infusion of monooctanoin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient [Treatment] intrabiliary infusion of monooctanoin [Effect] noncardiogenic pulmonary edema"}, {"id": "12166705_2_336", "context": "Mitomycin-C is used widely in the treatment of malignancies and is associated with serious dose related adverse effects including the occurrence of hemolytic uremic syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Mitomycin-C [Effect] hemolytic uremic syndrome"}, {"id": "1414247_2_337", "context": "Valproic acid induced coma is presented in an adult patient without a history of metabolic disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] adult patient without a history of metabolic disease [Treatment] Valproic acid [Effect] coma"}, {"id": "7355327_4_338", "context": "Three patients with no history of asthma or allergy developed bronchospasm while taking propranolol for hypertension.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Three patients with no history of asthma or allergy [Treatment] propranolol [Effect] bronchospasm"}, {"id": "10573314_2_339", "context": "To report two cases of warfarin therapy in which the addition of tolterodine resulted in prolonged international normalized ratios (INRs).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulted [Subject] two cases [Treatment] warfarin therapy in which the addition of tolterodine [Effect] prolonged international normalized ratios (INRs)"}, {"id": "8850251_2_340", "context": "In addition, an immediate erythematous macule was observed on the photopatch test site of mequitazine directly after UV exposure which was similar to the immediate erythema noted in chlorpromazine photoallergy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] observed [Treatment] mequitazine directly after UV exposure [Effect] an immediate erythematous macule"}, {"id": "879939_1_341", "context": "Acetazolamide-accelerated anticonvulsant osteomalacia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] accelerated [Treatment] Acetazolamide [Effect] anticonvulsant osteomalacia"}, {"id": "129501_2_342", "context": "Both patients suddenly became hypotensive after injection of chymopapain into a disk.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] became [Subject] Both patients [Treatment] injection of chymopapain into a disk [Effect] hypotensive"}, {"id": "17182354_2_343", "context": "Large dose of methylphenidate may cause cataract and glaucoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] methylphenidate [Effect] cataract and glaucoma"}, {"id": "7369302_3_344", "context": "Total blindness with a transient tonic pupillary response, denervation supersensitivity, and abnormal visual-evoked potentials developed in a 54-year-old man after the use of quinine sulfate for leg cramps.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a 54-year-old man [Treatment] quinine sulfate [Effect] Total blindness with a transient tonic pupillary response, denervation supersensitivity, and abnormal visual-evoked"}, {"id": "8404753_1_345", "context": "Carbamazepine-induced tics.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Carbamazepine [Effect] tics"}, {"id": "1655228_3_346", "context": "Three patients are reported without a history of angina pectoris who had clinical and electrocardiographic evidence of myocardial ischemia during and immediately after BCNU infusion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] had [Subject] Three patients are reported without a history of angina pectoris [Treatment] during and immediately after BCNU infusion [Effect] myocardial ischemia"}, {"id": "25298587_1_347", "context": "A rare debilitating neurological adverse effect of ranolazine due to drug interaction with clarithromycin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] adverse effect [Treatment] ranolazine; clarithromycin [Effect] debilitating neurological"}, {"id": "16046172_3_348", "context": "Septic knee arthritis after intra-articular hyaluronate injection.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] intra-articular hyaluronate injection [Effect] Septic knee arthritis"}, {"id": "17921794_3_349", "context": "The concomitant use, however, of colchicine and statin has been associated with the rapid onset of muscle weakness.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] colchicine and statin [Effect] the rapid onset of muscle weakness"}, {"id": "15588385_3_350", "context": "Successful treatment of hyperthyroidism with amiodarone in a patient with propylthiouracil-induced acute hepatic failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Subject] a patient with propylthiouracil-induced acute hepatic failure [Treatment] amiodarone [Adverse event] induced [Treatment] propylthiouracil [Effect] acute hepatic failure"}, {"id": "21330680_1_351", "context": "Olanzapine-induced parkinsonism associated with smoking cessation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] associated with smoking cessation; Olanzapine [Effect] parkinsonism"}, {"id": "20465622_4_352", "context": "CASE: We present an 11-year old male with Budd-Chiari syndrome who experienced profound worsening of chronic aphthous ulcers after immunosuppressive therapy was changed from tacrolimus to sirolimus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experienced [Subject] an 11-year old male with Budd-Chiari syndrome [Treatment] immunosuppressive therapy was changed from tacrolimus to sirolimus [Effect] profound worsening of chronic aphthous ulcers"}, {"id": "10190739_2_353", "context": "We report the cases of two patients who developed acute hepatitis after taking riluzole at the recommended dose (100 mg daily) for 7 and 4 weeks, respectively.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] taking [Subject] two patients [Treatment] riluzole at the recommended dose (100 mg daily) for 7 and 4 weeks [Effect] acute hepatitis"}, {"id": "20628041_1_354", "context": "An interaction between levodopa and enteral nutrition resulting in neuroleptic malignant-like syndrome and prolonged ICU stay.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulting [Treatment] levodopa and enteral nutrition [Effect] neuroleptic malignant-like syndrome and prolonged ICU stay"}, {"id": "10573314_14_355", "context": "Until further data are available, clinicians should be vigilant for a possible drug interaction when tolterodine therapy is initiated in a patient maintained on warfarin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] initiated [Subject] a patient [Treatment] tolterodine therapy [Effect] possible drug interaction"}, {"id": "15522120_13_356", "context": "The itch spread to the arms, abdomen and legs and the patient treated himself with clemastine and the itch disappeared.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] disappeared [Subject] The itch spread to the arms, abdomen and legs and the patient; himself [Treatment] clemastine [Effect] itch disappeared"}, {"id": "8391300_3_357", "context": "In this case report we present a rare drug interaction between erythromycin and ergotamine at normal doses causing lower extremity ischemia in a 36-year-old woman.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] causing [Subject] a 36-year-old woman [Treatment] a rare drug interaction between erythromycin and ergotamine at normal doses [Effect] lower extremity ischemia"}, {"id": "16978752_2_358", "context": "Neutropenia and agranulocytosis are risks known to occur with phenothiazines and clozapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occur [Treatment] phenothiazines and clozapine. [Effect] Neutropenia and agranulocytosis"}, {"id": "1695794_4_359", "context": "She had been taking rifampin prior to admission for acid-fast bacilli.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] taking [Subject] She [Treatment] rifampin"}, {"id": "6572542_3_360", "context": "The responsibility of CCNU in the pathogenesis of pulmonary fibrosis seems very likely.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] responsibility [Treatment] CCNU [Effect] pathogenesis of pulmonary fibrosis"}, {"id": "15863610_1_361", "context": "Malignant mixed mullerian tumor of the uterus in a patient taking raloxifene.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] taking [Subject] a patient [Treatment] raloxifene [Effect] Malignant mixed mullerian tumor of the uterus"}, {"id": "15516308_1_362", "context": "Fatal overdoses associated with quetiapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] quetiapine [Effect] Fatal overdoses"}, {"id": "16685112_3_363", "context": "Gemcitabine-induced rectus abdominus radiation recall.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Gemcitabine [Effect] rectus abdominus radiation recall"}, {"id": "19754002_2_364", "context": "We report on a serious side effect in a severely depressed 55-year-old woman, who presented an erythematous pigmented skin rash on the whole body under combination treatment with antidepressants, atypical antipsychotic drugs, the mood stabilizer lithium and the lipid-lowering drug pravastatin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] depressed 55-year-old woman [Treatment] combination treatment with antidepressants, atypical antipsychotic drugs, the mood stabilizer lithium and the lipid-lowering drug pravastatin [Effect] erythematous pigmented skin rash on the whole body"}, {"id": "15588385_4_365", "context": "We present a 20-year-old woman with Basedow-Graves' disease who developed PTU-induced fulminant hepatitis, which progressed to acute hepatic failure with grade III hepatic encephalopathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a 20-year-old woman with Basedow-Graves' disease [Treatment] PTU [Effect] fulminant hepatitis, which progressed to acute hepatic failure with grade III hepatic encephalopathy"}, {"id": "11283125_2_366", "context": "The European Organization for Research and Treatment of Cancer 58881 study was designed to test in a prospective multicentric randomized trial the value of high-dose (HD) intravenous (IV) cytarabine (Ara-C) added to HD IV methotrexate (MTX) to reduce the incidence of CNS and systemic relapses in children with increased-risk acute lymphoblastic leukemia (ALL) or stage III and IV lymphoblastic lymphoma treated with a Berlin-Frankfurt-Munster (BFM)-based regimen.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] to [Subject] children with increased-risk acute lymphoblastic leukemia (ALL) or stage III and IV lymphoblastic lymphoma [Treatment] high-dose (HD) intravenous (IV) cytarabine (Ara-C) added to HD IV methotrexate (MTX) [Effect] reduce the incidence of CNS and systemic relapses"}, {"id": "6113770_2_367", "context": "The authors postulate that two types of combined lithium-neuroleptic toxicity occur: a neuroleptic malignant extrapyramidal syndrome and a lithium toxicity that occurs in combination with phenothiazines, primarily thioridazine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occur [Treatment] lithium [Effect] neuroleptic toxicity [Adverse event] occurs [Treatment] lithium; in combination with phenothiazines, primarily thioridazine [Effect] a neuroleptic malignant extrapyramidal syndrome and a lithium toxicity"}, {"id": "1711090_1_368", "context": "Trans-catheter hepatic arterial injection of lipiodol soluble anti-cancer agent SMANCS and ADR suspension in lipiodol combined with arterial embolization and local hyperthermia for treatment of hepatocellular carcinoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Treatment] Trans-catheter hepatic arterial injection of lipiodol soluble anti-cancer agent SMANCS and ADR suspension in lipiodol combined with arterial embolization and local hyperthermia"}, {"id": "6693840_2_369", "context": "Gynecomastia associated with theophylline.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] theophylline [Effect] Gynecomastia"}, {"id": "16393774_1_370", "context": "Arthritis and bursitis in multiple sclerosis patients treated with interferon-beta.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Subject] multiple sclerosis patients [Treatment] interferon-beta"}, {"id": "1888256_3_371", "context": "To our knowledge, drug-induced fever has not been reported with the use of diltiazem hydrochloride, a commonly prescribed calcium channel blocker.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] drug; with the use of diltiazem hydrochloride, a commonly prescribed calcium channel blocker [Effect] fever"}, {"id": "11155197_1_372", "context": "Case studies in heparin-induced thrombocytopenia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] heparin [Effect] thrombocytopenia"}, {"id": "8316494_2_373", "context": "We describe a 41 yr old leprosy patient treated for 10 yrs with clofazimine who underwent laparotomy for severe abdominal pain.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] for [Subject] a 41 yr old leprosy patient [Treatment] 10 yrs with clofazimine [Effect] severe abdominal pain"}, {"id": "15061230_2_374", "context": "Osteonecrosis is a serious side effect of antiemetic treatment with dexamethasone and this serious complication should be incorporated in the current guidelines.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] side effect [Treatment] antiemetic treatment with dexamethasone [Effect] Osteonecrosis"}, {"id": "15663666_3_375", "context": "We report the development of scrotal ulcer in a patient with acute promyleocytic leukemia (APL) within 10 days of treatment with ATRA at a dose of 40 mg orally twice daily.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Subject] a patient with acute promyleocytic leukemia (APL) [Treatment] within 10 days of treatment with ATRA at a dose of 40 mg orally twice daily [Effect] scrotal ulcer"}, {"id": "14684937_1_376", "context": "After initiation of topical vitamin D3 ointment (20 micro g/g of tacalcitol) 10 g/day for the skin lesions, both the serum level of calcium and urinary excretion of calcium increased gradually.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] increased [Treatment] After initiation of topical vitamin D3 ointment (20 micro g/g of tacalcitol) 10 g/day [Effect] serum level of calcium and urinary excretion of calcium increased"}, {"id": "11485141_6_377", "context": "Vancomycin is the most frequently implicated drug, but other agents have been reported to cause LABD.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Vancomycin [Effect] LABD"}, {"id": "15623719_1_378", "context": "Vision declined after treatment with methylprednisolone, after which fundus examination became consistent with progressive outer retinal necrosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] methylprednisolone [Effect] Vision declined"}, {"id": "10682234_3_379", "context": "Eight days after the end of interferon treatment, he showed signs of inability to sit still for ten seconds and walked around constantly.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] inability [Subject] he [Treatment] Eight days after the end of interferon treatment [Effect] signs of inability to sit still for ten seconds and walked around constantly"}, {"id": "15895899_2_380", "context": "Drug-induced agranulocytosis during treatment with infliximab in enteropathic spondyloarthropathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] infliximab [Effect] Drug-induced agranulocytosis"}, {"id": "19555801_1_381", "context": "Aripiprazole-induced hiccups: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Aripiprazole [Effect] hiccups"}, {"id": "16728538_3_382", "context": "The hepatic enzyme disturbances normalized after discontinuation of pegvisomant.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] pegvisomant [Effect] The hepatic enzyme disturbances"}, {"id": "9777751_4_383", "context": "We present a case of a 58-year-old female patient with Graves' disease who developed AA in the third exposure to methimazole (MMI).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 58-year-old female patient with Graves' disease [Treatment] in the third exposure to methimazole (MMI) [Effect] AA"}, {"id": "16685112_2_384", "context": "CONCLUSIONS: This is the second case report that describes gemcitabine-induced radiation recall in rectus abdominus muscles after gemcitabine-based radiation therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] gemcitabine [Effect] radiation recall in rectus abdominus muscles"}, {"id": "16046172_2_385", "context": "One patient was an 80-year-old woman who was admitted for Staphylococcus aureus knee arthritis after several intraarticular injections of sodium hyaluronate and corticosteroids.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] an 80-year-old woman [Treatment] sodium hyaluronate and corticosteroids [Effect] Staphylococcus aureus knee arthritis"}, {"id": "6731466_5_386", "context": "Association of zomepirac administration with renal cortical necrosis is not known to have been previously demonstrated.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] Association [Treatment] zomepirac [Effect] renal cortical necrosis"}, {"id": "6427463_2_387", "context": "Vasomotor reactions after gold sodium thiomalate are well recognized.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] gold sodium thiomalate [Effect] Vasomotor reactions"}, {"id": "21515865_1_388", "context": "Moxifloxacin-acetaminophen-warfarin interaction during bacille Calmette-Guerin treatment for bladder cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] Moxifloxacin-acetaminophen-warfarin interaction; bacille Calmette-Guerin treatment"}, {"id": "15571949_1_389", "context": "In four patients, thrombosis occurred 2-45 days after severe hepatic veno-occlusive disease (HVOD) secondary to intensive chemotherapy containing busulfan.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Subject] four patients [Treatment] intensive chemotherapy containing busulfan [Effect] thrombosis occurred; severe hepatic veno-occlusive disease (HVOD)"}, {"id": "7139589_1_390", "context": "An adolescent male developed acute pancreatitis and pseudocyst of the pancreas 16 weeks after cessation of intramuscular L-asparaginase.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] An adolescent male [Treatment] cessation of intramuscular L-asparaginase [Effect] acute pancreatitis and pseudocyst of the pancreas"}, {"id": "22047557_1_391", "context": "A CFTR potentiator in patients with cystic fibrosis and the G551D mutation.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] in [Subject] patients with cystic fibrosis and the G551D mutation [Treatment] CFTR potentiator"}, {"id": "17205927_1_392", "context": "Quinapril is an angiotensin-converting enzyme inhibitor (ACE-inhibitor) and overdose can lead to prolonged hypotension and, less frequently, transient renal impairment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] can lead to [Treatment] Quinapril [Effect] prolonged hypotension and, less frequently, transient renal impairment"}, {"id": "9725786_1_393", "context": "We describe a renal transplant recipient maintained on cyclosporine and prednisone developing Nocardia Asteroides brain abscess.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developing [Subject] a renal transplant recipient [Treatment] maintained on cyclosporine and prednisone [Effect] Nocardia Asteroides brain abscess"}, {"id": "15588385_2_394", "context": "After an extensive review of the literature, we believe that this is the first communication of the successful use of amiodarone to control hyperthyroidism in a patient with PTU-induced fulminant hepatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] control [Subject] a patient with PTU-induced fulminant hepatitis [Treatment] amiodarone [Adverse event] induced [Treatment] PTU [Effect] fulminant hepatitis"}, {"id": "12042592_1_395", "context": "After identification of the index patient, additional inquiry revealed that the patient's mother was hospitalized previously for overwhelming sepsis associated with metamizole use.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] the patient's mother [Treatment] metamizole [Effect] overwhelming sepsis"}, {"id": "9671138_3_396", "context": "We report here on a heretofore undescribed respiratory syncytial virus (RSV) infection in a patient with a long-standing history of refractory CLL that was treated with fludarabine phosphate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] a patient with a long-standing history of refractory CLL [Treatment] fludarabine phosphate [Effect] respiratory syncytial virus (RSV) infection"}, {"id": "10812579_1_397", "context": "A 77-year-old woman with no history of epilepsy presented a probable nonconvulsive status epilepticus while receiving continuous intravenous morphine for back pain relating to vertebral metastasis of a malignant lymphoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] A 77-year-old woman with no history of epilepsy [Treatment] continuous intravenous morphine [Effect] a probable nonconvulsive status epilepticus"}, {"id": "16685007_2_398", "context": "Oral corticosteroids (OCS) may be associated with systemic adverse events (AEs), which can be reduced by replacing OCS with inhaled corticosteroids (ICS).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Oral corticosteroids (OCS) [Effect] systemic adverse events (AEs)"}, {"id": "15072497_1_399", "context": "Development of Peyronie's disease during long-term colchicine treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] long-term colchicine treatment [Effect] Peyronie's disease"}, {"id": "9007910_6_400", "context": "The principle treatment for DPD-deficient patients with severe acute 5-FU reactions is supportive care; however, the administration of thymidine potentially may reverse severe 5-FU-induced neurologic symptoms such as encephalopathy and coma.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] reverse [Subject] DPD-deficient patients with severe acute 5-FU reactions [Treatment] thymidine [Adverse event] induced [Treatment] 5-FU [Effect] neurologic symptoms such as encephalopathy and coma"}, {"id": "16599252_1_401", "context": "Adverse reaction in a patient with aspirin-induced asthma treated with zafirlukast.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient [Treatment] aspirin [Effect] asthma"}, {"id": "6788011_4_402", "context": "The nephrotic syndrome developed in a patient receiving therapy with gold for rheumatoid arthritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient [Treatment] therapy with gold [Effect] nephrotic syndrome"}, {"id": "6731466_6_403", "context": "This observation adds another dimension to the previously reported renal complications of nonsteroidal anti-inflammatory agents, especially zomepirac.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reported [Treatment] nonsteroidal anti-inflammatory agents, especially zomepirac [Effect] renal complications"}, {"id": "12488741_1_404", "context": "Clinical, spectroscopic, and imaging abnormalities resolved with discontinuation of metronidazole.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] resolved [Treatment] metronidazole [Effect] Clinical, spectroscopic, and imaging abnormalities"}, {"id": "20202988_8_405", "context": "In two other patients (one after OLTX and one with Crohn's disease), a raltegravir-based HIV therapy was started while patients received 1 or 2 mg of tacrolimus twice daily.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] received [Subject] two other patients (one after OLTX and one with Crohn's disease) [Treatment] raltegravir; 1 or 2 mg of tacrolimus twice daily."}, {"id": "16265343_2_406", "context": "Reversible cardiomyopathy caused by administration of interferon alpha.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused by [Treatment] administration of interferon alpha [Effect] Reversible cardiomyopathy"}, {"id": "8696525_1_407", "context": "Metipranolol associated granulomatous anterior uveitis: not so uncommon as thought.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Metipranolol [Effect] granulomatous anterior uveitis"}, {"id": "12851279_13_408", "context": "There was an increase in serious adverse events with bleeding in the tifacogin group in both cohorts (6.5% tifacogin and 4.8% placebo for high INR; 6.0% tifacogin and 3.3% placebo for low INR).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] adverse events [Treatment] tifacogin [Effect] bleeding"}, {"id": "3318771_1_409", "context": "We also describe a case of timolol-induced ocular pemphigoid.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a case [Treatment] timolol [Effect] ocular pemphigoid"}, {"id": "17016002_1_410", "context": "A 70-year-old man was admitted to our hospital because of dyspnea after taking an antihistaminic agent (homochlorcyclizine hydrochloride) for itching.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] taking [Subject] A 70-year-old man [Treatment] an antihistaminic agent (homochlorcyclizine hydrochloride) [Effect] dyspnea"}, {"id": "10212021_1_411", "context": "Methadone withdrawal when starting an antiretroviral regimen including nevirapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] starting [Treatment] an antiretroviral regimen including nevirapine [Effect] Methadone withdrawal"}, {"id": "9253492_4_412", "context": "The oligohidrosis caused by zonisamide was reversible in that the patient regained the ability to sweat within 2 weeks of the cessation of drug administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] of the [Subject] the patient [Treatment] zonisamide; cessation of drug administration [Effect] regained the ability to sweat within 2 weeks"}, {"id": "16317298_4_413", "context": "Radiation recall related to gemcitabine has been reported in lung and breast cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] gemcitabine [Effect] Radiation recall"}, {"id": "10435399_1_414", "context": "It carries a well-known risk of neutropenia and agranulocytosis, which necessitates the immediate discontinuation of clozapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] risk [Treatment] clozapine [Effect] neutropenia and agranulocytosis"}, {"id": "17827338_2_415", "context": "Vicriviroc (SCH 417690), a CCR5 receptor antagonist, is currently under investigation for the treatment of human immunodeficiency virus infection.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Treatment] Vicriviroc (SCH 417690), a CCR5 receptor antagonist"}, {"id": "9253492_2_416", "context": "Children receiving zonisamide should be monitored for oligohidrosis and the development of neurological symptoms associated with an elevation of body temperature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] monitored [Subject] Children [Treatment] zonisamide [Effect] oligohidrosis; development of neurological symptoms associated"}, {"id": "11147747_3_417", "context": "This concerns 2 male patients who experienced incontinence while taking venlafaxine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experienced [Subject] 2 male patients [Treatment] venlafaxine [Effect] incontinence"}, {"id": "1087773_2_418", "context": "Polyarthritis, hepatitis and anti-native DNA antibodies after treatment with ethambutol and rifampicin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] ethambutol and rifampicin [Effect] Polyarthritis, hepatitis and anti-native DNA antibodies"}, {"id": "15507779_4_419", "context": "We report an HIV-infected woman who developed mild leukopenia as the first sign of a nevirapine-related adverse event, which was followed by skin and hepatic toxicity associated with a more severe leukopenia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] HIV-infected woman [Treatment] nevirapine [Effect] mild leukopenia; followed by skin and hepatic toxicity associated with a more severe leukopeni"}, {"id": "18364401_2_420", "context": "OBJECTIVE: To report a case of rapidly occurring hyperglycemia that occurred in a geriatric patient 3 days after treatment with olanzapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurring [Subject] a geriatric patient [Treatment] olanzapine [Effect] hyperglycemia"}, {"id": "12851279_15_421", "context": "Tifacogin administration was associated with an increase in risk of bleeding, irrespective of baseline INR.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Tifacogin [Effect] an increase in risk of bleeding"}, {"id": "6618859_1_422", "context": "Gynecomastia developed in two epileptic patients some months after the addition of oral fluoresone 750 mg daily to the phenobarbital and phenytoin already being administered.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] two epileptic patients [Treatment] some months after the addition of oral fluoresone 750 mg daily to the phenobarbital and phenytoin already being administered [Effect] Gynecomastia"}, {"id": "6113770_1_423", "context": "The authors describe a case of combined lithium and haloperidol toxicity characterized by hyperpyrexia, severe rigidity, mutism, and development of irreversible tardive dyskinesia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] toxicity [Treatment] combined lithium and haloperidol [Effect] hyperpyrexia, severe rigidity, mutism, and development of irreversible tardive dyskinesia"}, {"id": "17665812_3_424", "context": "Occasionally, despite good therapeutic response, clozapine must be stopped due to dangerous side effects such as agranulocytosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due to [Treatment] clozapine [Effect] dangerous side effects such as agranulocytosis"}, {"id": "7139589_4_425", "context": "Three cases of pseudocyst of the pancreas in two women and one man have previously been reported with the use of intravenous L-asparaginase.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reported [Subject] two women and one man [Treatment] intravenous L-asparaginase [Effect] pseudocyst of the pancreas"}, {"id": "17182354_4_426", "context": "We report a case of Ritalin-associated cataract and glaucoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Ritalin [Effect] cataract and glaucoma"}, {"id": "19884751_3_427", "context": "We discuss a patient who developed severe renal tubular dysfunction secondary to short-term therapy with Amikacin, resulting in refractory hypokalemia, hypocalcemia, hypomagnesemia, metabolic alkalosis, and polyuria.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] short-term therapy with Amikacin [Effect] severe renal tubular dysfunction; resulting in refractory hypokalemia, hypocalcemia, hypomagnesemia, metabolic alkalosis, and polyuria"}, {"id": "1655228_1_428", "context": "Cardiac toxicity related to BCNU has not been described well.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] BCNU [Effect] Cardiac toxicity"}, {"id": "12891225_2_429", "context": "Aprepitant is a neurokinin(1) receptor antagonist that enhances prevention of chemotherapy-induced nausea and vomiting when added to conventional therapy with a corticosteroid and a 5-hydroxytryptamine(3) (5-HT(3)) antagonist.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] enhances [Treatment] Aprepitant; added to conventional therapy with a corticosteroid and a 5-hydroxytryptamine(3) (5-HT(3)) antagonist [Effect] prevention of chemotherapy-induced nausea and vomiting"}, {"id": "17123120_2_430", "context": "Thus, tacrolimus-induced HUS is a rare cause of ARF in nephrotic syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] tacrolimus [Effect] HUS"}, {"id": "15927910_3_431", "context": "Clinicians should be vigilant when monitoring for cardiotoxicity in patients receiving pentamidine throughout the duration of therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] patients [Treatment] pentamidine [Effect] cardiotoxicity"}, {"id": "14684937_3_432", "context": "The present case is the first report of hypercalcemia induced by vitamin D3 ointment and thiazide simultaneously.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] The present case [Treatment] vitamin D3 ointment and thiazide simultaneously [Effect] hypercalcemia"}, {"id": "11352235_1_433", "context": "CONCLUSION: Significant weight loss is a potential adverse event in patients with rheumatoid arthritis treated with leflunomide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] potential adverse even [Treatment] leflunomide [Effect] Significant weight loss"}, {"id": "7071645_2_434", "context": "We have described a man with classic rheumatoid arthritis who had membranous nephropathy associated with nephrotic syndrome not related to gold or penicillamine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] not related [Subject] a man with classic rheumatoid arthritis [Treatment] gold or penicillamine therapy [Effect] membranous nephropathy associated with nephrotic syndrome"}, {"id": "24531907_1_435", "context": "Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] for [Subject] HIV-infected patients [Treatment] Pharmacokinetics of etravirine; concomitantly treated with rifampin"}, {"id": "9352164_5_436", "context": "We thus concluded that an excessive dose of AZ had probably destroyed the gastric mucosal barrier or thrombocytopenia due to bone marrow disorder and thus eventually led to the development of hemorrhagic gastritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] had [Treatment] excessive dose of AZ [Effect] destroyed the gastric mucosal barrier or thrombocytopenia; hemorrhagic gastritis"}, {"id": "8430717_1_437", "context": "Acyclovir-induced neurotoxicity: concentration-side effect relationship in acyclovir overdose.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Acyclovir [Effect] neurotoxicity"}, {"id": "1680596_2_438", "context": "Psoriasis-like skin reaction in a patient with rheumatoid arthritis after sulphasalazine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a patient with rheumatoid arthritis [Treatment] sulphasalazine therapy [Effect] Psoriasis-like skin reaction"}, {"id": "10579985_4_439", "context": "We describe the clinical course of 2 patients with Crohn's disease (CD) in whom lymphoma was diagnosed after treatment with infliximab.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] diagnosed [Subject] 2 patients with Crohn's disease (CD) [Treatment] treatment with infliximab [Effect] lymphoma"}, {"id": "17275666_2_440", "context": "Valproic acid is commonly and effectively used in the treatment of idiopathic generalized epilepsies, including juvenile absence epilepsy.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] used [Treatment] Valproic acid"}, {"id": "14561622_3_441", "context": "We report a case of intrathecal methotrexate neurotoxicity manifesting as left arm weakness and aphasia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] manifesting [Subject] a case [Treatment] intrathecal methotrexate neurotoxicity [Effect] left arm weakness and aphasia"}, {"id": "22677303_11_442", "context": "According to the Drug Interaction Probability Scale, a causal relationship between the warfarin-cloxacillin interaction and increased INR value was rated \"probable\".", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] relationship [Treatment] warfarin; cloxacillin [Effect] increased INR value"}, {"id": "16393774_4_443", "context": "We present the cases of two female patients diagnosed with relapsing-remitting multiple sclerosis (RRMS) who developed inflammatory musculoskeletal manifestations, following IFN-beta therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] two female patients diagnosed with relapsing-remitting multiple sclerosis (RRMS) [Treatment] IFN-beta [Effect] inflammatory musculoskeletal manifestations"}, {"id": "440873_1_444", "context": "Dystonia associated with carbamazepine administration: experience in brain-damaged children.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated with [Subject] brain-damaged children [Treatment] carbamazepine administration [Effect] Dystonia"}, {"id": "20925534_10_445", "context": "In all, 51 patients had a gastrointestinal event; the event rate was 1.1% with omeprazole and 2.9% with placebo at 180 days (hazard ratio with omeprazole, 0.34, 95% confidence interval [CI], 0.18 to 0.63; P<0.001).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] had [Subject] 51 patients [Treatment] 1.1% with omeprazole and 2.9% with placebo [Effect] gastrointestinal event"}, {"id": "9865241_1_446", "context": "CONCLUSION: We report a case of the use of pamidronate for significant hypercalcemia secondary to acute vitamin D poisoning.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] for [Subject] a case [Treatment] pamidronate"}, {"id": "20925534_1_447", "context": "Clopidogrel with or without omeprazole in coronary artery disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] in [Treatment] Clopidogrel with or without omeprazole"}, {"id": "11001600_1_448", "context": "The cases are important in documenting that drug-induced dystonias do occur in patients with dementia, that risperidone appears to have contributed to dystonia among elderly patients, and that the categorization of dystonic reactions needs further clarification.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] contributed [Subject] patients with dementia; elderly patients [Treatment] risperidone [Effect] dystonia"}, {"id": "18580694_1_449", "context": "In addition, there is a report on prolonged ECT seizure related to ciprofloxacin, which has an epileptogenic property with a similar action to beta-lactam antibiotics.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] ciprofloxacin [Effect] prolonged ECT seizure"}, {"id": "10592946_2_450", "context": "After abstinence from oolong tea his delirium resolved.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] After [Treatment] oolong tea"}, {"id": "16901609_1_451", "context": "Anaphylaxis to intrathecal diamorphine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Treatment] intrathecal diamorphine [Effect] Anaphylaxis"}, {"id": "8726608_3_452", "context": "This case suggests that acyclovir when given intravenously in doses of 10 mg/kg may result in increased serum lithium concentrations.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] result [Treatment] acyclovir [Effect] increased serum lithium concentrations"}, {"id": "15522120_12_453", "context": "After approximately two weeks of sertraline treatment he noted an intense itching sensation in his scalp after eating a piece of chocolate cake.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] noted [Treatment] two weeks of sertraline [Effect] ntense itching sensation in his scalp"}, {"id": "8589490_2_454", "context": "Pigmentary aberrations are well known side effects of cytostatic chemotherapeutic agents.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] side effects [Treatment] cytostatic chemotherapeutic agents [Effect] Pigmentary aberrations"}, {"id": "7485371_1_455", "context": "CONCLUSION: Atovaquone should be added to the list of agents causing vortex keratopathy involving the corneal epithelium.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] causing [Treatment] Atovaquone [Effect] vortex keratopathy involving the corneal epithelium"}, {"id": "10812579_2_456", "context": "A generalized tonic-clonic seizure occurred a few minutes after injection of the morphine antagonist naloxone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Treatment] a few minutes after injection of the morphine antagonist naloxone [Effect] generalized tonic-clonic seizure"}, {"id": "7748076_1_457", "context": "CONCLUSION: Squamous metaplasia in these cases appears to be a consequence of progestin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] consequence [Subject] these cases [Treatment] progestin therapy [Effect] Squamous metaplasia"}, {"id": "6610943_4_458", "context": "This association should be considered in the period after vasopressin-treated gastrointestinal hemorrhage.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] vasopressin [Effect] gastrointestinal hemorrhage"}, {"id": "6693840_4_459", "context": "The gynecomastia regressed when the theophylline was discontinued.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] discontinued [Treatment] theophylline [Effect] gynecomastia"}, {"id": "3277077_1_460", "context": "Renal hypophosphatemia in this patient was caused by the erroneous intake of 1 g doxycycline.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Subject] this patient [Treatment] the erroneous intake of 1 g doxycycline. [Effect] Renal hypophosphatemia"}, {"id": "2297635_1_461", "context": "Despite a response of the meningeal tumor the patient developed in the third week of MTX treatment a progressive visual loss and loss of consciousness which worsened during subsequent Ara-C treatment and led to death within 3 weeks.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] the patient [Treatment] MTX treatment; subsequent Ara-C treatment; within 3 weeks. [Effect] a progressive visual loss and loss of consciousness; led to death"}, {"id": "1087773_1_462", "context": "After seven months' continuous treatment for suspected tuberculosis with rifampicin and ethambutol a nine-year-old boy developed polyarthritis, rash and hepatitis in association with anti-native DNA antibodies and positive antinuclear factor.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a nine-year-old boy [Treatment] seven months' continuous treatment; with rifampicin and ethambutol [Effect] polyarthritis, rash and hepatitis in association with anti-native DNA antibodies and positive antinuclear factor"}, {"id": "16609346_1_463", "context": "A few recent individual case reports have suggested that a myasthenic syndrome may be associated with statin treatment, but this association is not well described.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] A few recent individual case [Treatment] statin treatment [Effect] myasthenic syndrome"}, {"id": "21658326_2_464", "context": "Topical imiquimod and tumor necrosis factor (TNF)-alpha inhibitors have gained wide acceptance as safe and effective treatments for non-melanoma skin cancer (NMSC) and moderate to severe psoriasis, respectively.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatments [Treatment] Topical imiquimod [Potential therapeutic event] treatments [Treatment] tumor necrosis factor (TNF)-alpha"}, {"id": "6731466_1_465", "context": "Focal renal cortical necrosis associated with zomepirac.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] zomepirac [Effect] Focal renal cortical necrosis"}, {"id": "8850251_6_466", "context": "We experienced 2 cases of mequitazine-induced photosensitivity reaction in patients who took mequitazine for their dermatologic problems.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] patients [Treatment] mequitazine [Effect] photosensitivity reaction"}, {"id": "20349794_4_467", "context": "Carboplatin was substituted for cisplatin, and there were no further episodes of SIADH.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] substituted [Treatment] Carboplatin was substituted for cisplatin"}, {"id": "16490518_3_468", "context": "Severe steroid-induced glaucoma following intravitreal injection of triamcinolone acetonide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] intravitreal injection of triamcinolone acetonide [Effect] glaucoma"}, {"id": "16160485_1_469", "context": "CD20-negative T-cell-rich B-cell lymphoma as a progression of a nodular lymphocyte-predominant Hodgkin's lymphoma treated with rituximab: a molecular analysis using laser capture microdissection.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Treatment] rituximab [Effect] CD20-negative T-cell-rich B-cell lymphoma"}, {"id": "10717401_2_470", "context": "We report the case of an adult patient with acute lymphoblastic leukemia who presented with repeated transient ischemic attacks followed by a seizure during consolidation treatment with L-asparaginase.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] an adult patient with acute lymphoblastic leukemia [Treatment] consolidation treatment with L-asparaginase [Effect] repeated transient ischemic attacks followed by a seizure"}, {"id": "16317298_1_471", "context": "Gemcitabine-related radiation recall in a patient with pancreatic cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] a patient with pancreatic cancer [Treatment] Gemcitabine [Effect] radiation recall"}, {"id": "8404753_7_472", "context": "After development of the tics in 2, CBZ was continued at the same or higher dose, and the tics abated and then ceased spontaneously < or = 6 months.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Treatment] CBZ [Effect] tics"}, {"id": "16978752_4_473", "context": "Thus any case of severe neutropenia occurring in a patient receiving olanzapine is alarming to clinicians.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurring [Subject] a patient [Treatment] olanzapine [Effect] severe neutropenia"}, {"id": "18203308_4_474", "context": "We describe 3 AS patients treated with etanercept for active AS who developed new onset of CD while AS related symptoms responded well to etanercept.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] 3 AS patients [Treatment] etanercept for active AS [Effect] CD"}, {"id": "11510798_5_475", "context": "It is concluded that the aforementioned pathological manifestations were due to chemotherapy and included a pulmonary adverse reaction, a feature never previously associated with oxaliplatinum and 5-fluorouracil regimens.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] oxaliplatinum and 5-fluorouracil regimens [Effect] a pulmonary adverse reaction"}, {"id": "17619811_2_476", "context": "A case of colchicine-induced rhabdomyolysis is reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] colchicine [Effect] rhabdomyolysis"}, {"id": "7056119_4_477", "context": "Because of a recurrence of paroxysmal atrial fibrillation, the dose of the drug was increased to 1.4 g/day; 24 hours later AVT with syncope developed but responded promptly to atropine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] paroxysmal atrial fibrillation [Treatment] the dose of the drug was increased to 1.4 g/day [Effect] AVT with syncope [Potential therapeutic event] responded [Treatment] atropine"}, {"id": "17167851_2_478", "context": "Three male patients aged 78-83 years are presented, in whom severe hepatotoxic reactions emerged after CPA administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] Three male patients aged 78-83 years [Treatment] CPA [Effect] severe hepatotoxic reactions"}, {"id": "172214_2_479", "context": "Exacerbations of the heart failure were temporally related to the administration of the antitumor antibiotics actinomycin-D (NSC-3053) and mithramycin (NSC-24559).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] antitumor antibiotics actinomycin-D (NSC-3053) and mithramycin (NSC-24559) [Effect] Exacerbations of the heart failure"}, {"id": "18347524_1_480", "context": "Diffuse alveolar hemorrhage after leflunomide therapy in a patient with rheumatoid arthritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a patient with rheumatoid arthritis [Treatment] leflunomide [Effect] Diffuse alveolar hemorrhage"}, {"id": "15836666_2_481", "context": "We report a case of a 64-year-old man with secondary adrenocortical insufficiency who has been on a chronic transdermal fentanyl treatment because of sciatic pain syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Subject] a 64-year-old man [Treatment] a chronic transdermal fentanyl treatment [Effect] secondary adrenocortical insufficiency"}, {"id": "6440806_1_482", "context": "A 52-year-old, white female developed low-grade fever, cough, and dyspnea after 8 weeks treatment with sodium aurothiomalate for rheumatoid arthritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 52-year-old; white female [Treatment] sodium aurothiomalate [Effect] low-grade fever, cough, and dyspnea"}, {"id": "12786839_1_483", "context": "In both cases, high fever, skin rash, liver dysfunction and atypical lymphocytosis developed 3 weeks after initiating treatment with SASP.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] In both cases [Treatment] SASP [Effect] high fever, skin rash, liver dysfunction and atypical lymphocytosis"}, {"id": "12659609_2_484", "context": "OBJECTIVE: To report a case of severe chloroquine toxicity in the presence of high-grade chloroquine-resistant Plasmodium vivax.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] toxicity [Subject] high-grade chloroquine-resistant Plasmodium vivax [Treatment] chloroquine [Effect] severe chloroquine toxicity"}, {"id": "15857283_4_485", "context": "RESULTS: All cases developed corneal endothelial deposits after previous use of rifabutin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] All cases [Treatment] rifabutin [Effect] corneal endothelial deposits"}, {"id": "3136101_2_486", "context": "Two infants developed hyperkalemia shortly after cessation of prolonged ACTH therapy for infantile spasms.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Two infants [Treatment] shortly after cessation of prolonged ACTH therapy [Effect] hyperkalemia"}, {"id": "19318596_2_487", "context": "In this case, CIPS was considered to be probably associated with cyclosporine according to the Naranjo probability scale.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] cyclosporine [Effect] CIPS"}, {"id": "18751717_1_488", "context": "Acute syphilitic posterior placoid chorioretinitis following intravitreal triamcinolone acetonide injection.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] intravitreal triamcinolone acetonide injection [Effect] Acute syphilitic posterior placoid chorioretinitis"}, {"id": "7139589_2_489", "context": "Delayed pseudocyst of the pancreas can be a complication of intramuscular L-asparaginase.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] can [Treatment] intramuscular L-asparaginase [Effect] Delayed pseudocyst of the pancreas"}, {"id": "7783891_3_490", "context": "I report a 35-year-old woman with occult coronary artery disease who experienced cardiac arrest within minutes after receiving a first-time dose of subcutaneous sumatriptan for migraine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experienced [Subject] a 35-year-old woman with occult coronary artery disease [Treatment] within minutes after receiving a first-time dose of subcutaneous sumatriptan [Effect] cardiac arrest"}, {"id": "10332990_2_491", "context": "Epoprostenol (prostacyclin) is currently approved for treatment of primary pulmonary hypertension; however, it is being evaluated in other forms of pulmonary hypertension, particularly scleroderma.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Treatment] Epoprostenol (prostacyclin)"}, {"id": "11724089_4_492", "context": "OBJECTIVE: To report a fatal case of toxic epidermal necrolysis in a man who was treated with oral ofloxacin for epididymitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] man [Treatment] oral ofloxacin [Effect] fatal case of toxic epidermal necrolysis"}, {"id": "12869178_1_493", "context": "Massive pulmonary embolism due to late-onset heparin-induced thrombocytopenia following coronary artery bypass graft surgery: successful treatment with lepirudin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] heparin [Effect] Massive pulmonary embolism"}, {"id": "11283125_1_494", "context": "Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] Value [Subject] increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma [Treatment] high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol"}, {"id": "11450788_4_495", "context": "We report a case of fulminant hepatic failure associated with didanosine and masquerading as a surgical abdomen and compare the clinical, biologic, histologic, and ultrastructural findings with reports described previously.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] a case [Treatment] didanosine [Effect] fulminant hepatic failure"}, {"id": "16537817_10_496", "context": "An objective causal assessment suggests that rhabdomyolysis, renal failure, and possibly hepatotoxicity were probably related to an amiodarone-simvastatin interaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] an amiodarone-simvastatin interaction [Effect] rhabdomyolysis, renal failure, and possibly hepatotoxicity"}, {"id": "11105373_2_497", "context": "Nail staining from hydroquinone cream.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] from [Treatment] hydroquinone cream [Effect] Nail staining"}, {"id": "748238_2_498", "context": "The development of an IgG lambda-type monoclonal gammopathy and subsequent multiple myeloma in an epilepsy patient on diphenylhydantoin (DILANTIN) therapy for 20 years is reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Subject] an epilepsy patient [Treatment] diphenylhydantoin (DILANTIN) therapy for 20 years [Effect] an IgG lambda-type monoclonal gammopathy and subsequent multiple myeloma"}, {"id": "10698143_2_499", "context": "Ibuprofen overdose is usually characterized by GI upset, dizziness, and mild sedation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] characterized [Treatment] Ibuprofen overdose [Effect] GI upset, dizziness, and mild sedation"}, {"id": "20628041_5_500", "context": "His PD medications (pramipexole, entacapone, and immediate-release levodopa/carbidopa 100 mg/25 mg, 1.5 tablets 4 times daily) were administered via nasogastric tube.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] administered [Subject] His PD [Treatment] pramipexole, entacapone, and immediate-release levodopa/carbidopa 100 mg/25 mg, 1.5 tablets 4 times daily; via nasogastric tube"}, {"id": "18675768_15_501", "context": "CONCLUSIONS: This is the first report of a possible interaction between propafenone and citalopram, which caused propafenone adverse effects (eg, dizziness, falls) and mimicked coronary artery disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] propafenone; citalopram [Effect] adverse effects (eg, dizziness, falls) and mimicked coronary artery disease"}, {"id": "14614357_2_502", "context": "We report the case of a young healthy woman who presented an early overanticoagulation when receiving acenocoumarol for a first thromboembolic episode.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] a young healthy woman [Treatment] acenocoumarol [Effect] early overanticoagulation"}, {"id": "3708949_2_503", "context": "A patient with acute changes suggesting acute hepatitis after parenteral amiodarone administration is described.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] A patient [Treatment] parenteral amiodarone administration [Effect] acute changes suggesting acute hepatitis"}, {"id": "18364401_4_504", "context": "Subsequently, he developed hyperglycemia (fasting blood glucose 138 mg/dL) that resolved when olanzapine was stopped and recurred (fasting blood glucose 150 mg/dL) after 2 days of rechallenge with olanzapine 2.5 mg twice daily.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] resolved [Treatment] olanzapine was stopped [Adverse event] after [Treatment] 2 days of rechallenge with olanzapine 2.5 mg twice daily [Effect] hyperglycemia; recurred (fasting blood glucose 150 mg/dL)"}, {"id": "8151270_1_505", "context": "Fulminant hepatitis with severe lactate acidosis in HIV-infected patients on didanosine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] on [Subject] HIV-infected patients [Treatment] didanosine [Effect] Fulminant hepatitis with severe lactate acidosis"}, {"id": "18425523_4_506", "context": "Persisent ocular hypertension following intravitreal ranibizumab.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] intravitreal ranibizumab [Effect] Persisent ocular hypertension"}, {"id": "14968106_4_507", "context": "STUDY DESIGN: Case report of a 31-year-old woman who presented with toxic myelopathy due to intrathecal administration of doxorubicin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Subject] a 31-year-old woman [Treatment] intrathecal administration of doxorubicin. [Effect] toxic myelopathy"}, {"id": "18166746_4_508", "context": "The patient had a background of obsessive compulsive disorder treated with paroxetine.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Subject] The patient had a background of obsessive compulsive disorder [Treatment] paroxetine"}, {"id": "9704170_2_509", "context": "Clozapine is speculated to cause rhabdomyolysis in patients with defective calcium-activated K+ channels.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Subject] patients with defective calcium-activated K+ channels [Treatment] Clozapine [Effect] rhabdomyolysis"}, {"id": "11485141_2_510", "context": "CONCLUSIONS: We report the first case of gemcitabine-induced LABD.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] gemcitabine [Effect] LABD"}, {"id": "10752888_1_511", "context": "Nitrofurantoin-induced lung disease: two cases demonstrating resolution of apparently irreversible CT abnormalities.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Nitrofurantoin [Effect] lung disease"}, {"id": "2012922_2_512", "context": "Trazodone-induced transient hypomanic symptoms and their management.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Trazodone [Effect] transient hypomanic symptoms"}, {"id": "2219619_1_513", "context": "Acute aluminum toxicity after continuous intravesical alum irrigation for hemorrhagic cystitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] continuous intravesical alum irrigation [Effect] Acute aluminum toxicity"}, {"id": "18076602_1_514", "context": "Amphotericin B-induced cutaneous leucocytoclastic vasculitis: case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Amphotericin B [Effect] cutaneous leucocytoclastic vasculitis"}, {"id": "8726608_5_515", "context": "When measured, the serum lithium level had increased 4-fold during acyclovir therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] acyclovir [Effect] serum lithium level had increased 4-fold"}, {"id": "17504225_3_516", "context": "In this paper it is reported an evidence of pharmacokinetic interaction between clarithromycin and sirolimus in a kidney transplanted woman, suffering from pulmonary infection sustained by a bacterial pathogen, in particular Hemophilus Influenzae.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] between [Subject] a kidney transplanted woman, suffering from pulmonary infection sustained by a bacterial pathogen, in particular Hemophilus Influenzae [Treatment] clarithromycin and sirolimus [Effect] pharmacokinetic interaction"}, {"id": "12847760_1_517", "context": "A 25-year-old man with a history of mid-borderline (BB) Hansen's disease developing a reversal reaction after starting dapsone and rifampin therapy is presented.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] A 25-year-old man with a history of mid-borderline (BB) Hansen's disease [Treatment] dapsone and rifampin therapy [Effect] a reversal reaction"}, {"id": "15516308_15_518", "context": "In all cases, drugs in addition to quetiapine were detected, but in cases #1 and #2, the cause of death was considered to be a quetiapine overdose and the other drugs were not considered to be contributory.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Subject] cases #1 and #2 [Treatment] quetiapine overdose [Effect] death"}, {"id": "17275666_4_519", "context": "Similar to antiarrhythmic drugs aggravating particular arrhythmias, antiepileptic drugs can paradoxically induce new seizure types or exacerbate existing ones.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induce [Treatment] antiepileptic drugs [Effect] new seizure types or exacerbate existing ones"}, {"id": "16192734_3_520", "context": "We report here a rare case of ritodrine-hydrochloride-induced rhabdomyolysis in a pregnant patient with myotonic dystrophy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] pregnant patient with myotonic dystrophy. [Treatment] ritodrine-hydrochloride [Effect] rhabdomyolysis"}, {"id": "7748076_2_521", "context": "OBJECTIVE: To report the finding of squamous metaplasia within endometrial glands occurring as a result of progestin therapy of hyperplasia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] as a result of [Treatment] progestin therapy [Effect] squamous metaplasia within endometrial glands"}, {"id": "9007910_8_522", "context": "IMPLICATIONS FOR NURSING PRACTICE: Nurses must understand the pharmacology, mechanism of action, clinical presentation, potentially lethal risks, and traumatic psychosocial stresses experienced by DPD-deficient patients with cancer receiving 5-FU therapy in order to develop timely interventions and alternative plans of care.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] receiving [Subject] DPD-deficient patients with cancer [Treatment] 5-FU therapy"}, {"id": "8912599_2_523", "context": "Methotrexate is an effective but potentially toxic treatment for psoriasis.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Treatment] Methotrexate"}, {"id": "18203308_3_524", "context": "Typical symptoms of active CD occurred 11, 12, and 26 months after start of etanercept therapy, respectively.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Treatment] etanercept therapy [Effect] Typical symptoms of active CD"}, {"id": "53128_3_525", "context": "This progressed to tracheal compression with stridor after he had taken some aspirin for relief of the neck pain.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] progressed [Subject] he [Treatment] aspirin [Effect] tracheal compression with stridor"}, {"id": "9533061_2_526", "context": "OBJECTIVE: To report a case of toxin-positive Clostridium difficile-induced colitis (CDIC) after use of clindamycin phosphate vaginal cream.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] clindamycin phosphate vaginal cream [Effect] toxin-positive Clostridium difficile-induced colitis"}, {"id": "20234160_1_527", "context": "Severe vancomycin-induced anaphylactic reaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] vancomycin [Effect] anaphylactic reaction"}, {"id": "8876616_2_528", "context": "We report the case of a 74-year-old female patient who received the antide-pressant amitriptyline because of a major depression.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] received [Subject] a 74-year-old female patient; a major depression [Treatment] antide-pressant amitriptyline"}, {"id": "16192734_2_529", "context": "Rhabdomyolysis has been recognized as a complication of tocolytic therapy with ritodrine hydrochloride.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] ritodrine hydrochloride [Effect] Rhabdomyolysis"}, {"id": "18628507_5_530", "context": "Voriconazole (VRC) has not previously been reported to cause angio-oedema.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Voriconazole (VRC) [Effect] angio-oedema"}, {"id": "12477460_3_531", "context": "CONCLUSION: Tamoxifen may cause malignant transformation of endometriosis through atypical endometriosis even in the postmenopausal state.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Tamoxifen [Effect] malignant transformation of endometriosis through atypical endometriosis"}, {"id": "10573314_5_532", "context": "One patient had an episode of prostatitis, which was treated with levofloxacin immediately prior to tolterodine initiation.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Subject] One patient [Treatment] levofloxacin; tolterodine"}, {"id": "16393774_5_533", "context": "The first patient developed a monoarthritis 2 weeks after initiation of IFN-beta, which persisted during the 14 months of therapy and resolved with discontinuation of the medication.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] initiation [Subject] The first patient [Treatment] IFN-beta [Effect] monoarthritis"}, {"id": "10682234_9_534", "context": "The present report illustrates a rare case of refractory akathisia after interferon-alpha treatment and also that levodopa treatment would be theoretically and practically useful in reducing the neurotoxicity associated with interferon-alpha.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] interferon-alpha treatment [Effect] refractory akathisia [Potential therapeutic event] useful [Treatment] levodopa treatment [Adverse event] associated [Treatment] interferon-alpha [Effect] neurotoxicity"}, {"id": "18837734_1_535", "context": "Rosaceiform eruption induced by erlotinib.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] erlotinib. [Effect] Rosaceiform eruption"}, {"id": "6697887_2_536", "context": "The incidence of oral-verapamil-induced hypotension in the presence of concomitant beta-adrenergic blockade by the oral route is quite rare.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] oral-verapamil; in the presence of concomitant beta-adrenergic blockade [Effect] hypotension"}, {"id": "8726608_4_537", "context": "Until additional data are available, if intravenous acyclovir is administered concurrently with lithium, we recommend closely monitoring patients for signs of lithium toxicity and measuring serum lithium levels every second or third day.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] signs [Treatment] intravenous acyclovir is administered concurrently with lithium [Effect] lithium toxicity"}, {"id": "11283125_9_538", "context": "Disappointingly, with the dose schedule used in this protocol, HD Ara-C added to HD MTX, although well tolerated, failed to further decrease the incidence of CNS relapse or to improve the overall DFS.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] failed [Treatment] HD Ara-C; HD MTX [Effect] further decrease the incidence of CNS relapse or to improve the overall DFS"}, {"id": "3732375_1_539", "context": "Theophylline intoxication following viloxazine induced decrease in clearance.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] viloxazine [Effect] Theophylline intoxication"}, {"id": "11197767_3_540", "context": "Cercarial encystment at concentrations of 25000 microg/l or higher was significantly impaired by all test metals; however, at lower concentrations only zinc demonstrated toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] demonstrated [Treatment] lower concentrations; zinc [Effect] toxicity"}, {"id": "12504711_3_541", "context": "PURPOSE: We report an unusual paradoxical effect of brimonidine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] brimonidine [Effect] unusual paradoxical effect"}, {"id": "17387702_1_542", "context": "Renal failure after high-dose methotrexate in a child homozygous for MTHFR C677T polymorphism.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a child homozygous for MTHFR C677T polymorphism [Treatment] high-dose methotrexate [Effect] Renal failure"}, {"id": "19131789_2_543", "context": "Although his renal function recovered completely with high-dose leucovorin, hemodialysis, charcoal hemoperfusion, and carboxypeptidase G2, we present this case to emphasize that signs of renal toxicity may be present as early as 2 hours after the completion of a 4-hour MTX infusion, and to suggest that monitoring for MTX toxicity should perhaps begin within a few hours after the completion of 4-hour MTX infusion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] 2 hours after the completion of a 4-hour MTX infusion [Effect] renal toxicity [Potential therapeutic event] recovered [Treatment] high-dose leucovorin, hemodialysis, charcoal hemoperfusion, and carboxypeptidase G2"}, {"id": "10646879_2_544", "context": "Ten to 15% of patients treated with ifosfamide develop an encephalopathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] develop [Subject] Ten to 15% of patients [Treatment] ifosfamide [Effect] encephalopathy."}, {"id": "11352235_3_545", "context": "METHODS: We queried 35 rheumatologists at the Robert Breck Brigham Arthritis Center to determine if weight loss had occurred as an adverse event in patients treated with leflunomide between November 1998 and January 2000.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Subject] patients [Treatment] leflunomide [Effect] weight loss"}, {"id": "681921_3_546", "context": "This is the first report of a catatonic syndrome occurring in a patient receiving disulfiram treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurring [Treatment] disulfiram treatment [Effect] catatonic syndrome"}, {"id": "11096051_2_547", "context": "Management of hypophosphatemia induced by high-flux hemodiafiltration for the treatment of vancomycin toxicity: intravenous phosphorus therapy versus use of a phosphorus-enriched dialysate.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] Management [Treatment] intravenous phosphorus; phosphorus-enriched dialysate"}, {"id": "18569796_4_548", "context": "Two weeks following rechallenge with alendronate sodium resulted in recurrence of his scleritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulted [Treatment] alendronate sodium; Two weeks following [Effect] scleritis"}, {"id": "16901609_2_549", "context": "We believe this is the first report of intrathecal diamorphine causing anaphylaxis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] causing [Treatment] intrathecal diamorphine [Effect] anaphylaxis"}, {"id": "15811174_2_550", "context": "Clearance rates of cerivastatin metabolites in a patient with cerivastatin-induced rhabdomyolysis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] cerivastatin [Effect] rhabdomyolysis"}, {"id": "18505911_13_551", "context": "This case report and several others point toward azathioprine as a clinically significant inducer of warfarin resistance.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] inducer [Treatment] azathioprine [Effect] warfarin resistance"}, {"id": "18569796_3_552", "context": "PURPOSE: To report a case of nodular scleritis following alendronate sodium.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] alendronate sodium [Effect] nodular scleritis"}, {"id": "12869178_2_553", "context": "Most cardiac surgical patients have had previous exposure to heparin for diagnostic or therapeutic interventions and hence have an increased susceptibility to developing heparin-induced thrombocytopenia (HIT) postoperatively.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developing [Subject] Most cardiac surgical patients [Treatment] heparin [Effect] heparin-induced thrombocytopenia (HIT)"}, {"id": "7485371_2_554", "context": "PURPOSE: We studied a case of vortex keratopathy that was associated with the use of atovaquone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] a case [Treatment] atovaquone [Effect] vortex keratopathy"}, {"id": "16216617_2_555", "context": "While on a maximal dose of phenylephrine she developed prominent positive U waves, which disappeared with the cessation of the drug.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] she [Treatment] maximal dose of phenylephrine [Effect] positive U waves"}, {"id": "18751717_4_556", "context": "RESULTS: Two patients with ocular inflammation of unknown origin developed severe chorioretinitis after IVTA injection.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Two patients with ocular inflammation [Treatment] IVTA injection [Effect] severe chorioretinitis"}, {"id": "1695794_5_557", "context": "Disopyramide was started on admission for supraventricular tachycardia.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] started [Treatment] Disopyramide"}, {"id": "10759907_1_558", "context": "A 50-year-old woman with a history of migraine without aura, predominantly occurring around her menstrual periods, developed a spinal cord lesion following the use of zolmitriptan.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 50-year-old woman with a history of migraine without aura, predominantly occurring around her menstrual periods [Treatment] zolmitriptan [Effect] a spinal cord lesion"}, {"id": "19754002_3_559", "context": "The skin rash effect was most probably due, in first line, to olanzapine, but the cutaneous skin condition was triggered and aggravated by pravastatin, a 3-hydoxy-3-methylglutaryl-coenzyme A-(HMG-CoA)-reductase inhibitor, and lithium medication.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] olanzapine,; by pravastatin, a 3-hydoxy-3-methylglutaryl-coenzyme A-(HMG-CoA)-reductase inhibitor, and lithium [Effect] skin rash effect; cutaneous skin condition"}, {"id": "7639655_2_560", "context": "CONCLUSION: Anterior ischemic optic neuropathy may complicate treatment with interferon alfa.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complicate [Treatment] interferon alfa [Effect] Anterior ischemic optic neuropathy"}, {"id": "14742791_2_561", "context": "After 5 weeks of therapy, she stopped taking pantoprazole due to general malaise.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due to [Treatment] taking pantoprazole; After 5 weeks of therapy [Effect] general malaise"}, {"id": "9865241_5_562", "context": "We report the use of pamidronate for acute, severe hypercalcemia secondary to iatrogenic vitamin D poisoning.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] for [Treatment] pamidronate [Adverse event] secondary [Treatment] vitamin D [Effect] hypercalcemia"}, {"id": "11485141_1_563", "context": "According to the Naranjo probability scale, the relationship of gemcitabine treatment with cutaneous eruption in our patient is possible.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Subject] our patient [Treatment] gemcitabine treatment [Effect] cutaneous eruption"}, {"id": "18166746_3_564", "context": "Methylene blue was administered to a 58-yr-old woman undergoing a parathyroidectomy under general anesthesia.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] administered to [Subject] a 58-yr-old woman undergoing a parathyroidectomy under general anesthesia [Treatment] Methylene blue"}, {"id": "7712052_3_565", "context": "We describe two cases that illustrate the use of lithium in the treatment of veterans with PTSD who complained of serious problems with irritability or angry outbursts.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complained of [Subject] veterans with PTSD [Treatment] lithium [Effect] serious problems with irritability or angry outbursts"}, {"id": "15773973_2_566", "context": "It is well-recognized that flucloxacillin may occasionally result in fatal hepatic injury.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] result [Treatment] flucloxacillin [Effect] hepatic injury"}, {"id": "2943526_1_567", "context": "Neurologic toxicity associated with hepatic artery infusion HAI of FUdR.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated with [Treatment] hepatic artery infusion HAI of FUdR [Effect] Neurologic toxicity"}, {"id": "3136101_1_568", "context": "Hyperkalemia as a late side effect of prolonged adrenocorticotropic hormone therapy for infantile spasms.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Subject] infantile spasms [Treatment] adrenocorticotropic hormone [Effect] Hyperkalemia"}, {"id": "10082597_1_569", "context": "METHODS: We report two cases of pseudoporphyria caused by naproxen and oxaprozin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Subject] two cases [Treatment] naproxen and oxaprozin [Effect] pseudoporphyria"}, {"id": "18505911_4_570", "context": "She was treated with an average weekly warfarin dose of 39 mg (5.5 mg daily) prior to beginning azathioprine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Subject] She [Treatment] average weekly warfarin dose of 39 mg (5.5 mg daily) prior to beginning azathioprine therapy"}, {"id": "9279731_1_571", "context": "When the disease recurred conventional amphotericin B was used again, but had to be stopped because of severe side effects.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] amphotericin B [Effect] side effects"}, {"id": "3211830_2_572", "context": "Widespread cutaneous vasculitis associated with diltiazem.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] diltiazem [Effect] cutaneous vasculitis"}, {"id": "9726762_2_573", "context": "The following describes a patient on a stable regimen of warfarin who developed severe hypoprothrombinemia and bleeding 4 weeks after starting gemfibrozil.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient [Treatment] on a stable regimen of warfarin; 4 weeks after starting gemfibrozil [Effect] hypoprothrombinemia and bleeding"}, {"id": "15773973_3_574", "context": "We report the case of a 40-year-old woman who developed fulminant hepatic failure and aplastic anaemia following a course of oral flucloxacillin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 40-year-old woman [Treatment] a course of oral flucloxacillin [Effect] fulminant hepatic failure and aplastic anaemia"}, {"id": "16697705_2_575", "context": "This case highlights the possible development of acute coronary syndrome as a side effect of Capecitabine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Subject] This case [Treatment] Capecitabine [Effect] acute coronary syndrome"}, {"id": "7212107_2_576", "context": "These results indicate that lithium may cause biochemical hyperparathyroidism.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] may [Treatment] lithium [Effect] biochemical hyperparathyroidism"}, {"id": "10579985_2_577", "context": "The relationship between infliximab treatment and lymphoma in Crohn's disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] between [Treatment] infliximab [Effect] lymphoma"}, {"id": "15863610_7_578", "context": "CONCLUSION: There may be an association between raloxifene and the development of malignant mixed mesodermal tumor.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association [Treatment] raloxifene [Effect] malignant mixed mesodermal tumor"}, {"id": "19131789_3_579", "context": "Early recognition of renal toxicity of high-dose methotrexate therapy: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] recognition [Treatment] high-dose methotrexate therapy [Effect] renal toxicity"}, {"id": "8467620_2_580", "context": "The mild immunosuppression that occurs with methotrexate therapy probably places patients with rheumatoid arthritis at added risk of developing lymphoproliferative diseases, but coincidence cannot be excluded.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developing [Subject] patients with rheumatoid arthritis [Treatment] methotrexate [Effect] mild immunosuppression; lymphoproliferative diseases"}, {"id": "14561622_2_581", "context": "We attribute the clinical and radiographic findings to cytotoxic edema secondary to intrathecal methotrexate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] attribute [Treatment] intrathecal methotrexate [Effect] cytotoxic edema"}, {"id": "16843118_2_582", "context": "Morphine, an opium alkaloid, frequently causes side effects such as hyperhidrosis and facial flushing, but serious cutaneous adverse drug reactions are seldom observed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] causes [Treatment] Morphine [Effect] hyperhidrosis; facial flushing"}, {"id": "20465622_1_583", "context": "Severe aphthous stomatitis associated with oral calcineurin and mTOR inhibitors.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] oral calcineurin and mTOR inhibitors [Effect] Severe aphthous stomatitis"}, {"id": "17619811_1_584", "context": "A 79-year-old man with ischemic heart disease, chronic atrial fibrillation, chronic renal failure, hypothyroidism, and gout arthritis was hospitalized because of fatigue, myalgia, and leg weakness, shortly after starting treatment with colchicine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] A 79-year-old man with ischemic heart disease, chronic atrial fibrillation, chronic renal failure, hypothyroidism, and gout arthritis [Treatment] treatment with colchicine [Effect] fatigue, myalgia, and leg weakness"}, {"id": "17275666_6_585", "context": "This report describes a case of paradoxical, intravenous valproic acid-induced seizure exacerbation in a child with juvenile absence epilepsy, documented by video-electroencephalography.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a child with juvenile absence epilepsy [Treatment] intravenous valproic acid [Effect] seizure exacerbation"}, {"id": "18277922_1_586", "context": "She was treated with acyclovir and subsequently developed VZV antigen-positive zoster.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] She [Treatment] acyclovir [Effect] VZV antigen-positive zoster"}, {"id": "15857283_1_587", "context": "CONCLUSIONS: In these 3 cases, the unique positive ocular finding was corneal endothelial deposits, which may be related to the use of rifabutin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] rifabutin [Effect] corneal endothelial deposits"}, {"id": "7978578_1_588", "context": "Response of a promethazine-induced coma to flumazenil.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] promethazine [Effect] coma [Potential therapeutic event] Response [Treatment] flumazenil"}, {"id": "16978752_1_589", "context": "First, a review of the literature produced 41 anecdotic cases of neutropenia or agranulocytosis during treatment with olanzapine (Zyprexa) reported in a total of 24 publications.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] 41 anecdotic cases [Treatment] olanzapine (Zyprexa) [Effect] neutropenia or agranulocytosis"}, {"id": "8250714_2_590", "context": "Neurologic degeneration associated with nitrous oxide anesthesia in patients with vitamin B12 deficiency.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] patients with vitamin B12 deficiency [Treatment] nitrous oxide anesthesia [Effect] Neurologic degeneration"}, {"id": "1695794_3_591", "context": "Previous therapy with antiarrhythmics had resulted in intolerable adverse effects or no effect on the arrhythmia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulted [Treatment] antiarrhythmics [Effect] intolerable adverse effects [Potential therapeutic event] effect [Treatment] antiarrhythmics"}, {"id": "6239881_1_592", "context": "Allergic contact dermatitis to compound tincture of benzoin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Treatment] compound tincture of benzoin [Effect] Allergic contact dermatitis"}, {"id": "8610807_3_593", "context": "PURPOSE: To determine the cause of spontaneous choroidal hemorrhage in a 67-year-old man after a myocardial infarction and administration of tissue plasminogen activator.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] 67-year-old man after a myocardial infarction [Treatment] tissue plasminogen activator [Effect] spontaneous choroidal hemorrhage"}, {"id": "23970584_4_594", "context": "Forty-one days later, she developed severe iatrogenic Cushing's syndrome due to the drug-drug interaction between triamcinolone and her boosted protease inhibitor therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] she [Treatment] triamcinolone and her boosted protease inhibitor [Effect] Forty-one days later; severe iatrogenic Cushing's syndrome"}, {"id": "11341670_2_595", "context": "Pheripheral edema was observed in five female patients after taking proton pump inhibitors omeprazole, lansoprazole, or pantoprazole for 7-15 days for peptic acid diseases in recommended standard doses.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] taking [Subject] five female patients [Treatment] omeprazole, lansoprazole, or pantoprazole [Effect] Pheripheral edema"}, {"id": "18855892_5_596", "context": "We report the case of a child with metastatic osteosarcoma, who experienced an anaphylactic/anaphylactoid reaction to methotrexate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experienced [Subject] a child with metastatic osteosarcoma [Treatment] methotrexate [Effect] anaphylactic/anaphylactoid reaction"}, {"id": "17823522_5_597", "context": "It is tempting to speculate that interferon alpha may be involved in the pathogenesis of lichen nitidus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] involved [Treatment] interferon alpha [Effect] lichen nitidus"}, {"id": "18569796_1_598", "context": "CONCLUSION: Alendronate led to nodular scleritis and rechallenge caused recurrence of scleritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] led to [Treatment] Alendronate [Effect] nodular scleritis"}, {"id": "1469187_2_599", "context": "A massive digitoxin (DGTX) intoxication in a 36-year-old man (35 mg DGTX) was treated by prolonged and repeated i.v.-infusions of Fab fragments of anti-digitalis antibodies (FAB).", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Subject] A massive digitoxin (DGTX) intoxication in a 36-year-old man (35 mg DGTX) [Treatment] prolonged and repeated i.v.-infusions of Fab fragments of anti-digitalis antibodies (FAB)"}, {"id": "6788011_3_600", "context": "Gold-salt therapy may result in damage to proximal tubules that leak renal tubular antigens, which in turn complex with autoantibody and produce an autoimmune membranous nephropathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] result [Treatment] Gold-salt [Effect] damage to proximal tubules"}, {"id": "20199429_1_601", "context": "Only two case reports of adults with allergic contact dermatitis to this chemical exist in the literature, and we describe three more cases of children with recalcitrant atopic dermatitis found to have potential allergic contact dermatitis to bisabolol- a component of the Aquaphor emollient they were using to treat their atopic dermatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] have [Subject] three more cases of children with recalcitrant atopic dermatitis [Treatment] bisabolol- a component of the Aquaphor emollient [Effect] potential allergic contact dermatitis"}, {"id": "16160485_2_602", "context": "Recently, CD20-negative tumors have been described after Rituximab therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] Rituximab [Effect] CD20-negative tumors"}, {"id": "10560960_1_603", "context": "A 48-year-old woman who was treated for thyrotoxicosis with methimazole developed agranulocytosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 48-year-old woman [Treatment] methimazole [Effect] agranulocytosis"}, {"id": "10646879_1_604", "context": "Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] ifosfamide [Effect] encephalopathy"}, {"id": "15863610_4_605", "context": "We report a case of a women in whom a malignant mixed mesodermal tumor was diagnosed while she was taking raloxifene, which is also a selective estrogen receptor modulator.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] diagnosed [Subject] a women [Treatment] while she was taking raloxifene [Effect] a malignant mixed mesodermal tumor"}, {"id": "22677303_12_606", "context": "Interactions between warfarin and cloxacillin can result in serious adverse reactions.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] result [Treatment] Interactions between warfarin and cloxacillin [Effect] serious adverse reactions"}, {"id": "11724089_2_607", "context": "However, a large case-control study included three cases of either Stevens-Johnson syndrome or toxic epidermal necrolysis associated with ofloxacin use, but no details of the cases were given.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] three cases [Treatment] ofloxacin [Effect] Stevens-Johnson syndrome or toxic epidermal necrolysis"}, {"id": "879939_5_608", "context": "Acetazolamide may have accelerated the development of osteomalacia by several mechanisms, including increased renal calcium excretion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] accelerated [Treatment] Acetazolamide [Effect] osteomalacia"}, {"id": "14697943_1_609", "context": "In conclusion, RSDS is a relevant osteoarticular complication in patients receiving either anticalcineurinic drug (CyA or tacrolimus), even under monotherapy or with a low steroid dose.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] osteoarticular complication [Treatment] anticalcineurinic drug (CyA or tacrolimus) [Effect] RSDS"}, {"id": "14742791_5_610", "context": "There have been several reported cases of omeprazole-induced AIN.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] omeprazole [Effect] AIN"}, {"id": "9726762_4_611", "context": "This interaction may be overlooked by clinicians, which may result in a serious bleeding risk for patients on warfarin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] result in [Subject] patients [Treatment] warfarin [Effect] serious bleeding risk"}, {"id": "1966850_1_612", "context": "Adriamycin-induced cardiomyopathy aggravated by cis-platinum nephrotoxicity requiring dialysis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Adriamycin [Effect] cardiomyopathy [Adverse event] nephrotoxicity [Treatment] cis-platinum [Effect] nephrotoxicity requiring dialysis"}, {"id": "8145359_1_613", "context": "An 11-year-old boy who was treated with a relatively high dose of methotrimeprazine meleate (Levemepromazine) a phenothiazine antipsychotic drug, was admitted to the pediatric intensive care unit suffering from respiratory distress syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] suffering [Subject] An 11-year-old boy [Treatment] relatively high dose of methotrimeprazine meleate (Levemepromazine) [Effect] respiratory distress syndrome"}, {"id": "11762672_1_614", "context": "An adult male presented with central blindness after ingesting methanol.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] An adult male [Treatment] ingesting methanol [Effect] central blindness"}, {"id": "8523340_1_615", "context": "All developed mucocutaneous side effects within 20 weeks of beginning im gold therapy, at a time when RA had improved markedly compared to pretreatment status.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] beginning [Treatment] im gold therapy [Effect] mucocutaneous side effects"}, {"id": "1868481_2_616", "context": "Two children, 1 with idiopathic nephrotic syndrome and 1 with endo-extracapillary glomerulonephritis, presented an episode of seizures and transient blindness at different times after i.v. pulse methylprednisolone (IVPMP) treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] Two children, 1 with idiopathic nephrotic syndrome and 1 with endo-extracapillary glomerulonephritis [Treatment] i.v. pulse methylprednisolone (IVPMP) treatment [Effect] seizures and transient blindness"}, {"id": "12836099_1_617", "context": "Stevens-Johnson syndrome in a boy with nephrotic syndrome during prednisolone therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] a boy with nephrotic syndrome [Treatment] prednisolone [Effect] Stevens-Johnson syndrome"}, {"id": "18628507_4_618", "context": "To our knowledge, this is the first report of an angio-oedema associated with VRC.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] VRC [Effect] angio-oedema"}, {"id": "4014301_1_619", "context": "Insulin-induced cardiac failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Insulin [Effect] cardiac failure"}, {"id": "15522120_10_620", "context": "The symptoms disappeared with clemastine and betametasone treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] disappeared [Treatment] clemastine and betametasone [Effect] The symptoms disappeared"}, {"id": "11724089_6_621", "context": "This report rules out other causes of toxic epidermal necrolysis and implicates ofloxacin in what appears to be an atypical presentation of drug-induced toxic epidermal necrolysis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] drug-induced [Treatment] ofloxacin [Effect] toxic epidermal necrolysis"}, {"id": "3917429_1_622", "context": "Controversy concerning the nephrotoxicity of lithium is discussed, and recommendations for the evaluation of renal failure during lithium therapy are provided.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] lithium [Effect] nephrotoxicity; evaluation of renal failure"}, {"id": "6738830_1_623", "context": "A 56-year-old male parkinsonian patient developed a unique behavioral change following the oral administration of cinepazide, a cerebral vasodilator.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 56-year-old male parkinsonian patient [Treatment] the oral administration of cinepazide, a cerebral vasodilator [Effect] a unique behavioral change"}, {"id": "440873_3_624", "context": "The currently available clinical and neuropharmacologic data suggest that carbamazepine may be an antagonist of dopamine and that this property is responsible for the production of dystonia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] responsible [Treatment] carbamazepine [Effect] dystonia"}, {"id": "12042592_2_625", "context": "Metamizole, a nonsteroidal antiinflammatory agent, is prohibited in the United States because of the risk of agranulocytosis but is widely used in Mexico and other countries.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] risk [Treatment] Metamizole [Effect] agranulocytosis"}, {"id": "9777751_6_626", "context": "We conclude that the use of hemopoietic colony stimulating factors might be a suitable means to achieve the correction of severe thionamide-induced hematologic adverse reactions.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] thionamide [Effect] hematologic adverse reactions. [Potential therapeutic event] achieve [Treatment] hemopoietic colony stimulating factors"}, {"id": "8696525_2_627", "context": "Two case reports of bilateral granulomatous anterior uveitis are described in patients with open angle glaucoma treated with metripranolol 0.6% eye drops.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] Two case reports of bilateral granulomatous anterior uveitis; patients with open angle glaucoma [Treatment] metripranolol 0.6% eye drops"}, {"id": "7355327_2_628", "context": "Regardless of a negative history of asthma, therefore, life-threatening bronchospasm must be considered a possible complication of propranolol therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] propranolol [Effect] life-threatening bronchospasm"}, {"id": "11147747_2_629", "context": "In the present paper the authors describe 2 female patients who developed incontinence secondary to the selective serotonin reuptake inhibitors paroxetine and sertraline, as well as a third who developed this side effect on venlafaxine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] 2 female patients [Treatment] the selective serotonin reuptake inhibitors paroxetine and sertraline [Effect] incontinence"}, {"id": "1680596_1_630", "context": "Presented is a case story of a woman with classical rheumatoid arthritis, who during introduction of sulphasalazine (SASP) therapy developed a severe and lasting psoriasis-like skin reaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a woman with classical rheumatoid arthritis [Treatment] during introduction of sulphasalazine (SASP) therapy [Effect] psoriasis-like skin reaction"}, {"id": "19112808_1_631", "context": "Interstitial granulomatous dermatitis associated with darifenacin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] darifenacin [Effect] Interstitial granulomatous dermatitis"}, {"id": "11762672_2_632", "context": "Reversal of severe methanol-induced visual impairment: no evidence of retinal toxicity due to fomepizole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] methanol [Effect] visual impairment [Adverse event] due to [Treatment] fomepizole [Effect] retinal toxicity"}, {"id": "20925534_3_633", "context": "Proton-pump inhibitors (PPIs) are believed to decrease the risk of such complications, though no randomized trial has proved this in patients receiving dual antiplatelet therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] believed [Treatment] Proton-pump inhibitors (PPIs)"}, {"id": "10592946_4_634", "context": "The clinical course suggests that caffeine, which is present in oolong tea, was mainly responsible for the rhabdomyolysis as well as the delirium, although severe hyponatremia has been reported to cause rhabdomyolysis on rare occasions.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] responsible [Treatment] caffeine, which is present in oolong tea [Effect] rhabdomyolysis as well as the delirium"}, {"id": "11283125_8_635", "context": "Prevention of CNS relapse was satisfactorily achieved with HD IV MTX and intrathecal injections of MTX in children with increased-risk ALL or stage III and IV lymphoblastic lymphoma treated with our BFM-based treatment protocol in which cranial irradiation was omitted.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] Prevention [Subject] children with increased-risk ALL or stage III and IV lymphoblastic lymphoma [Treatment] HD IV MTX and intrathecal injections of MTX [Potential therapeutic event] treated [Subject] children with increased-risk ALL or stage III and IV lymphoblastic lymphoma [Treatment] our BFM-based treatment protocol in which cranial irradiation was omitted"}, {"id": "17823522_1_636", "context": "Generalized lichen nitidus with involvement of the palms following interferon alpha treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] interferon alpha treatment [Effect] Generalized lichen nitidus with involvement of the palms"}, {"id": "1422497_2_637", "context": "Hemorrhagic cystitis is a significant toxic effect of cyclophosphamide therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] significant toxic effect [Treatment] cyclophosphamide [Effect] Hemorrhagic cystitis"}, {"id": "7212107_1_638", "context": "Secondary hyperparathyroidism in certain patients with lithium nephrotoxicity is also possible.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] certain patients [Treatment] lithium [Effect] nephrotoxicity; Secondary hyperparathyroidism"}, {"id": "18755414_2_639", "context": "We report a case in which hemorrhage occurred in an asymptomatic falx meningioma known beforehand, after the internal use of low-dose aspirin for 16 months.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Subject] a case [Treatment] low-dose aspirin for 16 months [Effect] hemorrhage"}, {"id": "589261_3_640", "context": "Minor electrocardiographical changes were noted in five out of six patients who were not receiving a cardiac glycoside and four out of six who were receiving ouabain, and none of the 16 who were receiving digoxin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] four out of six [Treatment] ouabain [Effect] electrocardiographical changes [Adverse event] receiving [Subject] five out of six patients [Treatment] cardiac glycoside [Effect] electrocardiographical changes"}, {"id": "19754002_4_641", "context": "The allergic reaction started to develop after co-administration of pravastatin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] develop [Treatment] co-administration of pravastatin [Effect] allergic reaction"}, {"id": "11202801_3_642", "context": "We propose that cyclophosphamide be added to the list of exposures potentially associated with hepatic angiosarcoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] cyclophosphamide [Effect] hepatic angiosarcoma"}, {"id": "868978_2_643", "context": "The ocular motor disturbances are probably an expression of regional 5-FU neurotoxicity primarily affecting the brain stem.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] expression [Treatment] 5-FU [Effect] The ocular motor disturbances; neurotoxicity"}, {"id": "1966850_2_644", "context": "Complications of chemotherapy for a synovial sarcoma in an eight-year old boy included cisplatinum nephrotoxicity and adriamycin cardiotoxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] nephrotoxicity [Subject] an eight-year old boy [Treatment] cisplatinum [Effect] nephrotoxicity [Adverse event] cardiotoxicity [Subject] an eight-year old boy [Treatment] adriamycin [Effect] cardiotoxicity"}, {"id": "17504225_2_645", "context": "Bacterial infection is a frequent event in renal transplant recipients and often requires the use of antimicrobial agents.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] event [Subject] renal transplant recipients [Treatment] antimicrobial agents [Effect] Bacterial infection"}, {"id": "16685007_12_646", "context": "Study results suggest that ciclesonide significantly reduces the need for OCS in patients with severe, persistent asthma, while maintaining asthma control.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] reduces [Subject] patients with severe, persistent asthma [Treatment] ciclesonide"}, {"id": "14968106_1_647", "context": "CONCLUSION: This is, to our knowledge, the first report of severe myelopathy following accidental intrathecal administration of doxorubicin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] intrathecal administration of doxorubicin [Effect] severe myelopathy"}, {"id": "12854039_5_648", "context": "Multiple sclerosis-like disease secondary to alpha interferon.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Treatment] alpha interferon [Effect] Multiple sclerosis-like disease"}, {"id": "17921794_4_649", "context": "We report a case of a patient with mild chronic renal insufficiency who had been taking simvastatin for over a year and developed acute weakness within 3 weeks after the start of treatment with colchicine for acute gouty bursitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient with mild chronic renal insufficiency [Treatment] taking simvastatin for over a year; 3 weeks after the start of treatment with colchicine for acute gouty bursitis [Effect] acute weakness"}, {"id": "16603845_1_650", "context": "Shortly after chemotherapy and an injection of pegfilgrastim, the patient developed poorly defined, rapidly progressive erythema, edema, and pain in his right forearm.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] the patient [Treatment] pegfilgrastim [Effect] poorly defined, rapidly progressive erythema, edema, and pain in his right forearm"}, {"id": "20628041_2_651", "context": "To describe a probable interaction between enteral feeds and levodopa leading to neuroleptic malignant-like syndrome (NMLS) in a polytrauma patient with Parkinson's disease (PD).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] leading [Subject] a polytrauma patient with Parkinson's disease (PD) [Treatment] interaction between enteral feeds and levodopa [Effect] neuroleptic malignant-like syndrome (NMLS)"}, {"id": "16978752_3_652", "context": "Second, we report a case of neutropenia, which proved to be fatal in a schizophrenia patient receiving olanzapine and thiazide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] a schizophrenia patient [Treatment] olanzapine and thiazide [Effect] neutropenia"}, {"id": "21658326_3_653", "context": "While mild to moderate application site reactions (ASRs) are a well-known and common phenomenon associated with imiquimod, the potential of TNF-alpha blockers to elicit cutaneous inflammatory reactions has only recently been recognized.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] elicit [Treatment] TNF-alpha blockers [Effect] cutaneous inflammatory reactions [Adverse event] associated [Treatment] imiquimod [Effect] application site reactions (ASRs)"}, {"id": "6239881_2_654", "context": "Nineteen cases of allergic contact dermatitis to compound tincture of benzoin are described.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] described [Subject] Nineteen cases [Treatment] compound tincture of benzoin [Effect] allergic contact dermatitis"}, {"id": "8404753_3_655", "context": "We report 3 children with epilepsy who developed facial motor tics after initiation of CBZ for complex partial seizures.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] 3 children with epilepsy [Treatment] CBZ [Effect] facial motor tics"}, {"id": "11197767_2_656", "context": "The toxicity of cadmium, zinc and cadmium/zinc mixtures at concentrations ranging from 1000 to 50000 microg/l were investigated against cercariae and metacercariae of Parorchis acanthus obtained from the dog whelk Nucella lapillus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] against [Treatment] cadmium, zinc and cadmium/zinc mixtures at concentrations ranging from 1000 to 50000 microg/l [Effect] toxicity"}, {"id": "18354950_3_657", "context": "We report the syndrome of inappropriate antidiuresis as a much earlier side-effect of carbamazepine administration in a 29-year Nigerian female patient with generalized tonic-elonic seizures.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] side-effect [Subject] a 29-year Nigerian female patient with generalized tonic-elonic seizures [Treatment] carbamazepine [Effect] syndrome of inappropriate antidiuresis"}, {"id": "11310527_2_658", "context": "A patient was treated with warfarin for atrial fibrillation.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Subject] A patient [Treatment] warfarin"}, {"id": "19754002_1_659", "context": "Mood stabilizer therapy and pravastatin: higher risk for adverse skin reactions?", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] risk [Treatment] Mood stabilizer therapy and pravastatin [Effect] adverse skin reactions"}, {"id": "1602800_1_660", "context": "Pulmonary leukostasis secondary to all-trans retinoic acid in the treatment of acute promyelocytic leukemia in first relapse.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Treatment] all-trans retinoic acid [Effect] Pulmonary leukostasis"}, {"id": "15811174_1_661", "context": "A 74-year-old hypercholestrerolaemic woman taking cerivastatin (0.15 mg/day) for 22 days complained of general muscle weakness and muscle pain.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complained [Subject] A 74-year-old hypercholestrerolaemic woman [Treatment] cerivastatin (0.15 mg/day) [Effect] general muscle weakness and muscle pain."}, {"id": "7081289_3_662", "context": "There have been only two reports of cimetidine-induced hepatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] cimetidine [Effect] hepatitis"}, {"id": "3732375_2_663", "context": "A case is reported of theophylline intoxication due to a dramatic decrease in theophylline clearance following concomitant administration of viloxazine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] concomitant administration of viloxazine [Effect] theophylline intoxication"}, {"id": "7639655_1_664", "context": "Anterior ischemic optic neuropathy secondary to interferon alfa.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Treatment] interferon alfa [Effect] Anterior ischemic optic neuropathy"}, {"id": "12854039_6_665", "context": "PURPOSE: To describe bilateral optic neuritis that occurred as an adverse effect of recombinant and natural interferon alpha administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Treatment] recombinant and natural interferon alpha administration [Effect] bilateral optic neuritis"}, {"id": "12234159_2_666", "context": "Rofecoxib, used for dysmenorrhea, caused a herpetiform fixed drug eruption predominantly involving the lips with classic clinical and histological findings in a red-brown lesion on the dorsal hand.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] Rofecoxib [Effect] herpetiform fixed drug eruption predominantly involving the lips with classic clinical and histological findings in a red-brown lesion on the dorsal hand"}, {"id": "16609346_2_667", "context": "Statin-associated myasthenia gravis: report of 4 cases and review of the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] 4 cases [Treatment] Statin [Effect] myasthenia gravis"}, {"id": "4075534_3_668", "context": "Two reports of spindle coma are noted with alcohol and imipramine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] noted [Subject] Two reports [Treatment] alcohol and imipramine [Effect] spindle coma"}, {"id": "3003260_2_669", "context": "Cataracts induced by intermittent Decadron used as an antiemetic.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Decadron [Effect] Cataracts"}, {"id": "879939_2_670", "context": "Severe osteomalacia was present in two epileptic patients who were under long-term treatment with congeners of phenytoin, phenobarbital, and acetazolamide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] present [Subject] two epileptic patients [Treatment] long-term treatment with congeners of phenytoin, phenobarbital, and acetazolamide [Effect] osteomalacia"}, {"id": "3969689_4_671", "context": "Careful observations on hepatotoxicity are suggested when acetaminophen is prescribed with caffeine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] acetaminophen; caffeine [Effect] hepatotoxicity"}, {"id": "8912599_6_672", "context": "Erosion of psoriatic plaques: an early sign of methotrexate toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] methotrexate [Effect] Erosion of psoriatic plaques"}, {"id": "11696132_1_673", "context": "After extensive neurological 'work up', we realized that the anisocoria was related to the transdermal scopolamine patch that we had prescribed for weaning off the opioid.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] transdermal scopolamine patch [Effect] anisocoria"}, {"id": "12851279_1_674", "context": "Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] in [Treatment] tifacogin (recombinant tissue factor pathway inhibitor)"}, {"id": "15863610_5_675", "context": "CASE: A malignant mixed mesodermal tumor was diagnosed in a 64-year-old woman with a bicornuate uterus while she was taking raloxifene for osteoporosis prevention.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] diagnosed [Subject] a 64-year-old woman with a bicornuate uterus [Treatment] raloxifene [Effect] A malignant mixed mesodermal tumor"}, {"id": "16728538_1_676", "context": "After rechallenge with monotherapy pegvisomant, however, the hepatic enzyme disturbances reappeared within a few weeks, indicating that most likely pegvisomant alone and not the long-acting somatostatin analog or the combination of these two drugs was responsible for this case of drug-induced hepatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] responsible [Treatment] pegvisomant [Effect] hepatic enzyme disturbances reappeared; hepatitis"}, {"id": "22372628_2_677", "context": "To evaluate the long-term (up to 5 years exposure) safety and efficacy of lacosamide as adjunctive therapy in patients with uncontrolled partial-onset seizures taking one to three concomitant antiepileptic drugs (AEDs) in open-label extension trial SP756 (NCT00522275).", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] in [Treatment] long-term (up to 5 years exposure); lacosamide as adjunctive therapy; taking one to three concomitant antiepileptic drugs (AEDs)"}, {"id": "7071645_3_678", "context": "Complete remission of the nephrosis occurred after discontinuation of hydroxychloroquine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] occurred [Treatment] discontinuation of hydroxychloroquine [Effect] nephrosis"}, {"id": "18364401_1_679", "context": "CONCLUSIONS: Clinicians treating elderly patients with olanzapine should be aware of the potential for rapidly developing hyperglycemia and monitor such patients accordingly.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Subject] elderly patients [Treatment] olanzapine [Effect] rapidly developing hyperglycemia"}, {"id": "18661248_2_680", "context": "We describe a case of PRES in a patient with collapsing focal glomeruloesclerosis (collapsing FGS) with complete recovery after withdrawal of cyclosporine (CSA).", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] complete recovery [Subject] a patient with collapsing focal glomeruloesclerosis (collapsing FGS) [Treatment] withdrawal of cyclosporine (CSA)"}, {"id": "12022905_3_681", "context": "DISCUSSION: The occurrence of priapism in our patient was related to zuclopenthixol.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] our patient [Treatment] zuclopenthixol [Effect] priapism"}, {"id": "11202801_2_682", "context": "Hepatic angiosarcoma occurring after cyclophosphamide therapy: case report and review of the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurring [Treatment] cyclophosphamide therapy [Effect] Hepatic angiosarcoma"}, {"id": "11283125_3_683", "context": "After completion of induction-consolidation phase, children with increased-risk (risk factor > 0.8 or T-lineage) ALL or stage III and IV lymphoblastic lymphoma were randomized to receive four courses of HD MTX (5 g/m(2) over 24 hours every 2 weeks) and four intrathecal administrations of MTX (Arm A) or the same treatment schedule with additional HD IV Ara-C (1 g/m(2) in bolus injection 12 and 24 hours after the start of each MTX infusion) (Arm B).", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] receive [Subject] children with increased-risk (risk factor > 0.8 or T-lineage) ALL or stage III and IV lymphoblastic lymphoma [Treatment] After completion of induction-consolidation phase; four courses of HD MTX (5 g/m(2) over 24 hours every 2 weeks) and four intrathecal administrations of MTX (Arm A) or the same treatment schedule with additional HD IV Ara-C (1 g/m(2) in bolus injection 12 and 24 hours after the start of each MTX infusion) (Arm B)"}, {"id": "7756684_1_684", "context": "The dose-limiting toxicity of KW-2149 is pulmonary toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] toxicity [Treatment] KW-2149 [Effect] pulmonary"}, {"id": "15773973_1_685", "context": "Flucloxacillin-induced aplastic anaemia and liver failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Flucloxacillin [Effect] aplastic anaemia and liver failure"}, {"id": "18855892_8_686", "context": "Thus, we confirm that desensitization may be a safe procedure in patients with cancer who experience methotrexate-induced anaphylaxis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] patients with cancer [Treatment] methotrexate [Effect] anaphylaxis"}, {"id": "15286697_4_687", "context": "We further used immunohistochemistry (IHC) to examine the relative role of platelet-derived growth factor-B (PDGF-B), insulin-like growth factor I (IGF-I), transforming growth factor-beta1 (TGF-beta1) and cyclooxygenase-2 (COX-2) in the pathogenesis of BCNU-related pulmonary fibrosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] BCNU [Effect] pulmonary fibrosis"}, {"id": "2241449_1_688", "context": "Physicians using this \"new\" drug must be aware of the potential danger of sulfonamide-induced injury to the urinary tract.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] sulfonamide [Effect] injury to the urinary tract"}, {"id": "12504711_4_689", "context": "RESULTS: Brimonidine was observed to cause IOP elevation, confirmed on rechallenge, scoring 8 (strong probability) on an adverse drug reaction probability score.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Brimonidine [Effect] IOP elevation"}, {"id": "15507779_1_690", "context": "Severe leukopenia associated with mild hepatotoxicity in an HIV carrier treated with nevirapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Subject] an HIV carrier [Treatment] nevirapine [Effect] leukopenia"}, {"id": "1711090_2_691", "context": "The clinical effect and safety of Lp-TAE alone and combined with radiofrequency (RF) capacitive hyperthermia (HT) were evaluated in 20 patients with hepatocellular carcinoma (HCC) associated with cirrhosis of the liver.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] effect and safety [Subject] 20 patients with hepatocellular carcinoma (HCC) [Treatment] Lp-TAE alone and combined with radiofrequency (RF) capacitive hyperthermia (HT)"}, {"id": "3806824_1_692", "context": "Fibrosis of corpus cavernosum after intracavernous injection of phentolamine/papaverine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] intracavernous injection of phentolamine/papaverine [Effect] Fibrosis of corpus cavernosum"}, {"id": "440873_4_693", "context": "We have cared for three children in whom four episodes of dystonia proceeding to opisthotonus occurred in association with carbamazepine use.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Subject] three children [Treatment] carbamazepine [Effect] four episodes of dystonia proceeding to opisthotonus"}, {"id": "17275666_1_694", "context": "Juvenile absence epilepsy exacerbated by valproic acid.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] exacerbated [Subject] Juvenile absence epilepsy [Treatment] valproic acid [Effect] Juvenile absence epilepsy exacerbated"}, {"id": "15516308_10_695", "context": "These cases were chosen for study because they were all deaths as a result of suicidal ingestion of drugs in which quetiapine was considered a significant factor.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] considered [Treatment] quetiapine [Effect] they were all deaths"}, {"id": "16599252_2_696", "context": "We present a case of hypereosinophilia related to zafirlukast therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] a case [Treatment] zafirlukast therapy. [Effect] hypereosinophilia"}, {"id": "18855892_3_697", "context": "In patients with methotrexate-induced anaphylaxis, discontinuation of treatment may increase the risk of death due to cancer progression.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] discontinuation [Subject] In patients with methotrexate-induced anaphylaxis [Treatment] treatment [Effect] death due to cancer progression [Adverse event] induced [Treatment] methotrexate [Effect] anaphylaxis"}, {"id": "9737132_3_698", "context": "Pentazocine-induced fibrous myopathy and localized neuropathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Pentazocine [Effect] fibrous myopathy and localized neuropathy"}, {"id": "11096051_1_699", "context": "Intensive high-flux hemodiafiltration is often used in the management of vancomycin toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] management [Treatment] Intensive high-flux hemodiafiltration"}, {"id": "17823522_3_700", "context": "Here we present the case of a generalized lichen nitidus with involvement of the palms in a patient with hepatitis C after systemic treatment with interferon alpha and ribavirin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a patient with hepatitis C [Treatment] systemic treatment with interferon alpha and ribavirin [Effect] a generalized lichen nitidus with involvement of the palms"}, {"id": "6810714_1_701", "context": "The authors describe a woman with chronic schizophrenia who experienced delirium, grand mal seizure, and photosensitivity after the addition of propranolol to her neuroleptic regimen.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a woman with chronic schizophrenia [Treatment] propranolol [Effect] delirium, grand mal seizure, and photosensitivity"}, {"id": "16132305_2_702", "context": "We report a case of an infant with complex congenital heart disease who was placed on captopril for afterload reduction following cardiac surgery and subsequently developed pulmonary infiltrates with eosinophilia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] an infant with complex congenital heart disease [Treatment] captopril [Effect] pulmonary infiltrates with eosinophilia"}, {"id": "3084231_1_703", "context": "Possible pathophysiological mechanisms which may have been operative in this case include: a direct central nervous system (CNS) toxic effect of valproic acid; a paradoxical epileptogenic effect secondary to the drug; and an indirect CNS toxic effect mediated through valproic acid-induced hyperammonemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] valproic acid [Effect] a direct central nervous system (CNS) toxic effect; a paradoxical epileptogenic effect; hyperammonemia"}, {"id": "19583682_3_704", "context": "We report a case of serotonin syndrome induced by pharmacokinetic and pharmacodynamic interactions between three different selective serotonin-reuptake inhibitors (SSRI) and possibly ciprofloxacin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a case [Treatment] interactions between three different selective serotonin-reuptake inhibitors (SSRI) and possibly ciprofloxacin [Effect] serotonin syndrome"}, {"id": "12218252_1_705", "context": "Generalised pustular psoriasis induced by cyclosporin a withdrawal responding to the tumour necrosis factor alpha inhibitor etanercept.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] cyclosporin a withdrawal [Effect] Generalised pustular psoriasis [Potential therapeutic event] responding [Treatment] the tumour necrosis factor alpha inhibitor etanercept"}, {"id": "10592946_1_706", "context": "A 36-y-o patient with schizophrenia, who had consumed gradually increasing quantities of oolong tea that eventually reached 15 L each day, became delirious and was admitted to a psychiatric hospital.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] became [Subject] A 36-y-o patient with schizophrenia [Treatment] gradually increasing quantities of oolong tea that eventually reached 15 L each day [Effect] delirious"}, {"id": "3242521_1_707", "context": "Intraventricular nafcillin-induced seizures in a neonate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a neonate [Treatment] nafcillin [Effect] Intraventricular; seizures"}, {"id": "6671350_4_708", "context": "Nevertheless, the coagulopathy seemed to be most closely associated with the administration of the cephalosporin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated with [Treatment] cephalosporin [Effect] coagulopathy"}, {"id": "6873616_2_709", "context": "Intrahepatic cholestasis and sicca complex after thiabendazole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] thiabendazole [Effect] Intrahepatic cholestasis and sicca complex"}, {"id": "748238_3_710", "context": "We recommended periodic examination of the serum proteins in patients receiving diphenylhydantoin in order to detect development of monoclonal gammopathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] patients [Treatment] diphenylhydantoin [Effect] detect development of monoclonal gammopathy"}, {"id": "6671350_3_711", "context": "Moxalactam is more likely to be associated with platelet dysfunction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Moxalactam [Effect] platelet dysfunction"}, {"id": "8151270_2_712", "context": "This prompted us to suspect that ddI might be responsible for fulminant hepatitis in all three AIDS patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] be responsible for [Subject] three AIDS patients [Treatment] ddI [Effect] fulminant hepatitis"}, {"id": "10573314_3_713", "context": "Two patients, each receiving warfarin for stroke prophylaxis in association with chronic atrial fibrillation, developed adverse effects after the initiation of tolterodine for urinary disorders.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Two patients [Treatment] receiving warfarin for stroke prophylaxis in association with chronic atrial fibrillation; after the initiation of tolterodine for urinary disorders [Effect] adverse effects"}, {"id": "16288069_2_714", "context": "CASE SUMMARY: A 45-year-old HIV-positive man (CD4+ count 450 cells/mm(3) and history of AIDS-defining illness) presented with JHR after an initial intravenous dose of penicillin G for presumed neurosyphilis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] A 45-year-old HIV-positive man (CD4+ count 450 cells/mm(3) and history of AIDS-defining illness) [Treatment] an initial intravenous dose of penicillin G [Effect] JHR"}, {"id": "16393774_6_715", "context": "The second patient developed both autoimmune thyroid disease and a refractory pre-patellar bursitis after 50 months of IFN-beta therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] second patient [Treatment] 50 months of IFN-beta therapy [Effect] both autoimmune thyroid disease and a refractory pre-patellar bursitis"}, {"id": "3156465_3_716", "context": "We report an additional case of isotretinoin teratogenicity in which the patient had agenesis of the cerebellar vermis, multiple leptomeningeal neuroglial heterotopias, hydrocephalus, and abnormalities of the corticospinal tracts.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] teratogenicity [Subject] patient [Treatment] isotretinoin [Effect] agenesis of the cerebellar vermis, multiple leptomeningeal neuroglial heterotopias, hydrocephalus, and abnormalities of the corticospinal tracts"}, {"id": "13680140_1_717", "context": "Reversible sclerotic changes of lumbar spine and femur due to long-term oral isotretinoin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] long-term oral isotretinoin [Effect] Reversible sclerotic changes of lumbar spine and femur"}, {"id": "6725214_1_718", "context": "A case of priapism associated with trazodone is described.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] A case [Treatment] trazodone [Effect] priapism"}, {"id": "16678268_1_719", "context": "Severe adenovirus pneumonia (AVP) following infliximab infusion for the treatment of Crohn's disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] infliximab infusion [Effect] adenovirus pneumonia"}, {"id": "6693840_3_720", "context": "No other endogenous or exogenous cause for the gynecomastia could be found except for the theophylline.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] theophylline [Effect] gynecomastia"}, {"id": "16018164_5_721", "context": "This is a case of pseudoephedrine-induced intracerebral hemorrhage in a patient with an underlying vascular malformation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient with an underlying vascular malformation [Treatment] pseudoephedrine [Effect] intracerebral hemorrhage"}, {"id": "6651138_1_722", "context": "A 58-year-old woman developed unilateral acute angle-closure glaucoma four days after the application of a patch of transdermal scopolamine delivery system (TRANSDERM-V).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] A 58-year-old woman [Treatment] four days after the application of a patch of transdermal scopolamine delivery system (TRANSDERM-V) [Effect] unilateral acute angle-closure glaucoma"}, {"id": "12218252_2_723", "context": "We report a 50-year-old male patient with a 15-year history of psoriasis including mutilating psoriatic arthritis, in whom the withdrawal of cyclosporin A induced a generalised pustular exacerbation and a aggravation of the joint condition.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a 50-year-old male patient with a 15-year history of psoriasis including mutilating psoriatic arthritis [Treatment] the withdrawal of cyclosporin A [Effect] a generalised pustular exacerbation and a aggravation of the joint condition"}, {"id": "8726608_2_724", "context": "Six days after starting acyclovir she exhibited signs of lithium toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] she [Treatment] Six days after starting acyclovir [Effect] lithium toxicity"}, {"id": "11197767_1_725", "context": "Toxicity of cadmium and zinc to encystment and in vitro excystment of Parorchis acanthus (Digenea: Philophthalmidae).", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] Toxicity [Treatment] cadmium and zinc [Effect] Toxicity"}, {"id": "2717661_1_726", "context": "The syndrome of irreversible lithium-effectuated neurotoxicity (SILENT).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] effectuated [Treatment] lithium [Effect] syndrome of irreversible lithium-effectuated neurotoxicity (SILENT)"}, {"id": "589261_5_727", "context": "One patient on ouabain also developed cardiomyopathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] One patient [Treatment] ouabain [Effect] cardiomyopathy"}, {"id": "15863610_3_728", "context": "Data suggest that tamoxifen is involved in the pathogenesis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] involved [Treatment] tamoxifen [Effect] pathogenesis"}, {"id": "6794018_2_729", "context": "Intrahepatic cholestasis and cutaneous bullae associated with glibenclamide therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] glibenclamide therapy [Effect] Intrahepatic cholestasis and cutaneous bullae"}, {"id": "18262450_1_730", "context": "Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] enhances [Subject] painful diabetic neuropathy patients [Treatment] Prolonged-release oxycodone; gabapentin therapy"}, {"id": "14742791_3_731", "context": "OBJECTIVE: To describe what is believed, as of November 4, 2003, to be the first case published in the literature of acute interstitial nephritis (AIN) due to pantoprazole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] pantoprazole [Effect] acute interstitial nephritis (AIN)"}, {"id": "19555801_2_732", "context": "We report a patient of organic bipolar affective disorder who developed hiccups with the atypical antipsychotic aripiprazole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient of organic bipolar affective disorder [Treatment] the atypical antipsychotic aripiprazole [Effect] hiccups"}, {"id": "10682234_2_733", "context": "A 28 year-old man with chronic hepatitis B was administered interferon-alpha (5 x 10(6) IU) intramuscularly once a day for 28 days.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] administered [Subject] A 28 year-old man with chronic hepatitis B [Treatment] interferon-alpha (5 x 10(6) IU) intramuscularly once a day for 28 days"}, {"id": "21330680_2_734", "context": "The case of a patient taking high-dosage olanzapine who experienced parkinsonism after smoking cessation is reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experienced [Subject] a patient [Treatment] high-dosage olanzapine; smoking cessation [Effect] parkinsonism"}, {"id": "4066620_1_735", "context": "A 65-year-old woman with bipolar disorder and complicated cardiovascular disease who was on maintenance lithium therapy developed a movement disorder following high doses of trazodone for treatment of an acute depression.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] A 65-year-old woman with bipolar disorder and complicated cardiovascular disease who was on maintenance lithium therapy [Treatment] high doses of trazodone [Effect] a movement disorder"}, {"id": "19354059_1_736", "context": "The most common complication of warfarin use is adverse bleeding.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] use [Treatment] warfarin [Effect] adverse bleeding"}, {"id": "18166746_2_737", "context": "To report a case of autonomic, neurological and neuromuscular instability following methylene blue infusion for parathyroidectomy; to advance the argument for a diagnosis of serotonin syndrome; and to consider this diagnosis in previous, unexplained reports of adverse reactions amongst patients undergoing parathyroidectomy using methylene blue.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] methylene blue infusion for parathyroidectomy [Effect] autonomic, neurological and neuromuscular instability"}, {"id": "15571949_2_738", "context": "PVT during chemotherapy in children is a rare event and appears to be closely related to intensive chemotherapy containing busulfan and to be associated with HVOD.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] intensive chemotherapy containing busulfan and to be associated with HVOD; HVOD [Effect] PVT"}, {"id": "11724089_3_739", "context": "It is hoped that this case report creates awareness that ofloxacin-induced toxic epidermal necrolysis is possible.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] ofloxacin [Effect] toxic epidermal necrolysis is possible"}, {"id": "21630612_1_740", "context": "Concomitant use of simvastatin and amiodarone resulting in severe rhabdomyolysis: a case report and review of the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulting [Subject] a case [Treatment] Concomitant use of simvastatin and amiodarone [Effect] rhabdomyolysis"}, {"id": "9533061_10_741", "context": "CONCLUSIONS: This report indicates clindamycin phosphate vaginal cream as the most probable cause of CDIC due to the temporal relationship between the occurrence of diarrhea and clindamycin administration, lack of concomitant medications, and documentation of C. difficile toxin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] clindamycin phosphate vaginal cream [Effect] CDIC"}, {"id": "8308951_2_742", "context": "A case of intercerebral hematoma due to warfarin-induced coagulopathy is presented.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] warfarin [Effect] coagulopathy; intercerebral hematoma"}, {"id": "3171334_3_743", "context": "Severe visual loss after a single dose of vincristine in a patient with spinal cord astrocytoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a patient with spinal cord astrocytoma [Treatment] a single dose of vincristine [Effect] Severe visual loss"}, {"id": "10682234_5_744", "context": "Clonazepam, thioridazine, beta-blockers, anticholinergics, and bromocriptine did not ameliorate his akathisia.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] ameliorate [Subject] his [Treatment] Clonazepam, thioridazine, beta-blockers, anticholinergics, and bromocriptine"}, {"id": "7761316_1_745", "context": "Musculoskeletal complaints were the presenting symptoms in four of 44 children (9%) treated for relapsed Wilms' tumors with ifosfamide, a derivative of cyclophosphamide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Subject] four of 44 children (9%) [Treatment] ifosfamide [Effect] Musculoskeletal complaints"}, {"id": "8308951_1_746", "context": "Cutaneous exposure to warfarin-like anticoagulant causing an intracerebral hemorrhage: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] causing [Subject] a case [Treatment] Cutaneous exposure to warfarin-like anticoagulant [Effect] an intracerebral hemorrhage"}, {"id": "16317298_2_747", "context": "Gemcitabine should be added to the list of drugs known to cause radiation recall.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Gemcitabine [Effect] radiation recall"}, {"id": "12504711_1_748", "context": "A paradoxical ocular effect of brimonidine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] brimonidine [Effect] paradoxical ocular effect"}, {"id": "12234159_1_749", "context": "Fixed drug eruption to rofecoxib.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Treatment] rofecoxib [Effect] Fixed drug eruption"}, {"id": "9533061_8_750", "context": "DISCUSSION: No published clinical studies in patients receiving clindamycin vaginal cream for bacterial vaginosis have documented C. difficile toxin in stool samples of patients with diarrhea.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] for [Subject] patients [Treatment] receiving clindamycin vaginal cream"}, {"id": "14742791_1_751", "context": "Acute interstitial nephritis due to pantoprazole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] pantoprazole [Effect] Acute interstitial nephritis"}, {"id": "16515630_3_752", "context": "Physicians should keep in mind that taxanes such as paclitaxel have the potential to cause pneumonitis and lung fibrosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] taxanes such as paclitaxel [Effect] pneumonitis and lung fibrosis"}, {"id": "1238016_1_753", "context": "Infant twins sustained severe circumoral and pharyngeal burns from a concentrated solution of benzalkonium (Zephiran) chloride prescribed for treatment of candidiasis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] sustained [Subject] Infant twins [Treatment] a concentrated solution of benzalkonium (Zephiran) chloride [Effect] severe circumoral and pharyngeal burns"}, {"id": "3156465_2_754", "context": "Isotretinoin teratogenicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] Isotretinoin teratogenicity [Treatment] Isotretinoin [Effect] teratogenicity"}, {"id": "7081289_1_755", "context": "Hepatitis following cimetidine administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] cimetidine [Effect] Hepatitis"}, {"id": "10698143_4_756", "context": "We report the case of an 11-month-old female infant with a depressed level of consciousness after ingestion of ibuprofen whose mental status markedly improved with administration of naloxone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] an 11-month-old female infant [Treatment] ingestion of ibuprofen [Effect] a depressed level of consciousness"}, {"id": "17619811_5_757", "context": "Investigation confirmed the diagnosis of rhabdomyolysis, and discontinuation of colchicine resulted in resolution of clinical and biochemical features of rhabdomylysis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulted [Treatment] colchicine [Effect] rhabdomylysis"}, {"id": "7526455_1_758", "context": "A 73 year-old patient with Wolff-Parkinson-White syndrome and paroxysmic supraventricular tachycardia developed an acute reversible encephalopathy within 15 days of initiation of flecainide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] 73 year-old patient with Wolff-Parkinson-White syndrome and paroxysmic supraventricular tachycardia [Treatment] flecainide [Effect] acute reversible encephalopathy"}, {"id": "15522120_11_759", "context": "Since the depressive symptoms returned sertraline medication was initiated.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] initiated [Treatment] sertraline"}, {"id": "8589490_1_760", "context": "Supravenous hyperpigmentation in association with CHOP chemotherapy of a CD30 (Ki-1)-positive anaplastic large-cell lymphoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association [Treatment] CHOP chemotherapy [Effect] Supravenous hyperpigmentation"}, {"id": "11105373_1_761", "context": "A 33-year-old male presented with brown discolouration of the fingernails following the application of 4% hydroquinone in sorbolene cream and 0.1% tretinoin cream to the face intermittently for 9 months.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] application [Subject] A 33-year-old male [Treatment] 4% hydroquinone in sorbolene cream and 0.1% tretinoin cream to the face intermittently for 9 months [Effect] brown discolouration of the fingernails"}, {"id": "2241449_3_762", "context": "We describe two cases of sulfadiazine-induced crystalluria and renal failure in patients with acquired immunodeficiency syndrome, review the pertinent literature, and discuss the pathogenesis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] two cases; patients with acquired immunodeficiency syndrome [Treatment] sulfadiazine [Effect] crystalluria and renal failure"}, {"id": "17016002_2_763", "context": "Acute eosinophilic pneumonia caused by calcium stearate, an additive agent for an oral antihistaminic medication.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] calcium stearate, an additive agent for an oral antihistaminic medication [Effect] Acute eosinophilic pneumonia"}, {"id": "11563738_1_764", "context": "The cause of death was determined to be acute intoxication by olanzapine, and the manner of death was accidental.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] by [Treatment] olanzapine [Effect] death; acute intoxication"}, {"id": "2719905_1_765", "context": "Long lasting respiratory depression induced by morphine-6-glucuronide?", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] morphine-6-glucuronide [Effect] Long lasting respiratory depression"}, {"id": "623061_1_766", "context": "A toxic encephalopathy characterized by depressed level of consciousness, marked irritability, and ataxia developed in seven children, 5 years of age and younger, following administration of an antiemetic combination of pentobarbital and pyrilamine maleate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] seven children, 5 years of age and younger [Treatment] administration of an antiemetic combination of pentobarbital and pyrilamine maleate [Effect] A toxic encephalopathy characterized by depressed level of consciousness, marked irritability, and ataxia"}, {"id": "868978_1_767", "context": "Oculomotor disturbances associated with 5-fluorouracil chemotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] 5-fluorouracil chemotherapy [Effect] Oculomotor disturbances"}, {"id": "18258513_1_768", "context": "While doxorubicin was administered, the patient presented thoracic pain and breathing distress due to superior vena cava perforation by the central catheter and subsequent extravasation of the drug into the mediastinum.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] patient [Treatment] doxorubicin [Effect] thoracic pain and breathing distress"}, {"id": "21802143_5_769", "context": "An 18-year-old Japanese man weighing 53 kg with an anaplastic large cell lymphoma received continuous IV administration of TAC as post-transplantation prophylaxis against graft-versus-host disease (GVHD) after an allogeneic bone marrow transplantation (BMT).", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] prophylaxis [Subject] An 18-year-old Japanese man weighing 53 kg with an anaplastic large cell lymphoma [Treatment] received continuous IV administration of TAC; allogeneic bone marrow transplantation (BMT) [Effect] graft-versus-host disease (GVHD)"}, {"id": "10682234_1_770", "context": "Intravenous administration of levodopa ameliorated a refractory akathisia case induced by interferon-alpha.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] ameliorated [Treatment] Intravenous administration of levodopa [Adverse event] induced [Treatment] interferon-alpha. [Effect] refractory akathisia"}, {"id": "12567347_1_771", "context": "Patients with lymphoblastic lymphoma who had treatment with L-asparaginase and steroid are predisposed to the development of cortical venous thrombosis and may have this syndrome in addition to a dural puncture headache.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] predisposed [Subject] Patients with lymphoblastic lymphoma [Treatment] L-asparaginase and steroid [Effect] cortical venous thrombosis; dural puncture headache"}, {"id": "7783891_1_772", "context": "Because sumatriptan can cause coronary artery vasospasm, patients with significant risk factors for coronary artery disease should be carefully evaluated for cardiovascular disease prior to the use of sumatriptan.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] sumatriptan [Effect] coronary artery vasospasm"}, {"id": "11563738_2_773", "context": "This article describes the case of a 25-year-old man found dead at home who had been prescribed olanzapine for schizophrenia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] found [Subject] 25-year-old man; schizophrenia [Treatment] olanzapine [Effect] dead"}, {"id": "7258204_1_774", "context": "A 67-year-old man developed diarrhea shortly after a 10-day course of oral ampicillin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 67-year-old man [Treatment] a 10-day course of oral ampicillin [Effect] diarrhea"}, {"id": "16216617_1_775", "context": "Prominent positive U waves appearing with high-dose intravenous phenylephrine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] appearing [Treatment] high-dose intravenous phenylephrine [Effect] Prominent positive U waves"}, {"id": "16620273_2_776", "context": "Severe acidosis in patients taking metformin--rapid reversal and survival despite high APACHE score.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] taking [Subject] patients [Treatment] metformin [Effect] Severe acidosis"}, {"id": "1868481_1_777", "context": "Seizures and transient blindness following intravenous pulse methylprednisolone in children with primary glomerulonephritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] children with primary glomerulonephritis [Treatment] intravenous pulse methylprednisolone [Effect] Seizures and transient blindness"}, {"id": "16728538_4_778", "context": "We report on a patient with acromegaly who developed severe drug-induced hepatitis during combined treatment with the long-acting somatostatin-analog octreotide and the GH receptor antagonist pegvisomant.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient with acromegaly [Treatment] long-acting somatostatin-analog octreotide; GH receptor antagonist pegvisomant [Effect] hepatitis"}, {"id": "12851279_6_779", "context": "The primary efficacy population consisted of 1754 patients (> or =18 years) with severe sepsis and a high INR (> or =1.2) randomly assigned to intravenous infusion of either tifacogin (0.025 mg/kg per hour for 96 hours, n = 880) or placebo (arginine citrate buffer, n = 874), and 201 patients with a low INR (<1.2) randomly assigned to receive the same dose of either tifacogin or placebo.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] assigned [Subject] 1754 patients (> or =18 years) with severe sepsis and a high INR [Treatment] tifacogin"}, {"id": "20234160_3_780", "context": "We report a case of a 23-year-old man who developed a vancomycin-induced anaphylactic reaction in the treatment of methicillin-resistant Staphylococcus aureus infection.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 23-year-old man [Treatment] vancomycin [Effect] a vancomycin-induced anaphylactic reaction"}, {"id": "19884751_2_781", "context": "Recovery of the tubular dysfunction took 15 days following cessation of the offending drug, Amikacin.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] Recovery [Treatment] 15 days following cessation of the offending drug, Amikacin"}, {"id": "7139589_3_782", "context": "L-asparaginase-induced pancreatitis has been reported during or closely following administration of the drug.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] L-asparaginase [Effect] pancreatitis"}, {"id": "15286697_3_783", "context": "These novel findings may offer specific therapeutic targets in the treatment of BCNU-associated pulmonary fibrosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] BCNU [Effect] pulmonary fibrosis"}, {"id": "19212144_1_784", "context": "A 58-year-old man with advanced renal cell carcinoma developed grade 3 proteinuria (8.5 g/24 h) without microscopic hematuria or renal insufficiency five days after temsirolimus infusion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 58-year-old man with advanced renal cell carcinoma [Treatment] five days after temsirolimus infusion [Effect] grade 3 proteinuria (8.5 g/24 h) without microscopic hematuria or renal insufficiency"}, {"id": "9253492_1_785", "context": "A 2-year-old mentally retarded boy with frontal lobe epilepsy presented with an episode that resembled heat stroke during the administration of zonisamide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] A 2-year-old mentally retarded boy with frontal lobe epilepsy [Treatment] zonisamide [Effect] an episode that resembled heat stroke"}, {"id": "18166746_1_786", "context": "[Serotonin syndrome following methylene blue infusion during parathyroidectomy: a case report and literature review].", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] methylene blue infusion during parathyroidectomy [Effect] Serotonin syndrome"}, {"id": "868978_3_787", "context": "Two patients treated with 5-fluorouracil (5-FU) for disseminated adenocarcinoma of the colon developed cerebellar dysfunction typical of 5-FU neurotoxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] Two patients [Treatment] 5-fluorouracil (5-FU) [Effect] cerebellar dysfunction"}, {"id": "11510798_4_788", "context": "Once extensive microbiological studies proved negative, corticosteroids were given and a complete remission of clinical and radiological abnormalities was achieved.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] achieved [Treatment] corticosteroids [Effect] a complete remission of clinical and radiological abnormalities was achieved"}, {"id": "9886213_1_789", "context": "Disseminated muscular cysticercosis with myositis induced by praziquantel therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] praziquantel therapy [Effect] Disseminated muscular cysticercosis with myositis"}, {"id": "172214_1_790", "context": "Cardiomyopathy after widely separated courses of adriamycin exacerbated by actinomycin-D and mithramycin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] exacerbated [Treatment] widely separated courses of adriamycin; actinomycin-D and mithramycin [Effect] Cardiomyopathy; exacerbated"}, {"id": "11485141_3_791", "context": "Linear immunoglobulin A bullous dermatosis induced by gemcitabine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] gemcitabine [Effect] Linear immunoglobulin A bullous dermatosis"}, {"id": "10573314_12_792", "context": "The temporal association of the course of tolterodine with an elevated INR, the return to the previous warfarin dose-INR response relationship after tolterodine discontinuation, and the absence of other causes for the elevated INR were factors found in both patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] course [Subject] both patients [Treatment] tolterodine [Effect] elevated INR [Potential therapeutic event] return [Subject] both patients [Treatment] tolterodine discontinuation [Effect] return to the previous warfarin dose-INR response relationship"}, {"id": "15461766_2_793", "context": "The harlequin color change and association with prostaglandin E1.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association [Treatment] prostaglandin E1 [Effect] harlequin color change"}, {"id": "19336028_1_794", "context": "A case of tuberculosis in a patient on Efalizumab and Etanercept for treatment of refractory palmopustular psoriasis and psoriatic arthritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treatment [Subject] a patient [Treatment] Efalizumab and Etanercept [Effect] tuberculosis"}, {"id": "10225085_1_795", "context": "Although the two local anesthetics usually do not cause methemoglobinemia, we suspect that the displacement of lidocaine from protein binding by bupivacaine, in combination with metabolic acidosis and treatment with other oxidants, was the reason for the development of methemoglobinemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reason [Treatment] the displacement of lidocaine from protein binding by bupivacaine, in combination with metabolic acidosis and treatment with other oxidants [Effect] methemoglobinemia"}, {"id": "6851259_1_796", "context": "Nephrotic range pseudoproteinuria in a tolmetin-treated patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] patient [Treatment] tolmetin [Effect] Nephrotic range pseudoproteinuria"}, {"id": "19318596_4_797", "context": "With the first cyclosporine dose, the patient complained of leg pain that was most severe during the cyclosporine infusion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complained [Subject] With [Treatment] first cyclosporine dose [Effect] leg pain"}, {"id": "15811174_3_798", "context": "We report on a patient who developed acute rhabdomyolysis after taking cerivastatin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a patient [Treatment] cerivastatin [Effect] acute rhabdomyolysis"}, {"id": "8124920_2_799", "context": "In a patient suffering from rheumatoid arthritis, we report the first simultaneous occurrence of two side effects of low-dose methotrexate: an acute megaloblastic anaemia and a pneumonitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] an [Subject] patient suffering from rheumatoid arthritis [Treatment] low-dose methotrexate [Effect] acute megaloblastic anaemia and a pneumonitis"}, {"id": "11109149_3_800", "context": "We describe a 57-year-old man with acral erythrocyanosis progressing to acute digital ischemia and gangrene that developed after combined chemotherapy (bleomycin and methotrexate) used to treat a metastatic squamous cell carcinoma of the hypopharynx.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 57-year-old man with acral erythrocyanosis [Treatment] combined chemotherapy (bleomycin and methotrexate) [Effect] acute digital ischemia and gangrene"}, {"id": "2719905_2_801", "context": "We report a case of long lasting respiratory depression after intravenous administration of morphine to a 7 year old girl with haemolytic uraemic syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a 7 year old girl with haemolytic uraemic syndrome [Treatment] intravenous administration of morphine [Effect] a case of long lasting respiratory depression"}, {"id": "18071101_1_802", "context": "Although adverse effects are usually mild, the author reports here a case of leucocytopenia and thrombocytopenia with quetiapine treatment that required its discontinuation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Subject] a case [Treatment] quetiapine [Effect] leucocytopenia and thrombocytopenia"}, {"id": "3720318_1_803", "context": "Noncardiogenic pulmonary edema during intrabiliary infusion of mono-octanoin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] intrabiliary infusion of mono-octanoin [Effect] Noncardiogenic pulmonary edema"}, {"id": "589261_1_804", "context": "Cardiac glycosides are thought to prevent doxorubicin cardiomyopathy by competitively inhibiting doxorubicin at its receptor sites, but ouabain has a much shorter half life than doxorubicin and its metabolites and so is less effective than digoxin.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] thought to [Treatment] Cardiac glycosides"}, {"id": "18262450_7_805", "context": "Three hundred and thirty eight patients with moderate to severe painful diabetic neuropathy despite receiving their maximum tolerated dose of gabapentin, had oral prolonged-release oxycodone or placebo tablets added to their therapy for up to 12 weeks.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] receiving [Subject] Three hundred and thirty eight patients with moderate to severe painful diabetic neuropathy [Treatment] gabapentin; oral prolonged-release oxycodone or placebo tablets added to their therapy for up to 12 weeks"}, {"id": "22552763_4_806", "context": "We assessed the bleeding risk in patients treated with thromboprophylactic dabigatran etexilate, with and without concomitant NSAID or ASA.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] patients [Treatment] thromboprophylactic dabigatran etexilate, with and without concomitant NSAID or ASA [Effect] bleeding"}, {"id": "2532694_2_807", "context": "Dapsone-induced erythroderma with Beau's lines.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Dapsone [Effect] erythroderma with Beau's lines"}, {"id": "9870779_2_808", "context": "Methotrexate-induced hepatic necrosis requiring liver transplantation in a patient with rheumatoid arthritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient with rheumatoid arthritis [Treatment] Methotrexate [Effect] hepatic necrosis"}, {"id": "15516308_3_809", "context": "We present three cases from the Provincial Toxicology Center of British Columbia, Canada in which suicidal overdose deaths were associated with quetiapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] quetiapine [Effect] suicidal overdose deaths"}, {"id": "2830062_3_810", "context": "Both patients developed hypoadrenalism while on o,p'-DDD and apparently adequate dexamethasone replacement therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Both patients [Treatment] o,p'-DDD and apparently adequate dexamethasone replacement therapy [Effect] hypoadrenalism"}, {"id": "16046172_1_811", "context": "In the other patient, a 78-year-old woman, Neisseria mucosa knee arthritis occurred after a single sodium hyaluronate injection.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Subject] a 78-year-old woman [Treatment] a single sodium hyaluronate injection [Effect] Neisseria mucosa knee arthritis"}, {"id": "21729965_1_812", "context": "Implanon   failure in an HIV-positive woman on antiretroviral therapy resulting in two ectopic pregnancies.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulting [Subject] an HIV-positive woman [Treatment] Implanon   failure; on antiretroviral therapy [Effect] two ectopic pregnancies"}, {"id": "16341621_1_813", "context": "Massive prolapse of the urethral mucosa following periurethral injection of calcium hydroxylapatite for stress urinary incontinence.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] periurethral injection of calcium hydroxylapatite [Effect] Massive prolapse of the urethral mucosa"}, {"id": "2532694_1_814", "context": "A 35-year-old female with borderline lepromatous (BL) leprosy who suffered from dapsone-induced erythroderma is reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] A 35-year-old female with borderline lepromatous (BL) leprosy [Treatment] dapsone [Effect] erythroderma"}, {"id": "8912599_8_815", "context": "Well-known signs of methotrexate toxicity include bone marrow suppression and oral and gastrointestinal ulceration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] signs [Treatment] methotrexate [Effect] bone marrow suppression and oral and gastrointestinal ulceration"}, {"id": "18755414_1_816", "context": "Hemorrhage from a falx meningioma after internal use of low-dose aspirin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] internal use of low-dose aspirin [Effect] Hemorrhage from a falx meningioma"}, {"id": "9671138_2_817", "context": "Severe respiratory syncytial virus pulmonary infection in a patient treated with fludarabine for chronic lymphocytic leukemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] a patient [Treatment] fludarabine [Effect] Severe respiratory syncytial virus pulmonary infection"}, {"id": "9149614_2_818", "context": "Nonsustained polymorphous ventricular tachycardia during amiodarone therapy for atrial fibrillation complicating cardiomyopathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] amiodarone therapy [Effect] Nonsustained polymorphous ventricular tachycardia"}, {"id": "8316494_1_819", "context": "Severe abdominal pain in low dosage clofazimine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Treatment] low dosage clofazimine [Effect] abdominal pain"}, {"id": "12908837_1_820", "context": "Behavioral side effects associated with clonazepam may include agitation, aggression, hyperactivity, irritability, property destruction, and temper tantrums.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] clonazepam [Effect] agitation, aggression, hyperactivity, irritability, property destruction, and temper tantrums"}, {"id": "6671350_2_821", "context": "Coagulopathy associated with the use of cephalosporin or moxalactam antibiotics in acute and chronic renal failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] cephalosporin or moxalactam antibiotics [Effect] Coagulopathy"}, {"id": "9865241_2_822", "context": "Pamidronate therapy should be considered in patients with hypercalcemia secondary to acute vitamin D poisoning.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Treatment] vitamin D [Effect] hypercalcemia [Potential therapeutic event] therapy [Treatment] Pamidronate"}, {"id": "17090724_3_823", "context": "Use of the Naranjo probability scale indicated a highly probable relationship between the observed cardiac toxicity and amphotericin B deoxycholate therapy in this patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] relationship [Subject] patient [Treatment] amphotericin B deoxycholate [Effect] cardiac toxicity"}, {"id": "16132305_1_824", "context": "Captopril-induced pulmonary infiltrates with eosinophilia in an infant with congenital heart disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] an infant with congenital heart disease [Treatment] Captopril [Effect] pulmonary infiltrates with eosinophilia"}, {"id": "15836666_1_825", "context": "Chronic fentanyl application induces adrenocortical insufficiency.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induces [Treatment] Chronic fentanyl [Effect] adrenocortical insufficiency"}, {"id": "16132305_5_826", "context": "After discontinuing captopril and starting systemic steroids, her symptomatology rapidly improved, and her eosinophilia and radiographic abnormalities both resolved.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] resolved [Treatment] discontinuing captopril and starting systemic steroids [Effect] her eosinophilia and radiographic abnormalities both resolved"}, {"id": "12927328_1_827", "context": "We present a surprising case of a woman schizophrenic patient treated with clozapine suffering from EPS.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] suffering [Subject] a woman schizophrenic patient [Treatment] clozapine [Effect] EPS"}, {"id": "17016002_3_828", "context": "Therefore, we concluded that this patient's pulmonary disease was caused by calcium stearate, an additive for an antihistaminic drug.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Subject] this patient's [Treatment] calcium stearate; an additive for an antihistaminic drug [Effect] pulmonary disease"}, {"id": "3343188_2_829", "context": "Benzocaine-induced methemoglobinemia has been reported in man, dogs, and cats.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] man, dogs, and cats [Treatment] Benzocaine [Effect] methemoglobinemia"}, {"id": "8151270_3_830", "context": "We report two cases of fulminant hepatic failure in HIV-1-infected patients treated with didanosine (ddI).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Subject] HIV-1-infected patients [Treatment] didanosine (ddI) [Effect] fulminant hepatic failure"}, {"id": "11352235_2_831", "context": "Leflunomide-associated weight loss in rheumatoid arthritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Leflunomide [Effect] weight loss"}, {"id": "11450788_1_832", "context": "Antiretroviral-induced hepatic steatosis and lactic acidosis: case report and review of the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] case [Treatment] Antiretroviral [Effect] hepatic steatosis and lactic acidosis"}, {"id": "1756352_1_833", "context": "A woman developed delusional parasitosis when taking phenelzine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A woman [Treatment] phenelzine [Effect] delusional parasitosis"}, {"id": "8308951_4_834", "context": "Percutaneous absorption of warfarin causing coagulopathy, reported three times in the past, is a significant risk if protective measures, such as gloves, are not used.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] causing [Treatment] Percutaneous absorption of warfarin [Effect] coagulopathy"}, {"id": "10752888_2_835", "context": "We present two cases of nitrofurantoin-induced pulmonary toxicity in which the initial HRCT showed a widespread reticular pattern and associated distortion of the lung parenchyma, thought to represent established fibrosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] nitrofurantoin [Effect] pulmonary toxicity in which the initial HRCT showed a widespread reticular pattern and associated distortion of the lung parenchyma, thought to represent established fibrosis"}, {"id": "17619811_4_836", "context": "Colchicine-induced rhabdomyolysis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Colchicine [Effect] rhabdomyolysis"}, {"id": "16678268_2_837", "context": "We report a case of severe AVP three weeks following the administration of infliximab for the treatment of Crohn's disease (CD).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] infliximab [Effect] AVP"}, {"id": "10573314_7_838", "context": "In each patient, the initiation of tolterodine was associated with a significant increase in the patient's INR measured 10-14 days later.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated with [Subject] each patient [Treatment] the initiation of tolterodine [Effect] significant increase in the patient's INR"}, {"id": "9007910_4_839", "context": "DATA SYNTHESIS: Genetic deficiencies in DPD, the rate-limiting enzyme responsible for 5-FU catabolism, may occur in 3% or more of patients with cancer putting them at increased risk for unusually severe adverse reactions (e.g., diarrhea, stomatitis, mucositis, myelosuppression, neurotoxicity) to standard doses of 5-FU.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] putting [Subject] Genetic deficiencies in DPD, the rate-limiting enzyme responsible for 5-FU catabolism, may occur in 3% or more of patients with cancer [Treatment] standard doses of 5-FU [Effect] increased risk for unusually severe adverse reactions (e.g., diarrhea, stomatitis, mucositis, myelosuppression, neurotoxicity)"}, {"id": "21515865_11_840", "context": "According to the Drug Interaction Probability Scale, the development of supratherapeutic INRs was probably associated with concomitant acetaminophen and moxifloxacin use.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] concomitant acetaminophen and moxifloxacin use [Effect] development of supratherapeutic INRs"}, {"id": "17921794_1_841", "context": "Both colchicine and statin therapy may be associated with myopathy, which usually occurs after several months of therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] colchicine and statin therapy [Effect] myopathy"}, {"id": "6671350_1_842", "context": "Cephalosporins are most likely associated with Vitamin K deficiency.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Cephalosporins [Effect] Vitamin K deficiency."}, {"id": "18042092_2_843", "context": "Embolia cutis medicamentosa following subcutaneous injection of glatiramer acetate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] subcutaneous injection of glatiramer acetate [Effect] Embolia cutis medicamentosa"}, {"id": "3084231_3_844", "context": "Reversible valproic acid-induced dementia was documented in a 21-year-old man with epilepsy who had a 3-year history of insidious progressive decline in global cognitive abilities documented by serial neuropsychological studies.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a 21-year-old man with epilepsy who had a 3-year history of insidious progressive decline in global cognitive abilities [Treatment] valproic acid [Effect] Reversible; dementia"}, {"id": "17316891_1_845", "context": "We describe the case of a 50-year-old woman with advanced non-small cell lung cancer who developed status epilepticus shortly after receiving cisplatin and gemcitabine chemotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 50-year-old woman with advanced non-small cell lung cancer [Treatment] cisplatin and gemcitabine chemotherapy [Effect] status epilepticus"}, {"id": "18628507_3_846", "context": "Here, we report a case of angio-oedema associated with VRC therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] VRC therapy [Effect] angio-oedema"}, {"id": "18037876_2_847", "context": "Multiple syncopal episodes started to occur during thalidomide treatment, and a Holter electrocardiogram showed multiple abnormalities, with an episode of sustained ventricular tachycardia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occur [Treatment] during thalidomide treatment [Effect] Multiple syncopal episodes; and a Holter electrocardiogram showed multiple abnormalities, with an episode of sustained ventricular tachycardia"}, {"id": "9413296_1_848", "context": "A 25-year-old woman sought medical attention because of iliocaval manifestations of retroperitoneal fibrosis while she was taking methysergide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] while [Subject] A 25-year-old woman; she [Treatment] methysergide [Effect] iliocaval manifestations of retroperitoneal fibrosis"}, {"id": "18569796_2_849", "context": "Nodular scleritis following alendronate therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] alendronate [Effect] Nodular scleritis"}, {"id": "10573314_8_850", "context": "Thus, tolterodine was ineffective in both patients and was discontinued one to two days before the elevated INRs were determined during routine clinic visits.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] ineffective [Subject] both patients [Treatment] tolterodine"}, {"id": "2022118_1_851", "context": "However, the use of lithium should be avoided with any patient who is purging, since it may exacerbate the loss of intracellular potassium, thereby increasing the risk of cardiac toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] exacerbate [Subject] patient who is purging [Treatment] lithium [Effect] loss of intracellular potassium; increasing the risk of cardiac toxicity"}, {"id": "681921_2_852", "context": "Neurophysiological mechanisms which aid in elucidating the role of disulfiram in the etiology of catatonia are discussed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] etiology [Treatment] disulfiram [Effect] catatonia"}, {"id": "10717401_1_853", "context": "Sagittal sinus thrombosis associated with transient free protein S deficiency after L-asparaginase treatment: case report and review of the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] L-asparaginase treatment [Effect] Sagittal sinus thrombosis associated with transient free protein S deficiency"}, {"id": "4063627_3_854", "context": "This case demonstrates the association of selective IgA deficiency with remission in rheumatoid arthritis induced by fenclofenac as well as aurothiomalate and sulphasalazine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] This case [Treatment] fenclofenac; aurothiomalate; sulphasalazine [Effect] remission in rheumatoid arthritis"}, {"id": "18262450_14_855", "context": "This study provides the first evidence that co-administration of prolonged-release oxycodone and existing gabapentin therapy has a clinically meaningful effect in painful diabetic neuropathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] has [Treatment] co-administration of prolonged-release oxycodone and existing gabapentin therapy [Effect] clinically meaningful effect"}, {"id": "17504225_4_856", "context": "In the present case report, the concomitant administration of clarithromycin and sirolimus determined impressive increase of sirolimus trough blood concentrations from 6.2 up to 54 ng/mL and this increase was associated with an acute impairment of renal function, almost completely reversed upon both drugs discontinuation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] the concomitant administration of clarithromycin and sirolimus [Effect] acute impairment of renal function"}, {"id": "10190739_1_857", "context": "In one case, the readministration of riluzole was followed by the relapse of hepatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] readministration [Treatment] riluzole [Effect] the relapse of hepatitis"}, {"id": "16018164_3_858", "context": "Pseudoephedrine-induced hemorrhage associated with a cerebral vascular malformation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Pseudoephedrine [Effect] hemorrhage associated with a cerebral vascular malformation"}, {"id": "16490518_1_859", "context": "PURPOSE: To report a case of severe corticosteroid-induced glaucoma after intravitreal injection of triamcinolone acetate in a 34-year-old man without a history of glaucoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a 34-year-old man without a history of glaucoma [Treatment] intravitreal injection of triamcinolone acetate [Effect] glaucoma"}, {"id": "7369302_2_860", "context": "A transient tonic pupillary response, denervation supersensitivity, and abnormal visual-evoked potentials in quinine toxicity, to our knowledge, have not been previously reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reported [Treatment] quinine [Effect] transient tonic pupillary response, denervation supersensitivity, and abnormal visual-evoked potentials"}, {"id": "10682234_6_861", "context": "Two days' administration of levomepromazine 100 mg led him to a coma for 2 days.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] led [Treatment] Two days' administration of levomepromazine 100 mg [Effect] a coma for 2 days"}, {"id": "9777751_1_862", "context": "Methimazole-induced aplastic anemia in third exposure: successful treatment with recombinant human granulocyte colony-stimulating factor.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Methimazole [Effect] aplastic anemia"}, {"id": "18751717_2_863", "context": "BACKGROUND: We describe the ophthalmic features and clinical course of two cases of acute syphilitic posterior placoid chorioretinitis (ASPPC) that developed after intravitreal triamcinolone acetonide (IVTA) injection.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] intravitreal triamcinolone acetonide (IVTA) injection [Effect] acute syphilitic posterior placoid chorioretinitis"}, {"id": "14522628_2_864", "context": "Skin rash and splinter hemorrhages from ganciclovir.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] from [Treatment] ganciclovir [Effect] Skin rash and splinter hemorrhages"}, {"id": "15368548_5_865", "context": "We present a pediatric patient with leukemia and a severe, L-asparaginase-induced necrotizing pancreatitis, treated successfully with percutaneous drainage used to flush the infected necrotic parts.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] used to [Subject] pediatric patient with leukemia and a severe, L-asparaginase-induced necrotizing pancreatitis [Treatment] percutaneous drainage [Effect] flush the infected necrotic parts. [Adverse event] induced [Treatment] L-asparaginase [Effect] necrotizing pancreatitis"}, {"id": "11804071_3_866", "context": "Such anagen effluvium with lichenoid eruption following INH therapy has not been observed previously.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] INH [Effect] anagen effluvium with lichenoid eruption"}, {"id": "10646879_3_867", "context": "We conclude that MB is an effective treatment for ifosfamide-induced encephalopathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] ifosfamide [Effect] encephalopathy [Potential therapeutic event] treatment [Treatment] MB"}, {"id": "18354950_2_868", "context": "Hyponatraemia during low-dose carbamazepine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] low-dose carbamazepine [Effect] Hyponatraemia"}, {"id": "16697705_1_869", "context": "Acute coronary syndrome induced by capecitabine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] capecitabine therapy [Effect] Acute coronary syndrome"}, {"id": "3171334_1_870", "context": "A case of severe visual loss following a single dose of vincristine is described.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] A case [Treatment] a single dose of vincristine [Effect] severe visual loss"}, {"id": "16357738_3_871", "context": "We report a case of a young woman with SLE and thrombocytopenia, who developed severe perspiration, headache, and seizure after receiving cyclosporine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] young woman with SLE and thrombocytopenia [Treatment] cyclosporine [Effect] severe perspiration, headache, and seizure"}, {"id": "12507063_1_872", "context": "Although gabapentin withdrawal has been previously reported and usually consists of anxiety, diaphoresis, and palpitations, this is the first reported patient with generalized seizures and status epilepticus secondary to gabapentin withdrawal.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Subject] patient [Treatment] secondary to gabapentin withdrawal [Effect] generalized seizures and status epilepticus"}, {"id": "4014301_2_873", "context": "Self-limited edema is a well-recognized complication of insulin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] insulin [Effect] Self-limited edema"}, {"id": "15061230_1_874", "context": "It is very likely that the dexamethasone used in the antiemetic drug regimen contributed to the development of osteonecrosis in these patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] contributed [Subject] these patients [Treatment] dexamethasone [Effect] osteonecrosis"}, {"id": "12397859_1_875", "context": "A case is presented of a patient who experienced benzodiazepine withdrawal symptoms on discontinuation of nefazodone, an antidepressant that inhibits the cytochrome P450 3A4 isoenzyme.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] discontinuation [Subject] a patient [Treatment] nefazodone [Effect] benzodiazepine withdrawal symptoms"}, {"id": "3156465_1_876", "context": "Isotretinoin, a drug used for the treatment of acne, has been shown to have teratogenic effects.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] have [Treatment] Isotretinoin [Effect] teratogenic effects"}, {"id": "12022905_6_877", "context": "The capacity of zuclopenthixol to induce priapism is thought to be due to its antagonist activity on alpha-adrenergic receptors.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induce [Treatment] zuclopenthixol [Effect] priapism"}, {"id": "6572542_4_878", "context": "Two patients treated for chronic myeloid leukemia with high doses of CCNU (1100 mg/m2 and 1240 mg/m2, respectively) developed a fatal pulmonary fibrosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Two patients; chronic myeloid leukemia [Treatment] CCNU (1100 mg/m2 and 1240 mg/m2, respectively) [Effect] pulmonary fibrosis"}, {"id": "11724089_1_879", "context": "CONCLUSIONS: There is very little published information regarding ofloxacin-induced toxic epidermal necrolysis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] ofloxacin [Effect] toxic epidermal necrolysis"}, {"id": "18755414_3_880", "context": "Our case is the second one in which hemorrhage from a meningioma may have been induced by aspirin prophylaxis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] Our case is the second one [Treatment] aspirin prophylaxis [Effect] hemorrhage from a meningioma"}, {"id": "10225085_2_881", "context": "Methemoglobinemia after axillary block with bupivacaine and additional injection of lidocaine in the operative field.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] axillary block with bupivacaine and additional injection of lidocaine in the operative field [Effect] Methemoglobinemia"}, {"id": "10812579_3_882", "context": "Nonconvulsive status epilepticus: the role of morphine and its antagonist.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] the role [Treatment] morphine and its antagonist [Effect] Nonconvulsive status epilepticus"}, {"id": "8579054_1_883", "context": "Acute myeloid leukemia evolving from essential thrombocythemia in two patients treated with hydroxyurea.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] two patients [Treatment] hydroxyurea [Effect] Acute myeloid leukemia"}, {"id": "10698143_1_884", "context": "Central nervous system manifestations of an ibuprofen overdose reversed by naloxone.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] by [Treatment] naloxone"}, {"id": "20465622_2_885", "context": "BACKGROUND: Aphthous stomatitis, a common mucocutaneous disorder, is a well accepted complication of sirolimus therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] sirolimus [Effect] Aphthous stomatitis"}, {"id": "18675768_4_886", "context": "The goal of this article was to describe a potential drug-drug interaction between propafenone and citalopram, which caused symptoms of propafenone adverse effects.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] drug-drug interaction between propafenone and citalopram [Effect] symptoms of propafenone adverse effects"}, {"id": "7949255_1_887", "context": "Temporary neurologic abnormalities were observed in one out of 23 patients undergoing chemotherapy with high-dose methotrexate (HD-MTX) for osteogenic sarcoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] observed [Subject] one out of 23 patients [Treatment] chemotherapy with high-dose methotrexate (HD-MTX) [Effect] Temporary neurologic abnormalities"}, {"id": "18675768_13_888", "context": "This is the first report of a possible interaction between propafenone and citalopram, which caused propafenone adverse effects (eg, dizziness, falls) and mimicked coronary artery disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] propafenone and citalopram; propafenone [Effect] propafenone adverse effects (eg, dizziness, falls) and mimicked coronary artery disease"}, {"id": "1082426_1_889", "context": "Spontaneous bacterial peritonitis induced by intraarterial vasopressin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] intraarterial vasopressin therapy [Effect] Spontaneous bacterial peritonitis"}, {"id": "16685007_1_890", "context": "Ciclesonide reduces the need for oral steroid use in adult patients with severe, persistent asthma.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] reduces [Subject] adult patients [Treatment] Ciclesonide"}, {"id": "8250714_1_891", "context": "Five cases (four from the literature and one new case) are presented in which patients unsuspected of having vitamin B12 deficiency developed subacute combined degeneration of the spinal cord following nitrous oxide anesthesia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Five cases (four from the literature and one new case) are presented in which patients unsuspected of having vitamin B12 deficiency [Treatment] nitrous oxide anesthesia [Effect] subacute combined degeneration of the spinal cord"}, {"id": "12022905_1_892", "context": "CASE SUMMARY: We report the case of a 31-year-old patient hospitalized due to behavioral alterations and treated with oral zuclopenthixol, an antipsychotic from the thioxanthene family, who developed an acute, painful erection.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 31-year-old patient [Treatment] oral zuclopenthixol [Effect] acute, painful erection"}, {"id": "6401771_2_893", "context": "Three cases of acute renal toxicity in patients receiving long-term therapy with mitomycin C and 5-fluorouracil are reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reported [Subject] patients [Treatment] mitomycin C and 5-fluorouracil [Effect] acute renal toxicity"}, {"id": "9870779_1_894", "context": "A 40-year-old man with a long standing history of rheumatoid arthritis was treated with MTX over a 6 month period and developed an overwhelming hepatic necrosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 40-year-old man with a long standing history of rheumatoid arthritis [Treatment] MTX over a 6 month period [Effect] an overwhelming hepatic necrosis"}, {"id": "9627209_1_895", "context": "In case 1, a total daily dose of 25 mg sertraline, with nondetectable sertraline and desmethylsertraline blood levels, resulted in a doubling of the lamotrigine blood level with symptoms of toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulted [Subject] In case 1 [Treatment] a total daily dose of 25 mg sertraline [Effect] doubling of the lamotrigine blood level with symptoms of toxicity"}, {"id": "7355327_3_896", "context": "Since the bronchospasm was relieved with discontinuation of propranolol and supportive bronchodilator therapy, the bronchospasm was believed to be caused by propranolol.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] propranolol [Effect] bronchospasm"}, {"id": "6362443_2_897", "context": "A depressed woman with no history of bipolar illness developed a manic episode during treatment with fluoxetine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] A depressed woman with no history of bipolar illness [Treatment] fluoxetine [Effect] manic episode"}, {"id": "6725214_2_898", "context": "Priapism associated with trazodone therapy: case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] trazodone therapy [Effect] Priapism"}, {"id": "7639655_3_899", "context": "OBJECTIVE: To report the occurrence of anterior ischemic optic neuropathy as a complication of treatment with interferon alfa and to consider the possible underlying mechanisms for this association.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] interferon alfa [Effect] anterior ischemic optic neuropathy"}, {"id": "8850251_4_900", "context": "Mequitazine seemed to play a part similar to chlorpromazine, and absence of mequitazine-induced photosensitivity may be due to a relatively low dosage of the drug.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] mequitazine; due to a relatively low dosage of the drug [Effect] photosensitivity"}, {"id": "15927910_2_901", "context": "Although various manifestations of pentamidine-induced cardiotoxicity have been reported, to our knowledge, second-degree heart block associated with this agent has not been described.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] pentamidine [Effect] cardiotoxicity [Adverse event] associated [Treatment] pentamidine [Effect] second-degree heart block"}, {"id": "23115227_6_902", "context": "The mean weekly warfarin dose while the patient was receiving emtricitabine monotherapy was 13.3 mg (95% CI 12.7 to 13.8), with a mean international normalized ratio (INR) of 2.8 (95% CI 2.5 to 3.1).", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] receiving [Subject] the patient [Treatment] The mean weekly warfarin dose; emtricitabine monotherapy was 13.3 mg (95% CI 12.7 to 13.8)"}, {"id": "3806824_2_903", "context": "We report a case of penile fibrosis after intracavernous self-injection of a combination of phentolamine and papaverine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] intracavernous self-injection of a combination of phentolamine and papaverine [Effect] penile fibrosis"}, {"id": "6865827_3_904", "context": "This is, to the best of our knowledge, the first report of a case in which agranulocytosis followed treatment with both propylthiouracil and methimazole in the same patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] followed [Subject] the same patient [Treatment] both propylthiouracil and methimazole [Effect] agranulocytosis"}, {"id": "15522120_1_905", "context": "Itch and skin rash from chocolate during fluoxetine and sertraline treatment: case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] from [Treatment] chocolate during fluoxetine and sertraline treatment [Effect] Itch and skin rash"}, {"id": "18262450_11_906", "context": "Oxycodone-gabapentin co-administration was associated with less escape medication use (P = 0.03) and fewer nights of disturbed sleep (P < 0.05).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Oxycodone-gabapentin co-administration [Effect] less escape medication use (P = 0.03) and fewer nights of disturbed sleep (P < 0.05)"}, {"id": "6618859_2_907", "context": "Gynecomastia in epileptics treated with phenobarbital, phenytoin and fluoresone: two case reports.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] phenobarbital, phenytoin and fluoresone [Effect] Gynecomastia"}, {"id": "3542612_1_908", "context": "Captopril-induced lichen planus pemphigoides with pemphigus-like features.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Captopril [Effect] lichen planus pemphigoides"}, {"id": "6873616_3_909", "context": "The literature on thiabendazole-induced cholestasis and its association with sicca complex is reviewed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] thiabendazole [Effect] cholestasis"}, {"id": "8523340_2_910", "context": "How low can you go? Use of very low dosage of gold in patients with mucocutaneous reactions.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] Use [Subject] patients with mucocutaneous reactions [Treatment] very low dosage of gold"}, {"id": "23970584_3_911", "context": "A 55-year-old HIV-positive African woman received a single epidural triamcinolone injection for pain relief of postherpetic neuralgia.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] received [Subject] A 55-year-old HIV-positive African woman [Treatment] a single epidural triamcinolone injection"}, {"id": "6731466_2_912", "context": "Anaphylactoid shock, disseminated intravascular coagulation, and anuric renal failure requiring dialysis occurred in a patient receiving zomepirac sodium for toothache.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Subject] a patient; toothache [Treatment] zomepirac sodium [Effect] Anaphylactoid shock, disseminated intravascular coagulation, and anuric renal failure requiring dialysis"}, {"id": "11341670_1_913", "context": "During dose-finding studies for intravenous proton pump inhibitors omeprazole and pantoprazole, three of six young female volunteers receiving omeprazole and two young female volunteers receiving pantoprazole developed peripheral edema within 8 hr when high doses of the proton pump inhibitors were applied by continuous infusion together with large volumes of fluid.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] three of six young female volunteers [Treatment] omeprazole; high doses of the proton pump inhibitors were applied by continuous infusion together with large volumes of fluid [Effect] peripheral edema within 8 hr [Adverse event] developed [Subject] two young female volunteers [Treatment] pantoprazole; high doses of the proton pump inhibitors were applied by continuous infusion together with large volumes of fluid [Effect] peripheral edema within 8 hr"}, {"id": "10682234_7_914", "context": "Intravenous levodopa 25 mg ameliorated his akathisia symptoms drastically.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] ameliorated [Treatment] Intravenous levodopa 25 mg"}, {"id": "19318596_1_915", "context": "Cyclosporine-induced pain syndrome in a child undergoing hematopoietic stem cell transplant.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a child undergoing hematopoietic stem cell transplant [Treatment] Cyclosporine [Effect] pain syndrome"}, {"id": "3171334_5_916", "context": "Visual loss after a single small dose of vincristine has never been reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] a single small dose of vincristine [Effect] Visual loss"}, {"id": "12786839_2_917", "context": "Slow acetylator genotypes as a possible risk factor for infectious mononucleosis-like syndrome induced by salazosulfapyridine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced by [Treatment] salazosulfapyridine [Effect] infectious mononucleosis-like syndrome"}, {"id": "23970584_8_918", "context": "Clinicians should be aware of raltegravir-induced DRESS syndrome as well as the potential for drug-drug interactions due to protease inhibitor-based therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] raltegravir [Effect] DRESS syndrome"}, {"id": "12504711_2_919", "context": "CONCLUSION: Under certain circumstances topical brimonidine can cause paradoxical raised IOP necessitating vigilance in follow-up of patients on topical brimonidine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Subject] patients on topical brimonidine [Treatment] topical brimonidine [Effect] raised IOP"}, {"id": "12659609_9_920", "context": "Pharmacokinetic modeling suggested that the patient's initial over-treatment was as reported and that the predicted maximum serum concentration of chloroquine (902 micro g/L) was within the range seen in fatal chloroquine overdose.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] over-treatment [Subject] the patient's [Treatment] chloroquine (902 micro g/L) [Effect] fatal"}, {"id": "20925534_15_921", "context": "There was no apparent cardiovascular interaction between clopidogrel and omeprazole, but our results do not rule out a clinically meaningful difference in cardiovascular events due to use of a PPI.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] PPI [Effect] cardiovascular"}, {"id": "18855892_2_922", "context": "Anaphylactic/anaphylactoid reactions to methotrexate are rare.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Treatment] methotrexate [Effect] Anaphylactic/anaphylactoid reactions"}, {"id": "1422497_3_923", "context": "Continuous bladder irrigation of a 1% alum solution is a simple and generally safe method of chemical cautery to treat the bleeding urothelium.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treat [Treatment] Continuous bladder irrigation of a 1% alum solution"}, {"id": "10759907_3_924", "context": "The temporal relationship suggests that the spinal cord infarction may be related to the use of zolmitriptan.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] zolmitriptan [Effect] spinal cord infarction"}, {"id": "1756352_2_925", "context": "Delusional parasitosis associated with phenelzine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] phenelzine [Effect] Delusional parasitosis"}, {"id": "8610807_2_926", "context": "CONCLUSION: The administration of tissue plasminogen activator was responsible for the large extent of hemorrhage and should be considered in the differential diagnosis of hemorrhagic choroidal detachment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] responsible [Treatment] tissue plasminogen activator [Effect] large extent of hemorrhage"}, {"id": "9007910_1_927", "context": "Dihydropyrimidine dehydrogenase deficiency: a pharmacogenetic defect causing severe adverse reactions to 5-fluorouracil-based chemotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Treatment] 5-fluorouracil-based chemotherapy [Effect] severe adverse reactions"}, {"id": "16393774_2_928", "context": "Interferon-beta (IFN-beta) is a type I interferon used in the management of multiple sclerosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] used in [Treatment] Interferon-beta (IFN-beta) is a type I interferon"}, {"id": "18071101_2_929", "context": "Quetiapine-induced leucopenia and thrombocytopenia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Quetiapine [Effect] leucopenia and thrombocytopenia."}, {"id": "18425523_2_930", "context": "CONCLUSION: Severe and sustained ocular hypertension may occur after intravitreal ranibizumab.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] intravitreal ranibizumab [Effect] Severe and sustained ocular hypertension"}, {"id": "18425523_1_931", "context": "BACKGROUND: To describe the occurrence of ocular hypertension in four patients following injection of ranibizumab intravitreally.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurrence [Subject] four patients [Treatment] ranibizumab [Effect] ocular hypertension"}, {"id": "20234160_2_932", "context": "Vancomycin is widely used against methicillin-resistant Staphylococcus aureus infections, but it is associated with many adverse effects such as nephrotoxicity, ototoxicity, gastrointestinal disturbances, blood disorders, and two types of hypersensitivity reactions - an anaphylactoid reaction known as \"red man syndrome\" and anaphylaxis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Vancomycin [Effect] nephrotoxicity, ototoxicity, gastrointestinal disturbances, blood disorders, and two types of hypersensitivity reactions - an anaphylactoid reaction known as \"red man syndrome\" and anaphylaxis"}, {"id": "15093850_2_933", "context": "We report a case of unintentional overdose of oral pilocarpine tablets that resulted in bradycardia, mild hypotension, and muscarinic symptoms in a patient with Sjogren's syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulted [Treatment] pilocarpine [Effect] bradycardia, mild hypotension, and muscarinic symptoms"}, {"id": "16357738_1_934", "context": "Moreover, treatment with immunosuppressive drugs such as cyclosporine, cisplatin, tacrolimus, and interferon-alpha can induce a condition resembling RPLS.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induce [Treatment] immunosuppressive drugs such as cyclosporine, cisplatin, tacrolimus, and interferon-alpha [Effect] RPLS"}, {"id": "12854039_2_935", "context": "Case 1, a 62-year-old woman, developed bilateral optic neuritis with decreased sensation of vibration and increased deep tendon reflex in the lower extremities after a seven-month use of recombinant interferon alpha-2a for chronic active hepatitis C.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a 62-year-old woman [Treatment] a seven-month use of recombinant interferon alpha-2a for chronic active hepatitis C. [Effect] bilateral optic neuritis with decreased sensation of vibration and increased deep tendon reflex in the lower extremities"}, {"id": "9550246_1_936", "context": "A syndrome of increased affect in response to risperidone among patients with schizophrenia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] response [Subject] patients with schizophrenia [Treatment] risperidone [Effect] A syndrome of increased affect"}, {"id": "16393774_3_937", "context": "Therapy with IFN-beta has rarely been associated with the development of autoimmune disorders.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Treatment] IFN-beta [Effect] autoimmune disorders"}, {"id": "18977778_1_938", "context": "Despite these antithrombotic effects, the patient developed repeated venous thromboembolism during treatment with low-molecular-weight heparin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] treatment with low-molecular-weight heparin [Effect] repeated venous thromboembolism"}, {"id": "18354950_1_939", "context": "Hyponatraemia developed after rechallenge with controlled release carbamazepine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] rechallenge with controlled release carbamazepine [Effect] Hyponatraemia"}, {"id": "18505911_1_940", "context": "Azathioprine-induced warfarin resistance.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Azathioprine [Effect] warfarin resistance."}, {"id": "3084231_2_941", "context": "Reversible valproic acid-induced dementia: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] valproic acid [Effect] dementia"}, {"id": "6697887_1_942", "context": "Parenteral-verapamil-induced sustained hypotension.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Parenteral-verapamil [Effect] sustained hypotension"}, {"id": "1711090_6_943", "context": "The main side-effects of Lp-TAE combined with HT were low-grade fever, localized pain, myelo-suppression and liver dysfunction, but these were transient and eventually disappeared.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] side-effects [Treatment] Lp-TAE combined with HT [Effect] low-grade fever, localized pain, myelo-suppression and liver dysfunction"}, {"id": "6738830_2_944", "context": "Unique behavioral change with cinepazide in parkinsonism.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] cinepazide [Effect] Unique behavioral change"}, {"id": "3171334_4_945", "context": "The literature of vincristine optic nerve toxicity is reviewed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] toxicity [Treatment] vincristine [Effect] optic nerve toxicity"}, {"id": "7639655_4_946", "context": "PATIENTS: Two patients, ages 40 and 51 years, undergoing treatment with interferon alfa for malignant neoplasms experienced sudden bilateral, sequential visual loss with disc-related field defects and segmental optic disc edema.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experienced [Subject] Two patients, ages 40 and 51 years [Treatment] interferon alfa [Effect] bilateral, sequential visual loss with disc-related field defects and segmental optic disc edema"}, {"id": "14968106_2_947", "context": "Neurological improvement and rehabilitation potential following toxic myelopathy due to intrathecal injection of doxorubicin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due to [Treatment] intrathecal injection of doxorubicin [Effect] toxic myelopathy"}, {"id": "14522628_1_948", "context": "Generalised cutaneous rash associated with ganciclovir therapy has rarely been reported in literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated with [Treatment] ganciclovir therapy [Effect] Generalised cutaneous rash"}, {"id": "129501_1_949", "context": "Anaphylaxis after the injection of chymopapain occurs in about 1% of such cases.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurs [Subject] cases [Treatment] the injection of chymopapain [Effect] Anaphylaxis"}, {"id": "9253492_3_950", "context": "Heat stroke-like episode in a child caused by zonisamide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Subject] a child [Treatment] zonisamide [Effect] Heat stroke-like episode"}, {"id": "18166746_7_951", "context": "An interaction between methylene blue and serotonergic agents may give rise to the serotonin syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] rise [Treatment] methylene blue and serotonergic agents [Effect] serotonin syndrome"}, {"id": "11236070_2_952", "context": "These cases suggest the possibility that, in some patients, leukopenia or agranulocytosis during olanzapine treatment might be dose-related.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] in some patients [Treatment] olanzapine treatment [Effect] leukopenia or agranulocytosis"}, {"id": "18371508_1_953", "context": "Adult respiratory distress syndrome after treatment with pegylated interferon alpha-2a and ribavirin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] pegylated interferon alpha-2a and ribavirin [Effect] Adult respiratory distress syndrome"}, {"id": "16620273_1_954", "context": "CONCLUSIONS: The increasing prevalence of Type 2 diabetes and its treatment with metformin might result in more cases of lactic acidosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] result [Treatment] metformin [Effect] lactic acidosis"}, {"id": "18037876_3_955", "context": "Sustained ventricular tachycardia in a thalidomide-treated patient with primary plasma-cell leukemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] patient with primary plasma-cell leukemia [Treatment] thalidomide [Effect] Sustained ventricular tachycardia"}, {"id": "10579985_3_956", "context": "The second is a 29-year-old man with CD in whom nodular sclerosing Hodgkin's lymphoma was diagnosed 3 weeks after infusion with infliximab.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] diagnosed [Subject] a 29-year-old man with CD [Treatment] 3 weeks after infusion with infliximab [Effect] nodular sclerosing Hodgkin's lymphoma"}, {"id": "16317298_6_957", "context": "We suggest discontinuing gemcitabine if radiation recall is observed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] if [Treatment] discontinuing gemcitabine [Effect] radiation recall"}, {"id": "18523232_4_958", "context": "OBJECTIVE: To report the occurrence of acute cytolytic hepatitis in a patient exposed to pulse itraconazole therapy for 24 weeks and provide a concise review of the literature on cases of itraconazole-induced hepatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] exposed to [Subject] a patient [Treatment] pulse itraconazole therapy for 24 weeks [Effect] acute cytolytic hepatitis"}, {"id": "7712052_6_959", "context": "These findings should lead to further study of the role of lithium in the treatment of this symptom complex in patients with PTSD.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Subject] patients with PTSD [Treatment] lithium"}, {"id": "6928097_1_960", "context": "She was placed on adjuvant Adriamycin (doxorubicin) chemotherapy, but 6 months later died of Adriamycin toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] toxicity [Subject] She [Treatment] adjuvant Adriamycin (doxorubicin) chemotherapy [Effect] died of Adriamycin toxicity"}, {"id": "12477460_2_961", "context": "BACKGROUND: Ovarian cancer arising from an endometriotic cyst in a postmenopausal woman under tamoxifen therapy is rare.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] arising [Subject] a postmenopausal woman [Treatment] tamoxifen [Effect] Ovarian cancer"}, {"id": "15368548_1_962", "context": "L-asparaginase-induced pancreatitis is an uncommon but potential lethal complication of the treatment of leukemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] L-asparaginase [Effect] pancreatitis"}, {"id": "21515865_3_963", "context": "An 89-year-old man receiving long-term anticoagulation with warfarin sodium (total weekly dosage of 19 mg) arrived at the anticoagulation clinic for his monthly visit.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] receiving [Subject] An 89-year-old man [Treatment] long-term anticoagulation with warfarin sodium (total weekly dosage of 19 mg)"}, {"id": "12851279_14_964", "context": "Treatment with tifacogin had no effect on all-cause mortality in patients with severe sepsis and high INR.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] effect [Subject] patients with severe sepsis and high INR [Treatment] tifacogin [Effect] mortality"}, {"id": "6572542_1_965", "context": "Although lung specimens were lacking from these three patients, it is suggested that the pulmonary toxicity of CCNU may be dose-related.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] three patients [Treatment] CCNU [Effect] pulmonary toxicity"}, {"id": "11452245_11_966", "context": "Concomitant use of clarithromycin or other potent inhibitors of CYP3A4 with repaglinide may enhance its blood glucose-lowering effect and increase the risk of hypoglycemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] enhance [Treatment] Concomitant use of clarithromycin or other potent inhibitors of CYP3A4 with repaglinide [Effect] blood glucose-lowering effect and increase the risk of hypoglycemia"}, {"id": "1888256_1_967", "context": "Drug-induced fever due to diltiazem.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due to [Treatment] diltiazem [Effect] fever"}]}